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Cryptosporidium parvum subverts the host innate immune
response through manipulation of CRAMP expression during
neonatal infection
W. Guesdon1, T. Pezier1, F. Drouet1, S. Menard2, F. Laurent1 &
S. Lacroix-Lamande1
1Animal Health, UMR1282 Inra-Universite, Nouzilly, France,
2Toxalim, UMR 1331 INRA/INP/UPS, Toulouse, France
Due to the immaturity of their immune system, neonates are highly
sensitive to intestinal infections. During the neonatal period, antimi-
crobial peptide (AMP) expression differs substantially from that of
adults as this is the case for the cathelicidin-related antimicrobial
peptide CRAMP expressed preferentially in the neonatal period while
conversely other AMPs such as Reg3c are expressed later in life.
Among enteric neonatal diseases, Cryptosporidiosis is a zoonotic
disease and is highly prevalent in in young infant less than 5 years
old in underdeveloped country and in neonatal ruminants world-
wide. Cryptosporidium parvum is the etiological agent of this diar-
rheal disease and infects exclusively epithelial cells. Innate immunity
is important to control the acute phase of infection in neonates with
dendritic cells and IFNc playing a major role. Antimicrobial peptides
are important contributors of innate immunity, but the role of
CRAMP, which is elevated in the intestine of neonates has never
been investigated during Cryptosporidiosis so far.
In this work, we used the neonatal murine model of cryptosporid-
iosis and unlike all the other antimicrobial peptides analyzed
CRAMP expression in the intestinal epithelial cells was significantly
reduced during infection. This reduced CRAMP expression is inde-
pendent of IFNg, a cytokine strongly produced during infection but
also Myd88 and gut flora independent. When C. parvum infected
neonatal mice orally received exogenous CRAMP to compensate the
reduced expression of this AMP, the parasitic load of neonates was
significantly decreased. In addition, when free parasites were in
direct contact with CRAMP, this AMP affects the viability of spor-
ozoites, the first free infectious form of this parasite. All together,
these data suggest that C. parvum induces the reduction of CRAMP
expression to escape the anti-parasiticidal effect of CRAMP. The
molecular mechanism by which the parasite subverts epithelial-
derived CRAMP production is currently under investigation.
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Faecalibacterium prausnitzii strain HTF-F and its extracellular
polymeric matrix attenuate clinical parameters in DSS-induced
colitis
O. Rossi1, M. Schwarzer2, T. Hudcovic2, D. Srutkova2, S. Duncan3,
H. Flint3, J. Samsom4, H. Harmsen5 & J. Wells1
1Host-Microbe Interactomics, Wageningen University, Wageningen,
Netherlands, 2Academy of Sciences of the Czech Republic, Prague,
Czech Republic, 3Rowett Institute of Nutrition and Health, University
Aberdeen, Aberdeen, UK, 4Department of Pediatrics, Erasmus Medical
Center, Sophia Children’s Hospital, Rotterdam, Netherlands,
5Department of Medical Microbiology, UMCG, Groningen, Netherlands
Introduction: A decrease in the abundance and biodiversity of intes-
tinal bacteria within the Firmicutes phylum has been associated with
inflammatory bowel disease (IBD). In particular, the anti-inflamma-
tory bacterium Faecalibacterium prausnitzii, member of the Firmi-
cutes phylum and one of the most abundant species in healthy
human colon, is underrepresented in the microbiota of IBD patients.
Method: In this study we investigated the capacity of F. prausnitzii
strain A2-165, the biofilm forming strain HTF-F and the extracellular
polymeric matrix (EPM) isolated from strain HTF-F, to suppress inflam-
mation in the mouse dextran sodium sulphate (DSS) colitis model.
Results: The two F. prausnitzii strains have anti-inflammatory effects
in the DSS colitis model.F. prausnitzii HTF-F is more effective than
A2-165 partly because of the immune-regulating properties of the
EPM. The immunomodulatory effects of the EPM are mediated
through the TLR2-dependent modulation of IL-12 and IL-10 cyto-
kine production in antigen presenting cells. Both F. prausnitzii HTF-
F and the EPM may have a therapeutic use in IBD.
003
Roseburia hominis regulates immunity through TLR-5 dependent
responses
A.M. Patterson, E. Monnais, A.G.P. Coutts, N.H. McKenzie,
E. Logan, M. Delday, I.E. Mulder & G. Grant
Gut Immunology, Life Sciences Innovation Building, Cornhill Road,
Aberdeen, UK
Commensal bacteria play a fundamental role in maintaining immune
homeostasis a complex balance between immune stimulation and appro-
priate responsiveness and immune suppression and tolerance. Break-
down of these immune regulatory processes lead to chronic
inflammation associated with intestinal dysbiosis. The immune modulat-
ing properties of Roseburia hominis, a flagellate gut anaerobe, were
investigated in colonised conventional and colitic mouse models. Oral
administration of Roseburia hominis to conventional mice with colitis
caused by Dextran Sodium Sulphate altered intestinal immune responses,
attenuated gut inflammation and reduced the severity of colitis. This
protection was associated with a modulation and expansion of the T reg-
ulatory cell population triggered by R. hominis. The role of flagellin in
directing these immune responses was investigated in vitro and in vivo.
Part funded by RESAS, Scotland and part funded by GT Biologics.
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A specific tolerance inducing vector for therapeutic treatment of
autoimmune diseases
C. Hansson, K. Sch€on & N. Lycke
Microbiology and Immunology, Gothenburg University, Gothenburg,
Sweden
Introduction: We have developed a novel platform for intranasal treat-
ment of autoimmune diseases in which ADP-ribosylation determines
whether immunity or tolerance is induced. Hence, cholera toxin
A1-subunit based immunomodulation through the CTA1-peptide-DD
fusion protein promotes enhancement, while inactive mutants induce
suppression. Whereas the target population after intranasal administra-
tion of both constructs was CD103+CD11blow DC’s, both active and
inactive mutants induced strong CD4 T cell priming, but they differen-
tially affected CD4 T cell differentiation. This way inactive mutant con-
structs generated regulatory CD4 T-cells producing IL-10 and effectively
preventing experimental autoimmune encephalitis (EAE) and collagen-
induced arthritis (CIA), when carrying relevant peptides. Targeted DCs
expressed low levels of CD80, CD86 and CD40, while, by contrast,
ADP-ribosylating CTA1-peptide-DD constructs gave significantly
enhanced co-stimulation. Suppression was global in that regulatory
T-cells following treatment were able to suppress adoptively transferred
na€ıve CD4 T cells and could subsequently maintain tolerance.
Conclusion: The use of specifically tolerance-inducing fusion pro-
teins may be a way forward in the search of effective treatments
against autoimmune diseases. The immunomodulating effect on the
CD103+CD11blow DCs will be described and the requirement for
CTA1-binding to Gs alpha evaluated in detail, using Cre-lox Gs
alpha-deficient mice.
005
A study on T follicular helper cells (TFH) in human NALT and
effect of CpG-DNA on TFH -mediated antibody production
A. Aljurayyan1, N. Upile2, C. Vaughan2, C. Xie2, R. Sharma2,
H. Beer3, M.S. McCormick3, S. Gordon4 & Q. Zhang1
1Clinical infection, Microbiology and Immunology, Ronald Ross
Building, Liverpool, UK, 2ENT Department, Alder Hey Children’s
Hospital, Liverpool, UK, 3ENT Department, Royal Liverpool University
Hospital, Liverpool, UK, 4Liverpool School of Tropical Medicine,
Liverpool, UK
Background: T Follicular helper cells (TFH) have been identified as
a distinct CD4+ T cell subset and considered important for germinal
centre function and critical for T cell-dependent B cell antibody pro-
duction. Therefore it may be an effective strategy to enhance vaccine
immunogenicity by promoting TFH numbers/function in humans.
Adenotonsillar tissues are nasopharynx-associated lymphoid tissue
(NALT) and important in response to intranasal vaccination.
Aims: We analysed TFH numbers and function in NALT from children
and adults and studied whether and how CpG-DNA promotes TFH
function leading to enhancement of mucosal immunity to influenza.
Methods: Mononuclear cells (MNC) were isolated from adenotonsillar
tissue of children and adults, and TFH number (CD4+/CXCR5+/
ICOS+) and function were analysed by flowcytometry and intracellular
cytokine staining. Purified CXCR5+ TFH were co-cultured with B cells
with/without influenza antigens and CpG-DNA. Haemagglutinin (HA)-
specific antibody production was analysed by ELISA and Elispot assay.
Results: A prominent number of TFH were identified in NALT
which were considerably higher than PBMC, and the mean NALT
TFH number in children was significantly higher than in adults.
NALT TFH were shown to express high levels of IL-21 and that were
important for B cell antibody production. Co-culture of purified
TFH but not non-TFH with B cells promoted antibody production.
Stimulation of adenotonsillar MNC by CpG-DNA significantly
increased TFH number and that was correlated with HA-specific
antibody production following influenza antigen stimulation.
Co-incubation with purified plasmacytoid dendritic cells significantly
enhanced the CpG-DNA-mediated antibody production.
Conclusion: A prominent number of TFH were shown in human
NALT especially in children and that were highly active in B cell-
help for antibody production. CpG-DNA promoted NALT TFH cells
which correlated with the enhancement of HA-specific antibody pro-
duction. To enhance vaccine immunogenicity by promoting TFH
function may be an effective vaccination strategy.
006
A20/TNFAIP3 as a brake on intestinal inflammation and
tumorigenesis
L. Vereecke1, S.V. Silva2, T. Billiet3, J.H. van Es4, C. McGuire1,
K. Slowicka1, M. Sze1, M. van den Born4, G.D. Hertogh5,
H. Clevers4, J. Raes6, P. Rutgeerts3, S. Vermeire3, R. Beyaert1 &
G. van Loo1
1Inflammation Research Centre, Technologiepark 927, Ghent, Belgium,
2Department of Microbiology and Immunology, Rega In, Belgium,
3Department of Clinical and Experimental Medicine, Leuven, Belgium,
4Hubrecht Institute for Developmental Biology and S, Utrecht,
Netherlands, 5Department of Morphology and Molecular Pathology,
Leuven, Belgium, 6Department of Microbiology and Immunology, Rega
In, Leuven, Belgium
Intestinal immune homeostasis is established through complex inter-
action between commensal bacteria, the intestinal epithelium and
mucosal immune cells. A defective interaction between these com-
partments can result in intestinal pathology. A crucial mediator in
establishing this homeostasis is the transcription factor NF-kappaB,
since it regulates multiple protective mechanisms in intestinal epithe-
lial cells (IEC’s), and pro-inflammatory responses in mucosal
immune cells. NF-kappaB activation is tightly controlled by its nega-
tive feedback regulator A20, which in addition has pronounced anti-
apoptotic functions. Genetic studies identified polymorphisms in the
A20 locus associated with multiple inflammatory and auto-immune
pathologies, including coeliac and Crohn’s disease. To investigate the
physiological role of A20 in intestinal immune homeostasis, we gen-
erated tissue specific A20 knockout mice. We found that A20 has
predominant anti-apoptotic functions in IEC’s and predominant
anti-inflammatory functions in myeloid cells. By deleting A20 in
both IEC’s and myeloid cells, we generated a novel mouse model of
intestinal inflammation which is characterized by early Paneth and
goblet cell loss. Older mice suffer from ileitis and severe colitis which
often progresses to colorectal cancer development. These findings
suggest that defects in proper A20 function may contribute to the
development and progression of inflammatory bowel disease and
cancer in humans.
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Ablation of macrophages by prolonged blockade of CSF1R
signalling depletes M-cell differentiation in the intestinal
epithelium
A. Sehgal1, D. Donaldson2, D. Hume2 & N. Mabbott2
1University of Edinburgh, Easter Bush, Midlothian, Edinburgh, UK,
2The Roslin Institute and RDSVS, University of Edinburgh, Easter
Bush, Midlothian, Edinburgh, UK
The gut-associated lymphoid tissue (GALT), including Peyer’s
patches (PPs) and isolated lymphoid follicles lack afferent lymphatics
ª 2014 The Authors. © 2014 John Wiley & Sons Ltd, Immunology, 143 (Suppl. 1), 12–42
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and directly sample mucosal antigens by specialized epithelial cells in
the follicular associated epithelia (FAE), known as microfold (M)
cells. M cell differentiation has been attributed to factors released by
cells within the sub-epithlelium dome of PP but very little is known
about factors within crypts that may affect M cell differentiation. Here
we provide evidence of macrophages in close contact with Paneth
cells in intestinal crypts may play a role in M cell differentiation.
In our study, mice were treated with an anti-CSF1R monoclonal
antibody (M279) for 6 weeks. This led to a complete ablation of
CD68+CD11c+Csf1r-EGFP¬ macrophages in the gut. Our study
demonstrates a loss of M cells and a reduction in antigen uptake
in the FAE of PP of mice. We also found a loss of Paneth cells in
intestinal crypts however we found no expression of CSF1R on Pa-
neth cells indicating this may be due to loss of macrophages in
close contact with intestinal crypts. These data suggest that macro-
phages may have a more intimate relationship with Paneth cells
than previously understood and may control M cell differentiation
within the FAE by providing a scaffold for intestinal crypt prolifer-
ation function.
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Activation and differentiation of human lamina propria (myeloid)
cells during the initiation of intestinal inflammation
J. Gras1, M. Paparella1, B. Brors2, T. Giese1, F. Lasitschka1,
G. Wabnitz1, M. AlSaeedi1, S. Schiessling1, S. Meuer1 &
J. Schr€oder-Braunstein1
1University Hospital Heidelberg, Heidelberg, Germany, 2German
Cancer Research Center, Heidelberg, Germany
Mucosal lamina propria cells of IBD patients are highly activated in
contrast to the hyporesponsive phenotype of these cells under homeo-
static conditions. Given, that human studies are based on patient biop-
sies taken years after disease onset, the molecular events initially
causing this inflammation are still largely unknown. In this study, we
aimed to characterize early activation mechanisms of lamina propria
cells including myeloid cells by utilizing an ex vivo human intestinal
organ culture model which was recently described by us. In this model,
healthy human colonic mucosa was depleted of epithelial cells by
EDTA treatment which resulted in the activation of lamina propria
immune cells and their emigration out of the tissue. Global gene
expression analysis of lamina propria cells obtained by laser-capture
microdissection prior and after loss of the epithelial layer revealed an
induction of myeloid (activation) surface receptors such as CD80,
CD83, CCR7, as well as inflammatory mediators like IL1B, IL-23p19
in lamina propria cells in situ. Upregulation of these markers/media-
tors was confirmed in emigrated HLA-DR+CD11c+CD14- and HLA-
DR+CD11c+CD14+ lamina propria myeloid cells when compared to
peripheral blood myeloid cells by qRT-PCR and/ or flow cytometry. In
addition, bioinformatic analysis of in situ gene expression profiles
revealed the induction of signalling pathways not yet associated with
the activation of lamina propria (myeloid) cells under inflammatory
conditions, e.g. the response to unfolded protein. The upregulation of
known target genes of this pathway such as GADD153, C/EBPa^, and
HSPA5 in the latter cell population was subsequently confirmed in situ
by qRT-PCR and/ or immunofluorescence. These findings provide
insight into molecular events underlying the change from a hypore-
sponsive to a highly activated phenotype in lamina propria (myeloid)
cells at the very onset of inflammation.
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Adjuvants modulate the immune response elicited by oral
vaccination with adenovirus based vectors
J. Revaud1, J. Shaw1, Y. Unterfinger1, J. Maye2, N. Versille2,
B. Klonjkowski1, J. Ben-Arous2 & J. Richardson1
1UMR Virologie, ENVA, Maisons-Alfort, France, 2Seppic, France
Introduction: Oral delivery of vaccines is effective in inducing muco-
sal immunity and thus represents a highly relevant route for improved
vaccines. At present, however, most orally delivered vaccines are live
attenuated vaccines, which present a risk of reversion to virulence.
Vaccines derived from recombinant adenoviruses (rAd) that have
been rendered replication incompetent provide a safer alternative.
Such vaccines elicit potent humoral and cellular immune responses
(IR) after parenteral delivery, but have proven less effective as oral
vaccines, potentially in relation to such factors as insufficient stability
of the vector in the gastro-intestinal environment, sub-optimal pene-
tration of the intestinal barrier, insufficient presentation by antigen-
presenting cells or a local immunological context biased towards
immunological tolerance. It is possible that many of these obstacles
could be overcome by appropriate use of adjuvants.
Objective: The objective of this work was to determine the effect of
several classes of adjuvant on the amplitude and quality of the
immune response after oral administration of rAd.
Method: To this end, a vector derived from a type 5 human adeno-
virus and encoding the reference antigen ovalbumin (ova) was
administered to mice by the intra-gastric route in the presence of
various adjuvants. The humoral IR against ova was evaluated in
serum, feces and vaginal lavage fluids by ELISA. For two adjuvants,
the cellular IR against ova was assessed in spleen, intestine (ileum)
and mesenteric lymph nodes by intracellular cytokine staining and
flow cytometry.
Results: The initial results indicate that the tested adjuvants can
indeed modulate the humoral and cellular IR after oral administra-
tion of rAd, but each in a different manner. It should thus be possi-
ble to modify, both quantitatively and qualitatively, the IR elicited
by orally delivered rAd by using adjuvants. Further work will address
the impact of the different adjuvants at sequential steps involved in
induction of the IR.
010
CCR2 expression defines a functionally distinct population of
conventional DCs in intestinal mucosa
C. Scott1, C. Bain2, P. Wright2, D. Sichien1, M. Guilliams1,
B. Lambrecht1, S. Milling2 & A.M. Mowat2
1Inflammation Research Centre, Ghent, Belgium, 2Institute of Infection,
Immunity and Inflammation, University of Glasgow, Glasgow, UK
The origin and functions of mononuclear phagocytes (MPs) in the
intestine have been a source of confusion for some time, partly
because overlapping markers such as CD11c, CD11b, CX3CR1,
MHC class II and CCR2 have been used to distinguish dendritic cells
(DCs) from macrophages (MFs). While CD103+ intestinal MPs
appear to be genuine DCs, the nature of CD103– MPs remains con-
troversial. By combining phenotypic, gene profiling and kinetic
analysis, we show that CD103–CD11b+ MPs in both the small and
large intestine comprise distinct populations of DCs and MFs.
CD64-CD103-CD11b+ MPs are classical DCs, being derived from
Flt3L-dependent DC-committed precursors, migrating in afferent
lymph, turning over rapidly in vivo and priming na€ıve CD4+ T cells.
In contrast, the CD64+ subset of CD103-CD11b+ MPs is sessile and
avidly phagocytic, derives from Ly6Chi monocytes in a non-Flt3-
dependent manner and turns over slowly in vivo. Surprisingly
however, the monocyte/MF lineage marker CCR2 is expressed by a
ª 2014 The Authors. © 2014 John Wiley & Sons Ltd, Immunology, 143 (Suppl. 1), 12–42
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significant proportion of CD103-CD11b+ DCs and there is a selec-
tive decrease in CD103-CD11b+ DCs in mice lacking this chemokine
receptor. CCR2+CD103- DCs in the LP express IRF4, their presence
is partially dependent on this transcription factor in vivo and they
have a selective ability to drive IL-17a production by T cells both in
vivo and in vitro. Furthermore, an equivalent population of
CCR2+CD103- DCs is present in human intestine Together, these
data highlight the heterogeneity of intestinal MPs and reveal a bona
fide population of CCR2+ conventional DCs, which is involved in
priming mucosal Th17 responses.
011
CCR7 expression of intestinal myeloid cells and their migratory
potential
G. Desalegn1, G.-L. Moschovakis1, A. Schridde1, L. Utrianen2,
S.W. Milling2, R. F€orster1 & O. Pabst1
1Institute of Immunology, Hannover Medical School, Hannover,
Germany, 2Institute of Infection, Immunity and Inflammation,
University of Glasgow, Glasgow, Scotland
CD103+ DCs and CX3CR1+ lamina propria (LP) cells represent
non-overlapping populations with distinct precursors in the small
intestine. Our group suggested that CD103+ DCs but not CX3CR1hi
cells migrate to the mesenteric lymph nodes (mLN) where they
prime na€ıve T cells. We observed that CX3CR1int cells are present
in intestinal lymph but not CX3CR1hi cells (Schulz O et al, 2009).
In contract, recently published data indicated that in microbiota-
depleted mice CX3CR1hi cells become migratory and enter into lym-
phatics and mLN in a CCR7-dependent manner (Diehl GE et al,
2013). We therefore established a novel mouse model to monitor
CCR7 expression and its regulation in vivo. In this mouse model
insertion of GFP disrupts the function of the CCR7 gene. Upon
stimulation, cells from CCR7-GFPki/ki mice up-regulate CCR7/GFP
but are not able to migrate because of the disrupted CCR7. In con-
trast, cells from CCR7-GFPki/wt mice can up-regulate CCR7 and are
capable of migrating to the draining LN. Mice were treated with
antibiotic or left untreated, and gavaged with R848 14 hours prior
to analysis. Whereas intestinal CD103+ and CD103– DCs up-regu-
lated CCR7/GFP after R848 stimulation both in antibiotic treated
and untreated mice, CD64+ macrophages didn’t express CCR7 even
after microbiota depletion. CD11c+MHCII+CD64-CD103- LP cells
expressed the chemokine receptor. Moreover, in CXCR1GFP/+ mice,
CX3CR1int but not CX3CR1hi cells were found in the mLN after
R848 in the antibiotic treated and untreated mice. Thus, CD103+
CX3CR1- and CD103-CXCR1int DCs express CCR7 upon stimula-
tion. In contrast, intestinal macrophages characterized by a
CD64+CX3CR1hi phenotype did not upregulate CCR7 irrespective
of the microbiota status in these mice.
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CD103+DC play a key role in the innate immune mechanisms
protecting the epithelium against neonatal enteric infections
F. Laurent, L. Lantier, S. Lacroix-Lamande, F. Drouet,
W. Guesdon & A. Gnahoui-David
AH, Centre Val de Loire UMR ISP bat 213, Nouzilly, France
Neonates are generally more susceptible than adults to infectious dis-
eases. Their intestinal immune system is in development and subject
to numerous changes after birth, facing the colonization by the
commensal flora, alimentary antigens, and aggression by enteric
pathogens. Cryptosporidium parvum is a highly prevalent zoonotic
protozoan parasite that develops only in the gastrointestinal
epithelium and causes profuse diarrhea that can be life threatening
in very young children and immunocompromised individuals. Neo-
natal mice are highly susceptible to C. parvum but the infection is
self-limited, whereas adult mice are resistant unless immunocompro-
mised. Accumulating evidences obtained with the neonatal mouse
model demonstrate the key role of innate immunity to control the
acute phase of the infection. Conditional depletion of CD11c+ cells
demonstrated their essential role for the control of the infection both
in neonates and adults (1). We therefore investigated the contribu-
tion of CD103+ DC to the age-dependent susceptibility to infection.
We found that neonates presented a marked deficit in CD103+ DC
in the intestinal lamina propria during the first weeks of life and
artificially increasing the number of intestinal CD103+ DC by
administering FLT3-L significantly reduced susceptibility to the
infection. We next identified an unexpected mechanism of recruit-
ment of the CD103+DC during the infection with several transgenic
mouse models. Indeed, rapid recruitment of CD103+DC was
depending on the production of CXCR3-binding chemokines pro-
duced by IEC in response to IFNɣ. In addition to this key role in
CD103+ DC recruitment, IFNɣ is known to inhibit intracellular para-
site development. We demonstrated that during neonatal infection
CD103+ DC produce IL-12 and IFNɣ in the lamina propria and the
draining lymph nodes. Thus, CD103+DC are key players in the
innate immune control of C. parvum infection in the intestinal epi-
thelium. The relative paucity of CD103+ DC in the neonatal intestine
contributes to the high susceptibility to intestinal infection. Our
work makes a substantial increase in the understanding of the role
of immune effectors involved in the control of the acute phase of C.
parvum infection and paves the way to immune modulation strate-
gies (2) targeting intestinal DC for strengthening neonatal immune
system against enteric infections.
(1) Lantier et al. PLoS Pathog. 2013
(2) Lantier et al. J Infect Dis. 2014 KW Dendritic Neonate Innate
Infection
013
CD11b is required for oral tolerance by regulating Treg
frequencies in the small intestine
A. Schridde1 & O. Pabst2
1Institute of Immunology, Carl-Neuberg-Str. 1, Hannover, Germany,
2Institute of Molecular Medicine, Pauwelsstraße 30, Aachen, Germany
Intestinal tolerance requires the activation of FoxP3+ regulatory T
cells (Tregs) in the mesenteric lymph nodes by CD103+ dendritic
cells and their subsequent homing to the intestine. Signalling by resi-
dent CD11b+F4/80+CX3CR1high macrophages present in the intesti-
nal lamina propria leads to further Treg expansion. We have
previously shown that the high expression of CX3CR1 by resident
macrophages is necessary for their expression of IL-10. In CX3CR1-
deficient mice, reduced IL-10 expression leads to a loss in Treg
expansion in the small intestinal lamina propria and hence abrogates
oral tolerance.
Here, we show that signalling via CD11b, in addition to CX3CR1,
is also involved in regulating oral tolerance. Using delayed type
hypersensitivity measurements, we observed that CD11b-deficient
mice failed to establish oral tolerance. To investigate Treg induction
in the mLN and Treg frequencies in the small intestinal lamina pro-
pria in vivo, we performed adoptive transfer experiments in
CD11b-/- mice. Like in CX3CR1-deficient mice, Treg cells were
readily induced in the mesenteric lymph nodes at frequencies com-
parable to wild type mice. Moreover, expression levels of the gut
homing molecules a4b7 and CCR9 were unimpaired. On the con-
trary, Treg frequencies in the lamina propria were reduced in
CD11b-/- mice, possibly explaining the oral tolerance defect.
ª 2014 The Authors. © 2014 John Wiley & Sons Ltd, Immunology, 143 (Suppl. 1), 12–42
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In order to gain a comprehensive picture of the pathways that
might be changed in resident macrophages due to the deficiency of
CD11b and CX3CR1 we carried out complex transcriptome and
cytokine analysis. Based on these studies, we intend to define a pro-
file of intestinal macrophages that is important for their tolerogenic
function. These results in turn will open insights into pathways that
can be targeted for regulating Treg frequencies and oral tolerance
establishment.
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Changes in the pattern of expression of Fatty Acid Binding
Proteins in small intestine in untreated Coeliac Disease
N.B. Arias1, M. Garcia2, C. Bondar2, L. Guzman3, M. Yantorno4,
B. Corsico5 & F. Chirdo2
1LISIN-IIFP, INIBIOLP. UNLP, La Plata, Argentina, 2LISIN-IIFP.
UNLP, La Plata, Argentina, 3Servicio de Gastroenterologia. Hospital de
Ni~nos., La Plata, Argentina, 4Servicio de Gastroenterologia. Hospital
San Martin, La Plata, Argentina, 5INIBIOLP. UNLP, La Plata,
Argentina
Coeliac disease (CD) is an immune-mediated enteropathy that devel-
ops in genetically susceptible individuals following exposure to die-
tary gluten. Fully differentiated epithelial cells express two isoforms
of fatty acid binding proteins (FABPs): intestinal and liver, I- and
LFABP, respectively. I- and LFABPs belong to a family of small cyto-
solic proteins which bind and transport long chain fatty acids, but
also have other important biological roles in signalling pathways,
particularly those related to PPARs which link lipid metabolism and
inflammatory process.
The aim of this work was to analyse the pattern of expression of
I- and LFABP in small intestine in normal tissues and in those from
untreated CD patients as well as the evaluation of IFABP serum lev-
els in CD patients and non-CD controls. Expression of I- and
LFABP in duodenal tissues was assessed by confocal fluorescence
microscopy using specific polyclonal antibodies and by quantitative
PCR. Immunofluorescence analysis showed a differential pattern of
expression for both FABPs when normal tissue and severe enteropa-
thy were compared. I- and LFABP were expressed in the epithelium
in healthy mucosa and in the remaining epithelium in partial or
total villus atrophy. Slight labelling for IFABP was also observed in
the crypts in healthy mucosa. Remarkably, FABPs expression was
clearly increased in the crypts of intestinal mucosa in untreated CD.
Quantitative PCR analysis showed that mRNA levels for LFABP were
higher than those for IFABP in normal tissue. Employing bactin as
housekeeping gene, I- and LFABP mRNA levels were lower in duo-
denal samples from adult untreated CD patients than in healthy con-
trols (P < 0.01). In paediatric population this difference was not
observed. On the other hand, when villin was used as reference, the
levels of both FABPs were increased in enteropathy. Using a com-
mercial quantitative ELISA, we observed that IFABP serum levels
were higher in adult untreated CD patients compared with healthy
controls (P < 0.0001), patients on Gluten free diet (P = 0.023) and
inflammatory bowel disease patients (P < 0.001).
In conclusion, IFABP, which is likely released from the damaged
enterocyte, can be used as a biomarker providing additional infor-
mation in diagnosis and follow up of CD. The marked increase in I-
and LFABP expression in the crypts may reflect an accelerated rate
of enterocyte differentiation as compensatory mechanism due to the
increase in epithelial loss.
015
Characterisation of antigen-specific CD4+ T cells by using MHC
class II tetramers
G. Prota, E. Pettini, G. Pozzi, D. Medaglini & A. Ciabattini
L.A.M.M.B., Dipartimento di Biotecnologie Mediche, Universita di
Siena, Siena, Italy
In the context of vaccination, CD4+ T-cell primary activation can be
considered as an early biomarker of vaccine immunogenicity since it
is required for both the induction of high-affinity antibodies and
immune memory. To this aim, we have here characterized the
Ag-specific CD4+ T cell response following immunization with a
Mycobacterium tuberculosis vaccine antigen plus a liposome-based
adjuvant administered by two different routes (parenteral versus
mucosal). Ag85b-specific MHC class II tetramers were employed for
detecting Ag-specific CD4+ T cells. C57/BL6 mice were primed by
the subcutaneous or nasal route, and the clonal expansion of Ag-spe-
cific CD4+ T-cells was analyzed into respective draining lymph nodes
(LNs) and spleens by using Ag85b280-294 MHC class II tetramers.
Cells were also characterized for the expression of surface markers
and the production of cytokines. Prime-boost experiments, that
combined the nasal and parenteral routes, were also performed and
the cellular, as well as the humoral response were analysed. Tetra-
mer-positive CD4+ T cells were detected into respective draining
LNs with a peak 7-9 days after priming (about 0.12 and 0.3% of
total CD4+ T cells, following nasal and parenteral priming respec-
tively), and declined at day 14. Priming by the SC route induced a
stronger CD4+ T cell clonal expansion respect to the nasal one, and
a higher dissemination towards spleens and lungs. Upon parenteral
immunization about 20% of Ag85b-specific primed CD4+ T cells
were T follicular helper (Tfh) cells (CXCR5+PD1+), and about a
30% Th1 (CXCR3+). CD4+ T cells primed by the parenteral route
were efficiently boosted by nasal as well as parenteral immunization.
Ag85b280-294-MHC class II complexes can be efficiently used for
studying the immunogenicity of a tuberculosis vaccine in the mouse
model, and characterizing the cellular response after both priming
and boosting. Here, we showed that a single parenteral immuniza-
tion with a subunit tuberculosis vaccine induced the expansion of
Ag-specific CD4+ T cells that differentiated mainly into Tfh and
Th1, and that this vaccine formulation primes the immune system
better by the parenteral than the nasal route.
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Characterization of gastric tissue-resident memory CD8+ T cells
from children, adults and the elderly
J. Booth, F.R. Toapanta, R. Salerno-Goncalves, S. Patil,
H.A. Kader, A.M. Safta, S.J. Czinn, B.D. Greenwald & M.B. Sztein
Department of Pediatrics, Medicine and CVD, 685 West Baltimore
Street, Baltimore, USA
The main orchestrators of protective immunity in the stomach are T
cells. However, limited information is available on the presence and
function of the gastric T subsets mostly due to the difficulty in iso-
lating high numbers of viable cells from human gastric biopsies. To
overcome this shortcoming, we optimized a cell isolation method
that yielded high numbers of viable lamina propria mononuclear
cells (LPMC) from gastric biopsies obtained during upper GI endos-
copy . Classic memory T (TM) subsets were identified in gastric
LPMC obtained from children, adults and the elderly using flow
cytometry. A dominant effector memory (TEM) phenotype was
observed in gastric LPMC CD8+ T cells in all age groups. We then
evaluated whether these cells represented a population of gastric tis-
sue-resident memory T (TRM) cells by assessing expression of
CD103 and CD69. The vast majority of gastric LPMC CD8+ T cells
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either co-expressed CD103/CD69 (>70%) or expressed CD103 alone
(~20%). Thus, gastric LPMC CD8+ T cells had the characteristics of
TRM cells. In addition, gastric CD8+ TRM cells produced multiple
cytokines (IFN-c, IL-2, TNF-a, IL-17A, MIP-1b) and up-regulated
CD107a upon stimulation with mitogens. Furthermore, gastric CD8+
TRM demonstrated differences in the frequency, susceptibility to
activation and cytokine/multi-cytokine production profiles among
the age groups. Most notably, children’s gastric CD8+ TRM cells
responded differently to stimuli than gastric CD8+ TRM cells from
adults or the elderly. In conclusion, we demonstrate the presence of
gastric CD8+ TRM which exhibit diverse functional characteristics in
children, adults and the elderly.
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Constitutive Type I Interferon, via STAT1 activation, selectively
promotes regulatory T cell function in the healthy human
intestine, but not in IBD
E. Giles1, T.J. Sanders1, N.E. McCarthy1, I. Sanderson2,
J. Lindsay2, T.T. MacDonald1 & A.J. Stagg1
1Centre for Immunology and Infectious Disease, 4 Newark St, London,
UK, 2Centre for Digestive Diseases, 4 Newark St, London, UK
Background: Control of T-cell reactivity with the human intestinal
mucosa is poorly understood. Type I Interferon (T1IFN) signals via
JAK/STAT, particularly STAT1, and supports Treg function in
mouse models of colitis. T1IFN has been used as a treatment in
IBD. We therefore hypothesised that constitutive T1IFN had a regu-
latory role in human intestinal T cells.
Methods: Endoscopic biopsies or resection specimens were frozen
for immunohistochemistry (IHC) or cultured in the presence of neu-
tralising anti-IFNb or isotope control. Cells were harvested, stimu-
lated with anti-CD3/CD28 antibodies and analysed for cytokine
production by intracellular staining and by multiplex ELISA of cul-
ture supernatants. Phosphorylated STAT1 was measured by flow
cytometry with or without prior T1IFN stimulation. Colonic sections
were stained with ant-IFNb and analysed using fluorescent IHC.
CD3+ T-cells were FACS sorted and expression of Interferon Stimu-
lated Genes (ISGs) and SOCS 1 and 3 determined by q-RT-PCR.
Results: IFNb was detected in the lamina propria of control and
IBD tissue and ISGs (MXA and 250AS) were expressed by intestinal
T cells. In vitro, IFNb neutralisation reduced the frequency of
pSTAT1+ intestinal T cells (n = 6, P = 0.05) and, in healthy con-
trols, decreased the proportion of IL10-producing intestinal T cells
(n = 8, P = 0.01). There was a trend for more IFNc-producers and
IFNc levels in supernatants were significantly increased (n = 10,
P = 0.016). In IBD, intestinal T cells were more responsive to IFNb,
as assessed by ISG induction, (n = 10, P < 0.03) and pSTAT1 was
increased in T-cells isolated from IBD patients (n = 30 IBD, 16 con-
trol, P = 0.03). Concordantly, SOCS1 expression was decreased in
IBD samples compared to controls (n = 8 IBD, 6 control),
P = 0.047). In contrast to controls, neutralisation of IFNb in IBD
samples led to a generalised increase in cytokine production, with an
increase in T cells producing all cytokines examined (IL-10, IFNc,
IL-17 and TNFa, n = 10).
Discussion: T1IFN is present in the human intestinal mucosa and in
health may have a regulatory role via T cell production of IL-10.
There is increased responsiveness of the T1IFN pathway in T cells
from IBD patients, associated with a generalised suppression of cyto-
kine production. Thus, T1IFN effects are context dependant, which
may explain differing clinical effects of therapeutic T1IFN and
potentially responses to other environmental factors.
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CTA1-3M2e-DD; a broadly protective vaccine candidate against
influenza virus
D.G. Eliasson1, K. Schon1, X. Saelens2 & N. Lycke1
1Microbiology and Immunology, Medicinaregatan 7A, Gothenburg,
Sweden, 2VIB-Molecular Biomedical Research, University of Ghent,
Belgium
Few mucosal vaccines have successfully been launched on the market.
This is partly because of the lack of potent mucosal vaccine adjuvants.
We have generated a targeted fusion protein based on the non-toxic
mucosal adjuvant CTA1-DD, harboring tandem repeats of the con-
served matrix protein 2 ectodomain (M2e) of influenza A virus. This
mucosal influenza vaccine candidate, CTA1-3M2e-DD, was found to
confer strong protective immunity against a lethal challenge infection
with live influenza virus in mice. Although anti-M2e IgG antibodies
correlated with protection in Balb/C mice, this correlation was less
prominent in congenic Balb/B mice. These mice exhibited poor resis-
tance to the challenge infection despite comparable anti-M2e IgG
antibody titers. Hence, we hypothesized that CD4 T cell recognition
of the M2e epitope conferred a better level of protection than specific
serum antibody levels alone. Next we analyzed the TCR-repertoire
that recognized M2e and investigated the type of T cell response
induced subsequent to immunization. The CD4 T cell response was
oligoclonal and the recall response to M2e in immunized Balb/C mice
was dominated by IL-17. In addition, vaccinated IL-17 deficient mice
showed reduced survival following live challange, indicating involve-
ment of Th17 M2e-specific CD4 T cells in protection against influ-
enza. The M2e specific T cells were present in low frequencies in
draining lymph nodes, spleen and lung for more than 12 month after
i.n. immunizations and upon re-encounter with antigen they showed
exceptional ability to expand and protect mice from a lethal influenza
dose. Moreover, a significant increase in anti-influenza hemagglutinin
(HA) IgG antibody levels was found in serum subsequent to live chal-
lenge of nude mice that have been reconstituted with memory influ-
enza-specific CD4+ T cells, suggesting that those M2e memory T cells
could provide B cell help to unrelated na€ıve B cells.
The CTA1-3M2e-DD fusion protein is, thus, a highly promising
mucosal vaccine candidate that promotes both antibody and CD4 T
cell M2e-specific immunity, both contributing to protection against
live influenza virus infection. Our study highlights the importance of
CD4 T cells for protection against influenza infections.
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Cyclosporine A treatment of T cells induces apoptosis and
decreases the production of IL-13 in ulcerative colitis
S. Steiner, M. Neurath, R. Atreya & B. Weigmann
Medical Clinic 1, University Clinic Erlangen, Germany
Introduction: Inflammatory bowel disease (IBD) is a chronic inflam-
mation of the digestive tract caused by a dysregulated immune
response. The two major forms of IBD are ulcerative colitis (UC) and
Crohn´s disease (CD). The immunosuppressive drug cyclosporine A
(CsA) is a potential rescue treatment to avoid colectomy in severe ste-
roid-refractory UC patients, whereas CsA treatment has no beneficial
effect in CD patients. The molecular mechanism of action of CsA in
UC is nevertheless incompletely understood. The aim of this study
was to investigate the effect of CsA on a possible modulation of cyto-
kine production and apoptosis induction by peripheral blood mono-
nuclear cells (PBMCs) of controls and patients with UC or CD.
Methods: Human PBMCs were isolated from whole blood samples
and cultured with anti-CD3/CD28 antibodies in the presence or
absence of CsA. Supernatants were taken for analysis of cytokine
production (TNFa, IFNg, TGFb IL-4, IL-5, IL-10, IL-13, IL-17A,
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IL-17F) by ELISA assays. To determine apoptosis induction FACS
analysis for AnnexinV staining and fluorescent stainings for CD4
and TUNEL were performed. Additionally, expression of caspase-8,
Bcl-xL, Bcl-2 and Bax were analysed by qPCR.
Results: It was found that levels of IFNc remained unaffected after
the addition of CsA. In UC patients, levels of IL-13 were significantly
reduced after CsA treatment in vitro, whereas in PBMCs of controls
and CD patients IL-13 production was unaffected by CsA treatment.
Levels of TNFa, IL-10 and IL-17A were significantly reduced after
CsA treatment in PBMCs of all patients groups. TGFb and IL-4 pro-
duction was significantly decreased with addition of CsA in controls,
but was unaltered in UC and CD patients. Controls showed a signifi-
cant reduction of IL-5 and IL-17F production after CsA treatment.
Levels of IL-5 were also significantly decreased in UC patients in the
presence of CsA, whereas levels of IL-17A were significantly reduced
in CD patients. Additionally, cultured CD4+ PBMCs of controls and
UC patients underwent apoptosis which was induced independent of
the mitochondrial apoptosis pathway, but dependent on activated
caspase-8 signalling.
Conclusion: IBD patients, suffering from Th2 associated UC, can be
treated successfully with CsA. This study demonstrates for the first
time that CsA selectively induces apoptosis in CD4+ blood cells of
UC patients in a mitochondrial independent way associated with a
diminished production of the Th2-like cytokine IL-13.
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Deletion of IL-4Ra on Macrophages renders mice resistant to
intestinal inflammation
G. Pickert
Institute of Translational Immunology, Oberezahlbacher strasse 63,
Mainz, 55131, Germany
Background and Aims: The inflammatory bowel diseases (Crohn’s
disease (CD) and ulcerative colitis (UC)) are illness characterized by a
chronic clinical course of relapse and remission associated with self-
destructive inflammation of the gastrointestinal tract. In both UC and
CD, leukocyte infiltration into the intestine is fundamental event in
disease development and progression. Th2 cytokines IL-4 and IL-13
are known susceptibility factors for IBD and induce their biological
functions through a common receptor, the IL-4 receptor alpha chain
(IL-4Ra). We investigated whether activation of interleukin IL-4Ra
systemic and on macrophages determines their effector functions and
mediates intestinal inflammation in experimental mice model.
Methods and Results: We studied the role of IL-4Ra by using the sys-
temic IL-4RaKO and macrophage-specific IL-4RaKO (IL-4RaLysM)
mice in a mouse model of dextran sodium sulphate induced colitis.
Mice were challenged with 2.5% DSS for 14 days to induce colitis.
DSS-treated systemic and macrophage specific IL-4RaKO mice were
resistant and showed protection to DSS-induced intestinal inflamma-
tion compared to WT mice. IL-4RaKO and macrophage-specific IL-
4RaKO (IL-4RaLysM) mice have no/less inflammation, indicating
no/less weight lost and no epithelial erosions compared to WT mice.
Resistance to DSS-induced inflammation in IL-4RaKO/IL-4RaLysM
mice correlated with reduced numbers of inflammatory cells like F4/
80 and Neutrophils in the colonic mucosa and showing well-struc-
tured epithelial cell layer without any damage.
Conclusions: IL-4Ra plays an important role in inflammatory bowel
disease. Deficiency of IL-4Ra systemic and macrophage-specific IL-
4RaLysM mice reduces intestinal inflammation in a mouse model of
DSS induced colitis. Decreased inflammation is accompanied by lack
of proinflammatory immune response.
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Depletion of regulatory T cells in the APCmin/+ mouse model of
colon cancer enhances T cell recruitment and Th1 associated
responses
P. Akeus1, V. Langenes1, A. von Mentzer1, T. Sparwasser2,
S. Raghavan1 & M. Quiding-Ja¨rbrink1
1Microbiology and Immunology, Box 435, G€oteborg, Sweden, 2Institute
for Infection Biology, TWINCORE, Hannover, Germany
Regulatory T cells (Treg) are important to prevent autoimmunity,
microbial driven inflammation and allergy. In colorectal cancer,
Treg infiltration is associated with a better patient outcome, in
contrast to most other tumors. We have previously demonstrated
that Treg from cancer patients profoundly reduce transendothelial
migration of conventional T cells. To evaluate if Treg also affect
lymphocyte infiltration into intestinal tumors, we have used APC-
min/+ mice that spontaneously develop intestinal tumors due to a
mutation in the APC tumor suppressor gene. The frequencies of
FoxP3+ putative Treg, CD4+, and CD8+ T cells were determined
by flow cytometry and immunoflorescence and these analyses
revealed an accumulation of Treg and a decrease of conventional
T cells in the tumors. To evaluate if Treg actively inhibit lympho-
cyte migration into tumors, APCmin/+ mice were crossed with
DEREG mice, in which Treg can be selectively depleted with
diphteria toxin. Short term Treg depletion in tumor-bearing mice
resulted in increased frequencies of conventional T cells in the
tumors, and an increased frequency of proliferating (Ki67+) T
cells, suggesting that the increased T cell frequencies may at least
partly result from increased local proliferation in the tumors. Treg
depletion also resulted in a strong up-regulation of mRNA for the
Th1 associated chemokines CXCL9 (P < 0.01) and CXCL10
(P < 0.001) specifically in the tumors. In parallel, expression of
the corresponding chemokine receptor CXCR3 was increased on
conventional T cells migrating into the tumors after Treg deple-
tion. Depletion of Treg also resulted in increased T cell produc-
tion of IL-17 and IFN-gamma in the tumors. In conclusion, Treg
depletion results in increased accumulation of conventional T
cells, especially Th1 associated CXCR3+ T cells, in intestinal
tumors and targeting of Treg as an anti-tumor immunotherapy
may thus improve not only effector functions of activated T cells,
but also their recruitment to tumors.
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Dissecting the role of intestinal epithelial barrier in the
pathogenesis of ulcerative colitis
I. Dotti1, N. Planell1, R. Mora-Buch1, P. Jung2, E. Batlle2, J. Panes1
& A. Salas1
1IDIBAPS, Rossello 149-153, Barcelona, Spain, 2IRB, Baldiri Reixac 10,
Barcelona, Spain
Ulcerative colitis (UC) is a chronic inflammatory bowel disease
(IBD) of unknown aetiology. Alterations in the colonic epithelial
barrier contribute to the onset of UC. However, little data is avail-
able about the primary role of epithelial cell (EC) dysfunction in this
disease. Recently, a novel cell-culture system has been established to
study gastrointestinal EC physiopathology.
Using this approach we aim to investigate whether a primary
defect in intestinal EC function is present in UC patients that could
drive the development of an inflammatory response.
To this end, we collected biopsies from the sigmoid colons of 6
UC patients and 4 non-IBD controls. Isolated crypts were cultured
and stem EC were expanded in Matrigel as “organoids”. Total RNA
from stem and differentiated organoids was extracted for transcrip-
tional analysis.
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Our results show that control and UC organoids follow common
differentiation programs with comparable downregulation of stem
and proliferation markers (i.e., Lgr5, Ki67) and upregulation of EC
differentiation markers (i.e., MUC2, ANPEP, ChrA). However, statis-
tical analysis of microarrays revealed more than 800 genes differen-
tially expressed between control and UC organoids, with cellular
movement and development, lipid metabolism, and molecule trans-
port the most significantly altered cellular functions.
In the present study the organoid culture model has been success-
fully used to detect intrinsic differences in the epithelium of UC
patients. Validation experiments are ongoing to confirm our results
in an independent cohort of patients and to dissect the functional
meaning of such alterations.
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Early maternal separation induced commensal e. coli
overgrowth triggering visceral sensitivity and specific humoral
response in adult mice
A. Riba, M. Olier, C. Lencina, V. Bacquie, C. Harkat, M. Gillet,
C. Salvador-Cartier, M. Baron, C. Sommer, V. Mallet,
V. Theodorou & S. Menard
INRA, ToxAlim, 180 Chemin de Tournefeuille, Toulouse, France
Small Intestinal Bacteria Overgrowth (SIBO) in favor of Enterobacte-
riaceae is highly associated to Irritable Bowel Syndrome (IBS) a
functional gastrointestinal pathology where a specific humoral
response toward bacterial antigens has been observed. Symptoms of
IBS and SIBO are similar consisting in abdominal pain, bloating and
altered stool forms. Further, IBS symptoms can be generated and/or
exacerbated by early life stressful events. In this study, using the well
described rodent model of IBS: maternal separation, we developed a
mouse model of SIBO and studied its consequences on IBS symptom
and on humoral response toward microbiota.
MS increased visceral sensitivity and induced ileal and fecal over-
growth of E. coli in adult female mice. This overgrowth was associ-
ated with a decrease of fecal lysozyme antimicrobial activity and
increase of anti-E. coli IgG and IgA. In order to decipher whether or
not those alterations were a consequence of E. coli overgrowth, adult
mice were force fed daily with 109 commensal E.coli for 15 days. E.
coli gavage reproduced ileal and fecal overgrowth as well as visceral
hypersensitivity and increased anti-E. coli IgG and IgA. However, E.
coli gavage didn’t decrease lysozyme antimicrobial activity in feces
suggesting that lysozyme defect is a consequence of MS that can par-
ticipate to the E. coli overgrowth.
This study shows for the first time that (i) maternal separation in
mice weakened intestinal antimicrobial defense that might result to
intestinal E. coli overgrowth and (ii) intestinal E. coli overgrowth
was responsible for visceral hypersensitivity and systemic humoral
response toward microbiota.
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Early maternal separation leads to abnormal immune response
against commensal microbita in adult mice
A. RIiba, C. Lencina, V. Bacquie, C. Harkat, M. Gillet,
C. Cartier-Salvador, M. Baron, C. Sommer, V. Mallet, M. Olier,
V. Theodorou & S. Menard
INRA, ToxAlim, 180 Chemin de Tournefeuille, Toulouse, France
Neonatal period is characterized by immature intestinal epithelium
and immune system. Occurrence of adverse events during this per-
iod induces long lasting alterations of intestinal homeostasis associ-
ated with susceptibility to develop gastrointestinal disorders at
adulthood. To characterize the adverse effect of early stress on
immune system development, we analyzed the consequences of
maternal separation (MS) in mice on intestinal barrier functions and
systemic immune response toward microbiota.
In 50-days old male mice, MS increased intestinal permeability to
FITC-Dextran-4 kDa and visceral sensitivity. MS decreased fecal
lysozyme activity, IgA concentration and ILC3 population. This
breach in mucosal barrier function was associated with a systemic
IgG response against E. coli. Furthermore, MS increased anti CD3/
CD28-induced IFNc and IL10 secretion in splenocytes. These results
are in accordance with an increase of CD4+CD44highCD62Llow
active T cells and decreased CD4+CD25+Foxp3+ regulatory T cells.
Furthermore, MS decreased CD40 expression in CD11c+ and
CD11b+ leading to decrease of IL10 and TGFb secretion without
any modification of IFNc on E. coli-stimulated splenocytes suggest-
ing a defect of antigenic presentation. No modification (quantitative
nor qualitative) of fecal E. coli population was observed at 50 days
in MS mice.
For the first time, we demonstrated that early stressful events
impaired intestinal barrier functions leading to an exacerbated
humoral response toward microbiota. Inflammatory T cell response
was increased in MS mice but dampened by an antigenic presenta-
tion defect. Adult mice experiencing early stressful events mimic
common symptoms of gastrointestinal disorders and might by an
important factor in those pathologies.
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Early steps to explore mucosal immune components in a marine
vertebrate
W. E.-D. Aquino1, A. Olvera-Ramirez2 & K. Acevedo-Whitehouse1
1Unidad de Microbiologıa, FCN, UAQ, Queretaro, Mexico, 2Facultad
de Ciencias Naturales, UAQ, Mexico
Maturation of the mucosal immune system is influenced by the
environment, behavior and feeding, and, in carnivores and primates,
the first 12 months of life are critical for its proper development.
Regrettably, despite being the frontline for defense, little is known
about mucosal immunity of free-living mammals, and even less is
known about its ontogeny and ecological constraints. In this context,
we have used the California sea lion, a long-lived, sexually-dimor-
phic, amphibious top predator with well-characterized life stages, in
an attempt to understand the early development of mucosal immu-
nity and to investigate the contribution of ontogenic and energetic
traits on expression of mucosal immune components. At Granito
Island (Gulf of California), we collected rectal, genital, nasal and oral
swabs from 2-, 5- and 12-month old pups. Body condition and vari-
ous health parameters were determined for all. SDS-PAGE gels were
run on extracted proteins to characterize the profile of each mucosa.
Distinct band patterns were evident between mucosal types and
between age classes. Genital mucosa proteins differed between sexes
(F = 46.32, gdl= 41, P < 0.001), specially at 5-months of age. For all
stages of development, the anal mucosa showed the great diversity of
proteins (~100) and widest molecular range. Some bands were only
found at 2- and 12-month old pups (84 and 26 kDa, respectively).
Protein sequencing and immunodetection techniques will now allow
us to characterize the proteins, identify those with immune function,
and explore their ontogenic and energetic constraints.
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Effect of “acid protect” supplementation on the volatile faecal
metabolome of thoroughbred racehorses
N. Larkins1, C.J. Proudman2, J. Travers3, C.J. Probert3 &
K. Koare1
1Nutritional Laboratories, Monmouth, UK, 2School of Veterinary
Medicine, University of Surrey, Gulidford, Surrey, UK, 3Department of
Gastroenterology
The importance of the intestinal microbiome to mammalian health
is now widely recognised. Intestinal bacterial communities not only
contribute to digestion of food material but are important partners
in host-microbial co-metabolism. Studies in laboratory animals and
in humans have demonstrated profound effects of altered gut micro-
bial communities on many facets of mammalian health including
immunity, behaviour, heart disease and obesity. As a hindgut fer-
menter the horse is likely to be even more reliant upon its intestinal
microbiome than many other species. Faeces are easily sampled from
horses and offer a diagnostic window into the structure and function
of gut microbial communities. The volatile faecal metabolome, not
previously investigated in the horse, may offer opportunities for
monitoring equine intestinal health.
The aim of this study was to identify changes in faecal volatile
metabolome in Thoroughbred racehorses after supplementation with
Acid Protect
The study population of 8 Tb racehorse was selected using the
following criteria:
* Male and castrated
* Over 2 years of age
* In race training
* Healthy at the beginning of sampling
* No medication administered in previous 3 months
Fresh faecal samples were collected prior to exercise and frozen at
-80C prior to analysis. After the first two faecal samples were col-
lected horses received dietary supplementation with 75 g (tid) for
14 days.
Samples were thawed, warmed in a water bath to 38 C for
20 minutes, and volatile organic compounds (VOCs) adsorbed onto
a solid phase adsorption fibre for 30 minutes. VOC chromatograms
for each faecal sample were obtained by thermal desorption from the
fibre followed by separation by gas chromatography and identifica-
tion by mass spectrometry (GC-MS). Chromatograms were inter-
preted by both manual and automated readings to identify and
quantify VOCs present.
Conclusions:
* We have demonstrated the potential utility of faecal VOC analy-
sis by GC-MS for characterisation of the intestinal metabolic envi-
ronment.
* We demonstrate repeatable VOC profiles from similarly man-
aged horses.
* Our analysis can detect small shifts in VOC profile possibly
associated with dietary supplementation.
* Increase in butanoic acid in post-supplementation samples is of
particular interest as this compound is associated with enterocyte
health.
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Effect of six strains of probiotics on the integrity of a model of
intestinal epithelial monolayer
B. Martınez-Abad1, E. Montalvillo1, C. Escudero-Hernandez1,
J.A. Garrote2 & E. Arranz1
1Pediatris & Immunology, C/Ramon y Cajal 7, Valladolid, Spain,
2Genetics Lab. Hospital U. Rio-Hortega, Dulzaina 2, Valladolid, Spain
Enterocytes represent 80% of cells constituting the intestinal epithe-
lium. These cells act like a barrier and contribute to the local
immune responses by secreting several soluble factors. Under inflam-
matory conditions, the number of non-polarized enterocyte stem
cells increases due to the stimulation of the cell renewal process.
In this context, we proposed to analyse the effects of certain pro-
biotic bacteria using an intestinal epithelial culture model, Caco-2
cells. These cells were culture for 7 days (non-polarized and undif-
ferentiated cells) and for 21 days (polarized and differentiated cells)
and stimulated with probiotics at different concentrations. We analy-
sed the changes on chemokine expression, trans-epithelial electrical
resistance (TEER), distribution of zonula occludens (ZO)-1 by
immunofluorescence, and the bacterial capacity of adherence. We
found that non-polarized Caco-2 cells were more sensitive to bacte-
rial stimuli than fully polarized Caco-2 cells in chemokine expres-
sion. Moreover, the probiotic with the higher effect on chemokine
expression on non-polarized Caco-2 cells triggered an increase in the
monolayer’s TEER, in agreement with the fact that a slight increase
in pro-inflammatory response could reinforce the epithelial mono-
layer. We cannot confirm a relationship between the distribution of
ZO-1 and TEER´s increase, however we observed some membrane
changes in bacteria-stimulated Caco-2 cells. At the highest concen-
tration, some probiotics induced damage to the epithelial mono-
layer.
In summary, there are probiotics with no effect on the expression
of pro-inflammatory chemokines and these could be useful in the
maintenance of intestinal homeostasis, whereas others may have a
role to prevent damage to the epithelial monolayer.
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Effects of selective PI3Kd inhibitors on activation and
downstream signalling in T cells
K. Bj€orhall, S.R. Blomqvist, L. Yrlid, M. Gustavsson, M. Uddin,
N. Holden & K. Karabelas
AstraZeneca RIA iMED, Pepparedsleden 1, M€olndal, Sweden
The Class I phoshoinositide-3-kinase delta (PI3Kd) isoform regulates
essential immune functions in a wide variety of cells, including leu-
kocytes. Its importance in inflammation signalling, particularly in B
and T cells, has stimulated the clinical development of selective
PI3Kd inhibitors. As Th2-driven allergic airway inflammation plays
an important role in the pathogenesis of asthma, our aims was to
evaluate the effects of a selective PI3Kd inhibitor on T cell activation
in an ovalbumin (OVA)/ anti-CD3-induced airway inflammation
model in transgenic OT.2 mice in vivo.
We have developed highly selective PI3Kd inhibitors that block
the release of IL-5 in human PBMCs and IL-17 by human Th17
cells, in a concentration-dependent manner in vitro. To elucidate the
pharmacodynamic effects of our PI3Kd inhibitors on effector/mem-
ory T helper cells in the lung, we used OVA specific, MHC class II
restricted ab T-cell receptor (TCR) OT.2 transgenic mice. Upon
local OVA provocation challenge, T-cells were activated and
recruited into the lungs. Five days later, the OT.2 mice were given
an intranasal (i.n.) anti-CD3 challenge and the downstream effects
on PI3K signalling were measured through phosphorylation of S6
ribosomal protein (pS6RPSer235/236), cytokine release and T cell
activation markers (CD62L, CD69 and CD25) in the absence and
presence of a selective PI3Kd inhibitor.
We found that pS6RPSer235/236 were significantly downregulated
in CD4+T cells by our PI3Kd inhibitors 6 h after anti-CD3 challenge
(P < 0.002). However, no significant effects on activation markers
(CD62L, CD69 and CD25) on CD4+ T cells or on cytokine levels in
bronchoalveolar lavage fluid were observed at the same time-
point.The mechanism underlaying this dissociation in unclear.
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Our results show that S6RP is phosphorylated at Ser235/236 in
CD4+ T cells after anti-CD3 challenge and that this phosphorylation
is inhibited by selective PI3Kd inhibitors. We therefore conclude that
pS6RPSer235/236 can be used as a target engagement marker reflect-
ing PI3Kd activity in this in vivo model.
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Epithelial IL-1R2 acts as a homeostatic regulator of
inflammatory signals during remission of ulcerative colitis
R. Mora-Buch1, I. Dotti1, N. Planell1, E. Calderon-Gomez1,
P. Jung2, M.C. Masamunt1, E. Batlle2, J. Panes3 & A. Salas1
1IDIBAPS, Rossello 153, Barcelona, Spain, 2IRB, Baldiri Reixac 10,
Barcelona, Spain, 3Hospital Clınic de Barcelona, Villarroel 170,
Barcelona, Spain
Ulcerative colitis (UC) is a chronic colonic disease that presents peri-
ods of active inflammation followed by periods of remission. We
focused on indentifying regulatory mechanisms that favor intestinal
homeostasis during disease remission. A total of 180 UC patients
(UC active or remission) and 55 healthy non-IBD controls partici-
pated in the study. Using real-time PCR and ELISA of culture super-
natants from colon biopsies, we found that the interleukin-1 (IL-1)
decoy receptor gene (IL1R2) and secreted protein (IL-1sR2) were
significantly (P < 0.05) up-regulated during UC remission compared
to UC active and control mucosa. In contrast, the IL-1 receptor
antagonist (IL-1Ra), together with IL-1b, IL-1 receptor type 1 (IL-
1R1) and IL-1 receptor accessory protein (IL-1RAcP), were overex-
pressed in UC active mucosa. Immunostaining identified both lam-
ina propria IgA+ cells and adjacent mucosal epithelium as IL-1R2+.
Nevertheless, we found by intracellular flow cytometry staining
of digested biopsies that epithelial cells were the cellular source
responsible for the upregulation of IL-1R2 during UC remission.
Culturing whole colonic crypts or epithelial stem cells, we demon-
strated that IL-1R2 is negatively regulated by wnt/beta-catenin sig-
naling, and is therefore up-regulated during epithelial cell
differentiation. Importantly, IL-1R2 produced by isolated colonic
crypts of UC patients in remission, but not controls, reduced IL-8
induced by exogenous IL-1b. Furthermore, expression of the IL1R2
in the remitting mucosa could be a predictive molecule of UC
relapse during a 1-year follow-up. In summary, we hypothesize that
IL-1R2 represents a homeostatic molecule, whose increased expres-
sion during remission may represent an endogenous mechanism that
could dampen local inflammation and prevent disease relapse.
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Essential role of Dectin-1 in intestinal M cell-mediated reverse
transcytosis of SIgA-antigen complexes
N. Rochereau1, D. Drocourt2, E. Perouzel2, V. Pavot3,
P. Redelinghuys4, G.D. Brown4, X. Roblin1, B. Verrier5,
C. Genin1, B. Corthesy6 & S. Paul1
1Jean Monnet University, 15 rue Ambroise Pare, St-etienne, France,
2Cayla-InvivoGen, Toulouse, France, 3Institut de Biologie et Chimie des
Proteines, Lyon, France, 4University of Aberdeen, Aberdeen, UK,
5Institut de Biologie et Chimie des Proteines, Lyon, France, 6R&D
Laboratory of the Division of Immunology, Lausanne, Switzerland
Intestinal microfold (M) cells possess a high transcytosis capacity and
are able to transport a broad range of materials including particulate
antigens, soluble macromolecules and pathogens from the intestinal
lumen to inductive sites of the mucosal immune system. M cells are
also the primary pathway for delivery of secretory IgA (SIgA) to the
gut-associated lymphoid tissue. However, although the consequences
of SIgA uptake by M cells are now well known and described, the
mechanisms whereby SIgA is selectively bound and taken up remain
poorly understood. Here we first demonstrate that both the Ca1
region and glycosylation, more particularly sialic acid residues, are
involved in M cell-mediated reverse transcytosis. Second, we found
that SIgA is taken up by M cells via the Dectin-1 receptor, with the
possible involvement of Siglec-5 acting as a co-receptor. Third, we
establish that transcytosed SIgA is taken up by mucosal CX3CR1+
dendritic cells (DCs) via the DC-SIGN receptor. Fourth, we show that
mucosal and systemic antibody responses against the HIV p24-SIgA
complexes administered orally is strictly dependent on the expression
of Dectin-1. Having deciphered the mechanisms leading to specific
targeting of SIgA-based Ag complexes paves the way to the use of such
a vehicle for mucosal vaccination against various infectious diseases.
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Evaluation of immunogenicity and protective efficacy of Type III
Secretion System proteins of enteropathogenic bacteria
B. Jneid, M. Leonetti, P. Lamourette, K. Moreau,
M. Plaisance, A. Savatier, C. Creminon & S. Simon
CEA Saclay, IBITEC-S, SPI, LERI, Gif-sur-Yvette, France
Diarrheal diseases caused by bacterial pathogens e.g. Escherichia coli,
Salmonella enterica, Shigella flexneri, etc, remain a major public
health problem in developing countries, that contribute to the high
mortality rate, especially for children younger than 5 years [1]. These
bacteria have evolved an of molecules that are mostly secreted by
dedicated Type III Secretion System (T3SS). Part of the T3SS forms
an extracellular needle and syringe necessary to inject effector pro-
teins in the host cell, subverting normal cellular functions and caus-
ing enteric infections [2, 3]. In contrast to the large diversity
observed among the effectors proteins [4], the structural proteins
that compose the injectisome (OM ring, needle and needle tip) are
relatively conserved among the various pathogenic bacteria. Because
these proteins are required for pathogenesis and share similarities in
all virulent enteropathogenic bacteria, they are ideal candidate anti-
gens for a subunit-based, broad-spectrum vaccine. We will examine
the immunogenicity and protective efficacy of the different structural
proteins: needle proteins PrgI/MxiH/EscF, needle tip proteins SipD/
IpaD/EspA and OM ring proteins InvG/MxiD/EscC of S. enterica, S.
flexneri and E. coli respectively, alone or combined, in a mouse
model of infection. Keywords: Enteropathogenic bacteria, Type III
Secretion System, immunogenicity, vaccine.
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Follicle homing antigen presenting cells modulate TH2 bias
B. Barry, D.S. Donaldson & N.A. Mabbott
The Roslin Institute, The Roslin Institute Building, Edinburgh, UK
The expression of the chemokine receptor CXCR5 by dendritic cells
and their homing to B-cell follicles are suggested requirements for the
generation of T-helper type 2 (TH2) cells in response to infection. Pre-
vious studies revealed that bone marrow chimeric mice deficient in
CXCR5 in dendritic cells or CD4+ T-cells impaired the development of
both T-follicular helper (TFH) or TH2 cells after infection with Heligmo-
somoides polygyrus (Leon, Ballesteros-Tato et al. 2012). Using a refined
Cre/LoxP conditional gene expression model we have generated a spe-
cific CD11c-mediated CXCR5 knockout transgenic mouse on a C57Bl/
6 genetic background. Characterisation of this model has revealed that
CD11c+ cells are capable of trafficking to and are restricted within T-
cell regions of lymph nodes & spleen, and are unable to traffic into the
B-cell follicle. Infection with the gastrointestinal nematode Trichuris
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muris stimulates a TH2 dominated response in resistant mouse strains
such as C57Bl/6 with worm clearance occuring within 21 days. Mouse
strains susceptible to T. muris infection display a TH1 dominated
response and remain persistently infected. We investigated the ability
of CD11c-CXCR5-/- mice to mount an appropriate TH2 response to
T. muris infection to facilitate clearance. Unlike CXCR5 fl control
mice, CD11c-CXCR5-/- mice were unable to clear T. murisinfection
after 30 days. Gene expression analysis of cytokine responses in the
mesenteric lymph nodes of T. muris-infected mice revealed increased
IFNG, IL1B, IL2, IL6, IL10 and reduced IL4, IL9 and IL25 mRNA
expression in CD11c-CXCR5-/- mice compared to CXCR5 fl control
mice. These alterations in cytokine expression were associated with
increased expression of both IL-12 receptor beta subunits, IL12RB1
and IL12RB2, and the co-stimulatory molecules CD80 and CD86. We
have demonstrated that CXCR5 deficiency in CD11c+ cells alters the
ability to form a coherent TH2 type response to T. murisinfection, pre-
venting worm clearance. These data confirm that for the efficient for-
mation of a TH2 response to infection with intestinal nematodes,
CD11c+ cells are required to localise to the B-cell follicle via expression
of the chemokine receptor CXCR5. Leon, B., A. Ballesteros-Tato, et al.
(2012). “Regulation of TH2 development by CXCR5+ dendritic cells
and lymphotoxin-expressing B cells.” Nat Immunol 13(7): 681-690.
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Fossil fuel derived ambient particulate matter (pm10) induces
multiple pathways of activation in human dendritic cells (dc)
W. Martha, N. Mushtaq, M.N. E, W. Abigail, B. Rossa,
J. Sanders Theodore, M. Grigg Jonathan & A.J. Stagg
The Blizard Institute, Queen Mary, University of London, London, UK
Fossil fuel derived particulate matter (PM) is present within airway
myeloid cells of individuals exposed to pollution and is linked with
respiratory and systemic inflammatory disease. We hypothesize that
exposure of airway DC to fossil fuel PM enhances their ability to
induce inflammatory responses. Therefore, we examined the effects
of urban ambient PM of <10 µm (PM10) on human monocyte
derived DC (MoDC) and on ex vivo respiratory tract DC (RT-DC)
FACS sorted from induced sputum. DC phenotype was assessed by
flow cytometry and qRT-PCR; stimulatory capacity determined in a
mixed leukocyte reaction.
Like the TLR4 agonist LPS, PM10 induced ‘classical’ DC activa-
tion by dose-dependent up-regulation of MHC class II, CD40, CD86
and CCR7 as well as the production of IL-6 and IL-12p70. In accor-
dance with their mature phenotype, PM10 treated DC were more
stimulatory for naive CD4+ T cells. In contrast to LPS, PM10 also
induced the release of cytokines associated with inflammasome acti-
vation (IL-1b and IL-18) and IL-23. PM10 stimulation, but not LPS,
additionally induced aryl hydrocarbon receptor (AhR) signalling in
MoDC as indicated by AhR-dependent induction of the target gene
CYP1A1. PM10 also induced CYP1A1 in ex vivo RT-DC. Carbon
black particles, representing the particulate core of PM, did not acti-
vate DC indicating a critical role for other components.
Thus, fossil fuel derived PM10 induce a complex programme of
DC activation that includes classical maturation, inflammasome-
dependent cytokines and AhR signalling. How these pathways inter-
act to influence DC function and immune regulation in the human
airway is under investigation.
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Gut microbial antigen specific CD4+T cells from Crohn’s Disease
patients exhibit a pro-inflammatory Th17 phenotype
E. Caldero´n-Go´mez1, H. Bassolas-Molina1, R. Mora-Buch1,
I. Dotti1, R. Cabezon*, S. Singh2, J. Panes3, D. Benıtez-Ribas4 &
A. Salas1
1IDIBAPS, Rossello 149-153, Barcelona, Spain, 2Prometheus
Therapeutics and Diagnostics, San Diego, USA, 3Hospital Clınic
CIBERehd, Villarroel 170, Barcelona, Spain, 4CIBERehd, Rossello
149-153, Barcelona, Spain
Experimental models have led to the theory that chronic inflamma-
tion, as seen in Crohn’s disease (CD), results from a loss of tolerance
towards commensal microbiota. In fact, antibodies specific for
microbial components are found in 50% of CD patients, indicating
that a memory T-cell response might be generated as well. There is
yet little evidence, however, in human disease proving the later. In
testing reactivity to several gut microbial antigens in peripheral
blood, we have detected T-cell responses towards antigens including
FlaX, Fla2 and YidX in both healthy individuals and CD patients.
Interestingly, the proliferative response was significantly higher
among CD patients compared to controls, which also correlated with
an increased production of IFN-gamma and IL-17 as assessed by
ELISA. Intracellular cytokine staining showed the presence of Th17,
Th1 and Th17/Th1 cells among the FlaX, Fla2 and YidX-specific T-
cell populations, whose frequency was higher in CD. Furthermore,
real time-PCR analysis of RORc, IL-17A and IL-17F expression on
sorted FlaX, Fla2 and YidX-specific CD4+T cells revealed a clear bias
towards a pathogenic Th17 phenotype only in CD patients’ T
cells, but not in T cells from healthy controls. Thus, our data indi-
cate that T cells that react to the same gut microbial antigen have
been differently imprinted with a pro-inflammatory phenotype dur-
ing CD. We hypothesize that these circulating memory T cells may
contribute to sustain gut inflammation in CD upon antigen re-
encounter; their identification opens new avenues for antigen-direc-
ted therapies in CD.
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High fat feeding alters gut microbiota and protects mice from
colitis and colitis-associated colorectal cancer
S. Melgar1, C. O’Mahony1, S. Clarke1, G. Hurley1, A. Gavin1,
A. Quinlan1, A. Houston1, A. Mahmoud2, M. Bennett2, P. Cotter1
& F. Shanahan1
1Alimentary Pharmabiotic Centre, Cork, Ireland, 2Cork University
Hospital, Cork, Ireland
Inflammatory Bowel Disease (IBD) appears to be triggered by envi-
ronmental factors (e.g. diet, microbiota composition) leading to dys-
regulated immune responses in genetically susceptible individuals.
To date, studies exploring the cross-interaction between diet,
immune responses and microbiota in the pathology of IBD are lim-
ited. A recent study reported that a diet based on milk derived fat
led to the expansion of a specific pathobiont resulting in worsened
colitis in IL-10-/- mice. In this study, we examined the temporal
relationship between diet, the gut microbiota and immune responses
in experimental models of Colitis and Colitis-associated Cancer
(CAC). Mice were fed lard-based high fat diet (HFD-45%Kcal) or
low fat diet (LFD-10%Kcal), followed by AOM injection and 3x
DSS-cycles [(1.5%DSS-5 days & water-14 days), CAC-model] or
3xDSS-cycles (Colitis-model). HFD-feeding protected mice from
developing colitis and CAC as demonstrated by reduced tumour
incidence and numbers, improved colon length, body weight, and
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histological scores and reduced plasma and colonic/tumor inflamma-
tory mediators. Mice with Colitis and CAC fed with HFD presented
an improved microbial diversity, associated with a reduction in Pro-
teobacteria and an increase in Firmicutes and Verrucomicrobia com-
pared to their LFD-fed counterparts. Collectively and contrary to the
previous report using a milk fat based diet, we show that lard-based
HFD alters the gut microbial populations protecting against colitis
and reducing the risk for CAC. The data highlights a far more com-
plex regulation of lard-based HFD on microbiota composition and
host immune responses warranting further investigations on lard-
components and other diets as triggers IBD and CAC pathology.
Coliti-associated cancer; high fat diet; microbiota; colitis
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Histone acetylase inhibitors induce caspase-1 independent IL-1b
secretion
D. Stammler1, E. Tatjana1, M. Sarah2, J.-S. Frick2, A. Dalpke1,
K. Heeg1 & K.A. Bode1
1Department of Infectious Diseases -Med. Microbiol, Im Neuenheimer
Feld 324, Heidelberg, Germany, 2Institute of Medical Microbiology Uni.
T€ubingen, Elfriede-Aulhorn-Str. 6, T€ubingen, Germany
In the course of the last years evidence has accumulated showing that
histone deacetylase inhibitors (HDACi) have important immune mod-
ulatory activity. In the present work it is shown that in human and
murine dendritic cells and murine macrophages HDACi are strong
activators of LPS induced IL-1b processing and secretion. Strikingly,
this IL-1b secretion was independent of the inflammasome compo-
nents NLRP3, ASC and even caspase-1 and activation kinetics differed
completely from that observed after inflammasome activation. Inhibi-
tion studies showed that the histone deacetylase HDAC10 is responsi-
ble for this HDACi/LPS induced IL-1b secretion. Mechanistically,
HDACi/LPS induced IL-1b secretion was strictly dependent on Trif
and was associated with a functional impairment of autophagic pro-
cesses. Importantly, these data demonstrate that besides the conven-
tional inflammasome dependent IL-1b cleavage, dendritic cells and
macrophages are capable of activating IL-1b by a novel, alternative
mechanism. Treatment of mice with HDACi during the induction of a
dextran sulfate sodium-induced colitis resulted in a strong increase of
intestinal IL-1b. As naturally occurring HDACi like butyric acid are
physiologic components of the intestinal milieu, HDACi induced IL-
1b may have a physiological function in intestinal homeostasis.
Altogether the data demonstrate that in addition to the conven-
tional inflammasome dependent IL-1b activation dendritic cells and
macrophages are capable to activate IL-1b by a novel until now
unknown additional mechanism.
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Homeostatic mechanisms prevent ileitis in mice with deficient
MUC2 production
B. Sovran1, L. M.P. Loonen1, P. Lu2, E. Kranenbarg3, C. Belzer4,
M. Boekschoten5, P. van Baarlen1, M. Kleerebezem1, P. de Vos6,
J.M. Wells1, I. Renes7 & J. Dekker1
1Host Microbe Interactomics, Wageningen, Netherlands, 2Amsterdam
Medical Center, Amsterdam, Netherlands, 3Host Microbe Inetractomics,
Wageningen, Netherlands, 4Microbiology, Wageningen, Netherlands,
5Division of Human Nutrition, Wageningen, Netherlands, 6Department
of Pathology & Medical Biology, Groningen, Netherlands, 7Department
of Pedriatric, Rotterdam, Netherlands
Introduction and Objectives: Muc2 is the major component of the
intestinal mucus layer, and Muc2-/- mice spontaneously develop
colitis. Our aim was to investigate the role of the mucus barrier in
small intestine by comparing age-dependent biological responses in
mice with deficient Muc2 production.
Materials and Methods: Muc2+/+, Muc2+/- and Muc2-/- mice were
reared under SPF conditions and sacrificed at 2, 4, and 8 weeks of
age. Total RNA from ileum and colon was purified, and analysed for
full genome transcriptome analysis. Microbiota composition of faecal
samples was determined using a mouse intestinal chip (MITChip).
Morphological and immunohistological studies were performed on
segments of ileum and proximal colon.
Results and Discussion: Muc2-/- mice develop colitis in proximal
colon after 4 weeks, which worsens by week 8, as evidenced by pro-
gressive mucosal thickening, epithelial morphological changes and
bacterial invasion. No overt morphological changes were observed in
ileum, apart from longer villi due to hyperproliferation in the
Muc2-/- mice at weeks 4 and 8. Muc2 expression increased with age
in mice+/+; in Muc2-/+ mice expression was half that of Muc2 + /+
mice. Innate immune responses were elevated in ileum in Muc2-/-
and Muc2-/+ at weeks 4 and 8. By week 4 and 8, adaptive immune
responses and inflammatory signalling pathways, including NF-e^B
activation, were down-regulated in Muc2-/- and Muc2 + /-. Lipid
metabolism pathways were down-regulated in ileum at weeks 4 and
8 suggesting altered metabolic functions. Colonic microbial composi-
tion is different in Muc2-/- compared to Muc2 + /+, whereas the
differences are less obvious in ileum. In colon, Muc2 deficiency leads
to inflammation and tissue damage. In contrast, there are less histo-
logical changes in ileum despite increased cytokine and chemokine
expression, and decreased expression of inflammatory pathway genes.
In ileum, microbiota composition, lower total numbers of bacteria,
and/or intrinsic homeostatic mechanisms appear to prevent tissue
damage in Muc2-/-. Muc2+/- mice are a good model to study the
role of mucus in intestinal health and have implications for IBD
where mucus levels are reduced during active disease and remission.
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How can differentially acting ADP-ribosylating toxins effectively
prime CD4 T cells and affect germinal center size and function?
R.K. Chandode, L.F. Yrlid & N.Y. Lycke
Department of Immunology and Microbiology, Medicinaregatan 7 a,
Gothenburg, Sweden
The ultimate aim of vaccination is to induce long term protective
immunity. Accumulating evidence support a critical role of the choice
of adjuvant for an effective stimulation of immunological memory.
While cholera toxin (CT) is a potent adjuvant also pertussis toxin (PT)
host adjuvant functions, albeit it is better known to inhibit leukocyte
migration. Both toxins are ADP-ribosylating enzymes, but act on two
different G-proteins, Gsa and Gi, in targeted dendritic cells (DC).
While CT acts on Gsa and stimulates adenylate cyclase, leading to
increased intracellular cAMP-levels, PT also promotes intracellular
cAMP-levels, but only indirectly. We have undertaken extensive studies
of the adjuvant effect of CTA1-DD, a gene fusion protein that exploits
the enzymatic activity of CT, combined with a DC-targeting D-dimer
from Staphylococcus aureus protein A. Unexpectedly, targeted DC
failed to show increased cAMP--levels, while the adjuvant effect clearly
required Gsa in DC. However, the corresponding S1-DD fusion pro-
tein from PT was found to host potent adjuvant effects and similar to
CTA1-DD intranasal immunizations stimulated strong specific muco-
sal IgA and systemic IgG responses. Both CTA1-DD and S1-DD
induced enhanced germinal center (GC) reactions and primed CD4 T
cells to produce stronger IL-10, IL-17 and INF-c levels. Here we have
asked to what extent cAMP is involved and which signaling pathways
mediate the adjuvant functions of CTA1-DD and S1-DD by exploring
a mouse model with a distinct defect of Gsa in the DC cell subset.
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Human buccal epithelium acquires microbial
hyporesponsiveness at birth, a role for secretory leukocyte
protease inhibitor
C.L. Menckeberg1, J. Hol1, Y. Simons-Oosterhuis1,
H.C. Raatgeep1, L.F. de Ruiter1, D.J. Lindenbergh-Kortleve1,
A.M. Korteland-van Male1, S. El Aidy2, P. P.E. van Lierop1,
M. Kleerebezem2, M. Groeneweg3, G. Kraal4,
B.E. Elink-Schuurman5, J.C. de Jongste5, E. E.S. Nieuwenhuis1 &
J.N. Samsom1
1Laboratory of Pediatrics, Erasmus MC, Rotterdam, Netherlands,
2Laboratory of Microbiology, Wageningen University, Wageningen,
Netherlands, 3Department of Pediatrics, Maasstad Hospital, Rotterdam,
Netherlands, 4Dept. Molecular Cell Biology and Immunology, VUMC,
Amsterdam, Netherlands, 5Department of Pulmonary, Sophia
Children’s Hospital, Rotterdam, Netherlands
Repetitive interaction with microbial stimuli renders epithelial cells
(EC) hyporesponsive to microbial stimulation. Previously, we have
reported that buccal EC from a subset of pediatric Crohn’s disease
patients are not hyporesponsive and spontaneously released chemo-
kines. We now aimed to identify kinetics and mechanisms of acqui-
sition of hyporesponsiveness to microbial stimulation using primary
human buccal epithelium. Buccal EC collected directly after birth
and in later stages of life were investigated. Chemokine release and
regulatory signaling pathways were studied using primary buccal EC
and the buccal EC line TR146. Findings were extended to the intesti-
nal mucosa using murine model systems. Directly after birth primary
human buccal EC spontaneously produced the chemokine CXCL-8
and were responsive to microbial stimuli. Within the first weeks of
life these EC attained hyporesponsiveness, associated with inactiva-
tion of the NF-KB pathway and upregulation of the novel NF-KB
inhibitor SLPI but no other known NF-KB inhibitors. SLPI protein
was abundant in the cytoplasm and the nucleus of hyporesponsive
buccal EC. Knock-down of SLPI in TR146-buccal EC induced loss of
hyporesponsiveness with increased NF-KB activation and subsequent
chemokine release. This regulatory mechanism extended to the intes-
tine, as colonization of germfree mice elicited SLPI expression in
small intestine and colon. Moreover, SLPI deficient mice had
increased chemokine expression in small intestinal and colonic EC.
We identify SLPI as a new player in acquisition of microbial hyp-
oresponsiveness by buccal- and intestinal- epithelium in the first
weeks after microbial colonization.
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Human mucosa-associated invariant T (MAIT) cells are present
in colon adenocarcinomas, but secrete reduced amounts of
IFN-gamma
P. Sundstro¨m1, M. Sundquist1, J. Wong2 & M. Quiding-J€arbrink1
1Microbiology and Immunology, Sahlgrenska Academy, University of
Gothenburg, G€oteborg, Sweden, 2Microbiology, National University of
Singapore, Singapore
Mucosa-associated invariant T (MAIT) cells are innate-like T cells with
a conserved T cell receptor alpha-chain which recognize bacterial
metabolites of B vitamins presented on the invariant MR-1 molecule.
They are present in intestinal tissues and liver, and they are capable of
rapid production of IFN-gamma and IL-17 in response to bacterial
insult. In colon cancer, IL-17-driven intestinal inflammation promotes
tumor progression, while IFN-gamma-production is associated with
improved patient prognosis. However, virtually nothing is known
about MAIT cells in human tumors. Here we determined the presence
and functional capacity of human colonic MAIT cells, both in colon
tumors and tumor-free tissue. Flow cytometric analyses of
CD45+CD3+CD4-Valpha7.2+CD161high MAIT cells showed some-
what higher frequencies in tumor than unaffected colon tissues
(0.72  0.17%, versus 0.43  .11% of CD45+ leukocytes, P < 0.05),
but there was no correlation between MAIT cell frequencies and tumor
stage. The large majority of colonic MAIT cells are recently activated
memory/effector cells based on their expression of CD69 and CD45RO.
The majority of MAIT cells in unaffected colon tissues (77  15%,
meanSEM) produced IFN-gamma, while only 3  2% produced IL-
17. Colonic MAIT cells also produced TNFalpha (29  9%) and IL-2
(27  7%), as well as Granzyme B (GrB; 49  6%). In the tumors, sig-
nificantly lower frequencies (P < 0.01) of IFN-gamma-producing
MAIT cells were seen (49  9%), while there were no significant differ-
ences in the frequencies of IL-17-, TNFalpha-, IL-2-, and GrB-produc-
ing cells. In conclusion, we show that MAIT cells are able to infiltrate
colon tumors but that their ability to produce IFN-gamma is substan-
tially reduced. We suggest that MAIT cells have the capacity to promote
the local immune response to tumors, but that factors in the tumor
microenvironment act to reduce MAIT cell IFN-gamma production.
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Identification of signaling pathways involved in Rankl-Induced
M cell differentiation using 3-D enteroid cultures
M.B. Wood, D. Rios & I.R. Williams
Department of Pathology, 615 Michael St., Whitehead Bldg., Atlanta,
GA, USA
Microfold (M) cells are specialized antigen-sampling epithelial cells
restricted to the Peyer’s patches and isolated lymphoid follicles of
the small intestine. M cells take up particulate antigens from the
intestinal lumen and deliver these antigens to the lymphoid follicles
beneath the epithelium where adaptive immune responses are initi-
ated. Previous studies identified RANKL-RANK signaling and the Ets
transcription factor Spi-B as essential mediators for M cell differenti-
ation. In the past, it has been challenging to study M cell differentia-
tion in vivo due to their low numbers. We have established RANKL-
supplemented 3-D enteroid cultures in Matrigel as an in vitro model
system for studying the process of M cell differentiation. Primary en-
teroid cultures derived from wild type mice were stimulated with
RANKL at the time of the first subculture. Two days of RANKL
treatment is sufficient to strongly induce multiple M cell-associated
genes including Anxa5, Spib and Gp2 compared to unstimulated
control cultures. These genes are not induced in enteroids derived
from conditional knockout mice lacking RANK on intestinal epithe-
lial cells. In other RANKL-responsive cells, RANKL can activate mul-
tiple signaling pathways including NF-jB, MAP kinases, PI-3 kinase
and Src kinase. We used the enteroid model system to test whether
specific RANKL-activated signaling pathways play a critical role in
M cell differentiation. Inhibitors of MAP kinases, PI-3 kinase and
Src kinase did not interfere with RANKL-induced M cell differentia-
tion in C57BL/6 enteroid cultures. No induction of M cell-associated
genes was observed in enteroids from aly/aly mice with a nonfunc-
tional mutant allele of NF-jB-inducing kinase (NIK). These results
pinpoint the noncanonical NF-jB signaling pathway that requires
NIK as a key proximal event downstream of RANK engagement for
intestinal epithelial stem cells to commit to the M cell lineage.
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IL-17 is required for vaccine induced secretory IgA transport and
protection from Oral Cholera Toxin Challenge
C. McEntee, C. Davitt, A. Abautret-Daly, R.M. McLoughlin &
E.C. Lavelle
School of Biochemistry and Immunology, Trinity Biomedical Sciences
Institute, Dublin 2, Ireland
A role for interleukin (IL)-17 in the regulation of polymeric immu-
noglobulin receptor (pIgR) expression at mucosal surfaces has
recently been described (Jaffar et al, Cao et al). In this study we
investigated whether a deficiency in the IL-17 pathway impacted on
oral vaccine induced IgA responses and susceptibility to oral cholera
toxin challenge (OCTC). In our experience, three rounds of vacci-
nation with CT and CTB can induce sufficiently high CTB-specific
IgA titres to confer protection against OCTC. Thus, wild-type
(WT) C57BL/6 mice and IL-17R-/- mice were vaccinated three
times, two weeks apart with CT + CTB and challenged with CT
two weeks later. Vaccinated WT mice were fully protected from
CT-induced fluid accumulation following challenge whereas IL-
17R-/- mice exhibited substantial fluid accumulation in the caecum,
indicative of CT enterotoxicity. This susceptibility to OCTC corre-
lated with lower levels of faecal CTB-specific IgA in IL-17R-/- mice
when compared to WTs. However, this was not due to a general
defect in specific IgA production as CTB-specific antibodies in
intestinal tissue were comparable between WT and IL-17R-/- mice.
Furthermore, intestinal exposure to CT triggered a very rapid trans-
port of IgA into the lumen which was dependent on IL-17, IL-1
and the NLRP3 inflammasome. These findings suggest a key role
for the inflammasome-IL-1-IL-17 axis in CT-induced IgA secretion
and protective immunity and that IL-17 may be a valuable biomar-
ker of oral vaccine efficacy.
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Immunization via conjunctiva and CALT as a route for chlamydia
vaccine delivery: Immune responses to PmpC, an outer
membrane protein of C. trachomatis
A. Inic-Kanada1, S. Belij1, M. Stojanovic2, E. Marinkovic2,
I. Stojicevic2, J. Montanaro1, E. Stein1, N. Bintner1, N. Sch€urer1,
A. Ladurner1 & T. Barisani-Asenbauer1
1LBCE OCUVAC, Medical University of Vienna, Vienna, Austria,
2Institute of Virology, Vaccines and Sera - TORLAK, Belgrade, Serbia
Trachoma is the world’s leading cause of preventable infectious ocular
disease. Although antibiotics are effective in treating active cases of the
illness, they do not prevent re-infection, which occurs with high fre-
quency in susceptible populations. Nevertheless the immunological
mechanisms responsible for protective immunity versus immunopa-
thology are still not well understood, although it is widely accepted that
T cell driven IFNc Th17 responses are critical for clearing the infection.
C57BL/6 mouse strain was immunized via the conjunctiva and
subcutaneously with polymorphic membrane protein C (PmpC), an
outer membrane protein of Chlamydia trachomatis. The amount of
PmpC administrated per dose was 40 lg/mice. Three immunizations
were performed at 2 weeks interval and the evaluation of local and
systemic immune response was assessed 2 weeks after the last immu-
nization. Conjunctival immunization with PmpC elicited higher con-
centrations of SIgA in tears in comparison to subcutaneous
immunization. C57BL/6 mice showed the highest proliferation values
when heat-inactivated Chlamydia trachomatis was used as a stimula-
tor. The conjunctival application of PmpC induced skewing of
PmpC-specific immune responses toward a Th1/Th17 profile, as
determined by the stimulation of IFNc and IL-17A secretion and/or
the concurrent pronounced reduction of IL-4 secretion.
Immunization via conjunctiva is a new approach to vaccine deliv-
ery against ocular surface infections. Our results revealed that PmpC
has a potential activate type 1 T-cellular immune response, which
holds essential for resolving chlamydial infection to higher extent
when applied via conjunctiva vs. subcutaneous immunization.
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Immunogenic effects of a new alpha-gliadin peptide on a
dendritic cell culture model
E. Montalvillo1, C. Escudero-Hernandez1, J.A. Garrote2 &
E. Arranz1
1Pediatrics & Immunology, C/Ramon y Cajal 7, Valladolid, Spain,
2Genetics Lab. Hospital U. Rio-Hortega, C/Dulzaina 2, Valladolid,
Spain
We have previously described a new gliadin peptide released by the
action of gliadin-degrading proteases from the duodenum of celiac
disease (CD) patients. The ability of this peptide to develop a humoral
immune response in vivo in CD patients was confirmed by the detec-
tion of IgA anti-deamidated 8-mer (d8mer) peptide in plasma samples
from these patients. Our aim here was to study the immunogenic
effects of this peptide in an in vitro model of dendritic cells. Periph-
eral blood-derived dendritic cells were obtained from CD patients
(both active CD, and on GFD) and healthy volunteers. Cell culture for
24 hours was stimulated with 100 lg/ml of each peptide (native 8mer
and d8mer, d33mer, 19mer, and control peptide). Dendritic cell mat-
uration and activation markers were analyzed, as well as the ability of
these cells to induce T cell proliferation in an autologous co-culture.
Dendritic cells from CD patients stimulated with d8mer show an
increased expression of CD80 (aCD, P < 0.001, GFD, P < 0.01) and
CD86 (aCD, P < 0.01, DSG, P < 0.05); whereas 33mer increased
CD83 (aCD, P < 0.001) and CD86 (aCD, P < 0.01, GFD, P < 0.05)
expression, compared to the corresponding basal culture. Dendritic
cells stimulated with both d8mer and d33mer induced proliferation
of IFNc-producing T cells in samples from all CD patients. Both,
19mer and native 8mer have no effects.
In summary, as with 33mer peptide, the d8mer peptide is
involved in the stimulation of dendritic cells and proliferation of IF-
Ngamma-producing T cells, probably independent of whether anti-
gen presentation is mediated HLA-DQ2 + or DQ2 dendritic cells.
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Immunological differences between left and right-sided colonic
tumours of patients with colorectal cancer
H.O. Al-Hassi1, G.H. Lee1, G. Malietzis1, D. Bernardo1,
E.R. Mann2, D. Reddi1, N.R. English1, R. Man3, R. K.S. Phillips4 &
S.K. Clark4
1Immunology, Antigen Presentation Research Group, Watford Road,
London, UK, 2Department of Medicine, Johns Hopkins University,
School of Medicine, Baltimore, USA, 3Wolfson Unit for Endoscopy, St
Mark’s Hospital, London, UK, 4Department of Surgery, St Mark’s
Hospital, Watford Road, London, UK
Introduction: Colorectal cancer (CRC) is one of the major causes of
cancer related mortality. Dendritic cells (DC) promote either tumour
immunity or tolerance but their effectiveness is dependent on tissue-
microenvironment. Growing evidence suggests that different sites
within the colon may have different tumour incidence, histopatho-
logical and prognostic outcomes. There are embryological, histologi-
cal and functional differences between the proximal and the distal
sides of the colon. However, the immunological differences between
the compartments in CRC remain unknown; we aim to explore
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differences and provide a mechanistic rational for them according to
the activity of DC in these compartments.
Methods: Phenotype, activation and migration markers of DC in
mucosal and tumour biopsies from proximal versus distal colon of
CRC patients were investigated using flow cytometry and immuno-
histology. Functional studies using migration assays were performed
to assess the effect of tumour microenvironment on the migratory
capacity of DC.
Results: In the tumour tissues, expression of the activation markers
CD40, CD86 was significantly higher on DC from the proximal
colon. Expression of b7 (a gut homing marker) and ILT3 (immature
DC marker) did not differ between compartments. Expression of
CCR7 (a lymph node migration marker) was significantly higher on
DC from the distal colon. In the mucosae, expression of CD40,
CD86 and CCR7 on DC was similar to that in tumour tissues. Sig-
nificantly greater migration towards CCL19 in vitro by DC from the
distal colon showed that CCR7 expression was functional. Expression
of b7 and ILT3 was significantly higher on DC from the distal
colon.
Conclusion: These immunological differences suggest that tumours
in the proximal colon have more activated DC and should be treated
as different entities from their distal counterparts. Right side
tumours are less frequent, more aggressive and the survival rate is
lower compared with left side CRC patients. This difference could be
due to evolution of these tumours so that some mutations in adeno-
mas in the right side of the colon enable survival of the higher
immune activity/surveillance at that site. Immunological differences
between left and right-sided CRC and its potential impact on disease
outcome may inform classification of patients with the same risk
stratification for clinical trials and for the development of persona-
lised treatment strategies. (Dendritic cell - Colorectal cancer)
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Immuno-modulatory properties of probiotics in DSS-colitis:
Impact on micro-RNA expression and bacterial diversity
F. Algieri1, A. Rodrıguez-Nogales1, J. Garrido-Mesa1,
N. Garrido-Mesa1, M.P. Utrilla1, M.E. Rodrıguez-Cabeza1,
N. Chueca2, F. Garcıa2 & J. Galvez1
1Pharmacology, Granada, Spain, 2San Cecilio University Hospital,
Granada, Spain
Introduction: Probiotics have been reported to be useful in IBD
treatment through different mechanisms, including their immuno-
modulatory properties and the impact in the microbiota composi-
tion. These effects can promote the down-regulation of
inflammation mediators including micro-RNAs. The aim was to
evaluate the immunomodulatory properties of different probiotics in
DSS model of mice colitis, emphasizing the relation between micro-
RNA expression and bacterial diversity.
Methods: Male C57BL/6 mice were pretreated with E. coli Nissle
1917 and L. fermentum CECT5716 at 5x108 UFC/mice/day for two
weeks before DSS-induced colitis (3% solution for 6 days in the
drinking water). Non-colitic and non-treated colitic groups were
included as reference. Six days after colitis induction, mice were sac-
rificed. The inflammatory status was evaluated by a disease activity
index (DAI), qPCR of inflammatory markers and micro-RNAs, and
changes induced in microbiota populations characterized by pyrose-
quencing. Statistical significance is set at P < 0.05.
Results: Probiotics administration resulted in an intestinal anti-
inflammatory effects evidenced macroscopically by lower DAI values.
Biochemically, it was observed a decreased expression of pro-inflam-
matory cytokines (IL-1b) and an increased expression in mucins
(MUC-2 and MUC-3) and tight junction proteins. Also, it was
established a micro-RNA expression profile which showed a reduced
expression of miR-143 and miR-375 while miR-155, miR-223 and
miR-150 were increased in this model. Probiotics were able to
restore the expression of these markers. Finally, dysbiosis and lower-
ing bacterial diversity was characterized in colitic mice by 454-py-
rosequencing, being restored by the treatment with each probiotic.
Discussion and Conclusion: Probiotics are able to increase the
diversity of microbiota as well as to alter the expression of different
inflammatory markers and micro-RNAs. These results support the
immuno-modulatory effects of probiotics and its use in IBD.
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Immunoproteasome subunit LMP7 drives the development of
colitis-associated carcinogenesis
A. Visekruna, N. Vachharajani & U. Steinhoff
Institute for Medical Microbiology, Marburg, Germany
Colorectal cancer (CRC) is the second leading cause of cancer-
related death worldwide. Chronic colonic inflammation often
progresses to CRC, whereby NF-kB-controlled expression of proin-
flammatory cytokines such as TNF-a, IL-6 and IL-17A provides a
crucial functional link between augmented immune responses and
development of colitis-associated carcinogenesis (CAC). We have
recently demonstrated the involvement of immunoproteasomes in
the regulation of NF-kB activity. Here, we show that the immuno-
proteasome subunit LMP7 is essential for development of CAC. We
found a striking difference between wild-type (WT) and LMP7 defi-
cient mice with respect to number of polyps and development of
dysplasia in the AOM/DSS murine model of colon carcinogenesis.
On day 76 after induction of CAC, all WT mice developed macro-
scopically visible adenocarcinomatous lesions, but no such lesions
were detected in LMP7 deficient mice. During the course of treat-
ment with AOM and DSS, a massive infiltration of immune cells
into the lamina propria of WT mice was accompanied with elevated
expression of TNF-a, IL-6, IL-17A and INF-g. On the other hand, a
decreased influx of neutrophils and low production of proinflamma-
tory cytokines were observed in LMP7 KO animals. Importantly, the
treatment with the selective LMP7 inhibitor (ONX-0914) blocked
the production of proinflammatory cytokines and attenuated pro-
gression of CAC in WT mice. Thus, the immunoproteasome might
be a specific target for development of anti-inflammatory drugs to
dampen the ongoing chronic inflammation and development of
CAC.
049
In vitro modelling of the effects of gluten and poly:IC on mucus-
secreting epithelium
L.R. Nielsen1, S. Hansen2, T. Barington3, S. Husby4 &
H. Toft-Hansen5
1Syddansk Universitet, Campus Vej 55, Odense M, Denmark, 2Institute
of Molecular Medicine, J.B. Winsløws Vej 21, 1., Odense C, Denmark,
3Department of Clinical Immunology, Sdr. Boulevard 29, Odense
University Hospital, Odense C, Denmark, 4Pediatric department, Sdr.
boulevard 29, Odense University Hospital, Odense C, Denmark,
5Paediatric Research Unit, Sdr. boulevard 29, Odense University
Hospital, Odense C, Denmark
Celiac disease is a chronic autoimmune enteropathy of the small
intestine triggered by ingestion of gluten and related prolamin pro-
teins in individuals with tissue type HLA DQ2 or 8. In the lamina
propria of the intestinal mucosa, gluten peptides are taken up by
antigen-presenting cells which induce inflammation by activation of
gluten-specific CD4 T cells. The integrity of the intestinal epithelial
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barrier depends on a mucus layer and intercellular tight junction
formation. Coeliac disease is characterized by enhanced intestinal
permeability, but the reason for this is largely unknown.
In the present work, we have grown a monolayer of gut epithelial
cells expressing tight junctions (caco-2) and gut epithelial cells pro-
ducing mucus (HT-29). We investigated if gluten had immunotoxic
effect on the epithelium and if these effects were changed by the
presence of a mucus layer.
We added chymotrypsin-treated gluten peptides to the apical side
of the membrane of caco-2- and HT-29 cells alone, and to a co-cul-
ture. Trans-epithelial electric resistance (TEER) was used as a mea-
sure of confluency and tight junction formation of the cells. In
addition, we added poly:IC simultaneously with gluten in order to
mimic a viral infection to test if this had any toxic effect on the epi-
thelium or a synergistic effect with gluten.
Our preliminary results show no significant changes between the
different treatments of the epithelium compared to bovine serum
albumin-treated controls. In future experiments we will use pepsin/
trypsin-treated gluten peptides, and preincubate the epithelium with
poly:IC before the addition of gluten.
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Interactions between intestinal epithelial cells and
Coxsackievirus B and the role of the Type III Interferons
V.M. Stone1, P. Larsson1, E. Domsgen1, U. Holmlund2,
E.S. Ekstr€om2 & M. Flodstr€om-Tullberg1
1Center for Infectious Medicine, Karolinska Institutet, Stockholm,
Sweden, 2Immunology, Stockholm University, Stockholm, Sweden
The Coxsackievirus B (CVB) family of enteroviruses (EVs) are sin-
gle-stranded RNA viruses that have been implicated in a number of
diseases including Type 1 diabetes (T1D), mycocarditis, hepatitis and
meningitis. CVBs infect via the intestinal tract and studies suggest
that T1D is associated with CVB infection in the gut mucosa,
although little is currently known about these interactions. Type III
interferons (IFNks) are important regulators in the permissiveness of
both primary human pancreatic islets and hepatocytes to CVB infec-
tion, and they have also been implicated in the control of rotavirus
infection in intestinal epithelial cells (IECs). However, to date, their
role in limiting EV infection, and more specifically CVB infection in
the gut is not known. Therefore, the focus of this study was to
examine the interactions between CVBs and IECs and to determine
whether the IFNks can regulate the permissiveness of IECs to infec-
tion. To examine this, we have used the two human colonic cell lines
HT-29 and CaCo2 and the common EV, CVB3.
In this study we demonstrate that both HT-29 and CaCo2 cells
express the two receptors used by CVBs to infect cells, namely CAR
and DAF. Moreover, we also show that both cell lines are susceptible
to infection with CVB3 as confirmed by plaque assay and the moni-
toring of cytopathic effects. 3 h and 6 h post infection, both cell
lines also appear to up-regulate the expression of IFNk1 (interleu-
kin-29, IL-29) and IFNk2 (IL-28a). RT-PCR analysis of the two
IFNk receptor subunits, IFNk-R1 and IL-10R2, confirmed that the
IEC lines express both subunits at the mRNA level. Furthermore,
treatment of the IECs with IFNk1 and IFNk2 for 6 h and 24 h up-
regulated the expression of a number of IFN stimulated genes
involved in antiviral defence mechanisms at both the mRNA and
protein level, as confirmed by RT-PCR and Western blotting.
From this study we can conclude that the two human IEC lines,
HT29 and CaCo2 are susceptible to infection with CVB3 and that
upon infection they up-regulate the expression of the IFNks. More-
over, the IECs also enter an antiviral state after treatment with the
IFNks. However, whether the IFNks protect against CVB infection
remains to be established. Further studies using a novel method for
culturing human intestinal tissue ex vivo will confirm whether these
findings are applicable in a more relevant model.
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Interleukin-10 inhibits human IFNc-secreting effector T cells
indirectly by controlling antigen-presenting cell function
S. Veenbergen1, M.A. van Leeuwen1, G.J. Driessen2,
L.F. de Ruiter1, H.C. Raatgeep1, D.J. Lindenbergh-Kortleve1,
L.A. van Berkel1, Y. Simons-Oosterhuis1, L. de Ridder1,
J.C. Escher1 & J.N. Samsom1
1Department of Pediatric Gastroenterology, Rotterdam, Netherlands,
2Pediatric Infectious Disease and Immunology, Rotterdam, Netherlands
Chronic inflammation of the gastrointestinal tract, as seen in inflam-
matory bowel disease, arises from abnormal reactivity of T cells to
commensal microbiota. Interleukin-10 (IL-10) plays a crucial role in
suppressing microbiota-specific T cell responses. However, it is
unknown how IL-10 prevents reactivation of effector T cells in the
human intestine. We have recently identified a homozygous loss-of-
function mutation in the IL-10RA gene of a pediatric patient with
early-onset colitis. In contrast to recently reported cases, disease
remission could be achieved without stem-cell transplantation, allow-
ing in-depth analysis of the mechanism by which IL-10 controls
human effector T cells. Lesional intestinal tissue taken at onset of
disease contained high numbers of IL-17+ and T-bet+ cells. In agree-
ment, IL-10 failed to control IFNc and IL-17 production by acti-
vated T cells derived from the IL-10RA-deficient patient in vitro. By
coculturing CD4+ T cells and monocyte-derived dendritic cells (DC)
from the IL-10RA-deficient patient and a healthy control, we
revealed that IL-10R expression on DC, and not on T cells, is impor-
tant for controlling IFNc production, and to a lesser extent IL-17
production, by effector T cells. Importantly, we demonstrated that
IL-10 plays a pivotal role in controlling the differentiation of imma-
ture monocyte-derived DC into inflammatory DC with a disease
promoting phenotype. Taken together, our study demonstrates that
IL-10 is essential to limit IFNc and IL-17 secretion by human effec-
tor T cells and reveals that IL-10 exerts its suppressive function on
IFNc-secreting effector T cells mainly indirectly by controlling anti-
gen-presenting cell function.
052
Intestinal inflammation induced by dietary cholesterol in
Zebrafish
F. Progatzky1, N.J. Sangha1, N. Yoshida1, M. McBrien1,
J. Cheung1, A. Shia2, J. Scott2, J.R. Marchesi3, J.R. Lamb1,
L. Bugeon1 & M.J. Dallman1
1Life Sciences, Imperial College London, London, UK, 2NHLI, Imperial
College London, London, UK, 3School of Biosciences, Cardiff University,
Cardiff, UK
Inflammatory bowel disease and other chronic, often systemic, auto-
inflammatory human disorders have considerately increased over the
past decade, coincidently with a rise in the consumption of diets
enriched in cholesterol or saturated fatty acids. The intestinal muco-
sal barrier first encounters dietary components, however, in vivo
information regarding their local and direct inflammatory effect on
the intestinal epithelium is lacking. We found that a single exposure
to a high cholesterol diet (HCD) results in localized accumulation of
myeloid cells in the intestine in both mice and zebrafish. Pharmaco-
logical interventions demonstrated that this acute myeloid cell accu-
mulation is dependent on cholesterol uptake via NPC1L1, NFkB,
NADPH oxidase and Cathepsin B, leading to capase-1 activity in
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intestinal epithelial cells. Through a novel morpholino oligonucleo-
tides delivery approach in zebrafish we found that inflammasome
activation in epithelial cells is dependent on ASC. Extending the
HCD exposure to 10 days results in localised functional dysregula-
tion, dependent on cholesterol binding/uptake and inflammasome
activation, and systemic pathologies. Our model reveals a novel
route by which dietary cholesterol can initiate intestinal inflamma-
tion and suggest its involvement in long-term pathologies of the
intestine. Further, our model illustrates the power of the zebrafish
system to study pathophysiological responses induced in the intesti-
nal epithelium in an intact organism and aspects of mucosal immu-
nology research that have been hampered in the past.
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Intestinal mucin-dendritic cell crosstalk in gut homeostasis
F. Melo-Gonzalez1, T.M. Fenton1, D.J. Thornton2 &
M.A. Travis1
1MCCIR, University of Manchester, Grafton Street, Manchester, UK,
2Wellcome Trust Centre for Cell Matrix Research, Oxford Road,
Manchester, UK
The gastrointestinal tract is lined with mucus, mainly composed of
the goblet cell secreted mucin MUC2. Despite this mucus layer, the
intestine still comes into contact with the commensal microbiota
and potential enteric pathogens. Thus, a fine regulation of the
immune system in the intestine is required to maintain gut homeo-
stasis and protect from infection. Intestinal dendritic cells (DCs) are
essential for sampling luminal antigens and promoting the appropri-
ate immune responses to the intestinal environment, promoting tol-
erogenic responses to commensals while orchestrating effector
responses against pathogens. Recent evidence has suggested that
interactions between intestinal DCs and mucins may modulate DC
function and subsequent immune responses. To determine the
potential for mucins to regulate DC function, we treated human
monocyte-derived DC with purified MUC2/Muc2 obtained from
intestinal cell lines and mouse large intestine. We found that expres-
sion of the pro-inflammatory chemokine interleukin 8 (IL-8) is sig-
nificantly upregulated by human DCs in the presence of MUC2/Muc2.
Additionally, mucin-treated DCs are able to enhance recruitment of
neutrophils in transmigration assays. Thus, in contrast to recent pub-
lished results suggesting potential anti-inflammatory properties of
MUC2, we find that this mucin may induce important pro-inflamma-
tory functions in DC. Further investigation is therefore required to
explore mucin-DC interactions during health and infection.
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Intestinal myeloid DCs display an activated phenotype and are
less susceptible to HIV-1 infection compared to blood DCs
M. Cavarelli1, B. Fusetti1, M. Tolazzi1, K. Tsilingiri2, M. Rescigno2
& G. Scarlatti1
1IRRCS San Raffaele Scientific Institute, Milan, Italy, 2European
Institute of Oncology, Milan, Italy
We recently showed that human colonic lamina propria (LP)
CD11c+ DC actively shuttle R5 HIV-1 across an intact epithelial bar-
rier and transfer infection to CD4+ T cells (Cavarelli, EMBO Mol-
Med 2013). However the susceptibility of intestinal DC to HIV
infection has been poorly investigated, due to difficulties in isolating
mucosal DC.
CD11c+ myeloid DC obtained from the colonic LP were further
characterized as CD103+ and CX3CR1 + and the expression of
HIV-1 receptors analyzed in comparison to blood DCs. Supernatant
obtained from an ex vivo culture of healthy human colonic mucosa
was used to condition monocyte-derived DC in an in vitro model as
to mimic the exposure of DC to intestinal microenvironment. Con-
ditioned--DC (C-DC) were analyzed by flow cytometry for the
expression of HIV-1 receptors and activation markers, and incubated
in vitro with either R5 or X4 HIV-1 to study their susceptibility to
infection.
C-DC displayed an activated phenotype, a significant down-regu-
lation of CCR5, CD4 and CX3CR1, an up-regulation of CXCR4 and
a moderate modulation of DC-SIGN expression compared to uncon-
ditioned DC. No change in the CD103 expression was observed.
Interestingly, both R5 and X4 HIV-1 integrated their genome and
replicated less efficiently in C-DC compared to unconditioned DC.
Colonic supernatants contained the CCR5-binding chemokines
Mip1b and MCP-1 and the CX3CR1 ligand fractalkine, whereas the
CXCR4 ligand SDF-1a was absent. IL-10 and IL-2, described to
induce CXCR4 up-regulation on DC, were also detected. Thus, this
specific intestinal milieu may determine the observed phenotype.
Both CX3CR1+ and CD103+ CD11c+ DCs were detected in human
colonic LP. Interestingly CD11c+ DC showed lower CCR5 and
higher CXCR4 expression compared to blood DC, and a similar acti-
vation profile, which confirmed the results obtained after intestinal
conditioning.
Thus, the intestinal microenvironment module the expression of
HIV receptors on DCs and their capability to replicate the virus.
Keywords: HIV-1, mucosal transmission, dendritic cells.
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Isolation, culture and monitoring of Chlamydia trachomatis and
suis using the pig model
T. K€aser, T. Cnudde, G. Hamonic, M. Rieder, K. Lai, A. Pasternak
& F. Meurens
VIDO-InterVac, 120 Veterinary Road, Saskatoon, Canada
Chlamydia trachomatis infections are the most common sexually
transmitted bacterial disease worldwide and infection rates are
especially high in aboriginal communities. C. trachomatis infects
genital tract mucosa and can cause severe health problems includ-
ing infertility and an increased risk for infections like HIV/AIDS.
A vaccine against C. trachomatis is currently not available but
urgently needed. In order to develop such a vaccine it is impor-
tant to study the immune response in a relevant animal model to
understand the host pathogen interactions in human chlamydial
infections. Pigs are the natural host of C. suis and infection with
C. trachomatis closely resembles the infection in humans. There-
fore, the pig is a relevant large animal model to study the host
pathogen interactions of C. trachomatis. Additionally, the method-
ology for a detailed analysis of the relevant T-helper and regula-
tory T-cell immune responses is available. The first steps in this
establishment are the propagation, purification and titration of
chlamydia on one side and the isolation of the host cell target of
chlamydia, genital tract epithelial cells, on the other side. Most of
the available protocols were established in the 1980s. This time
gap creates two main problems: First, some of the incorporated
chemicals are no longer easily available and second, most of the
incorporated methods are obsolete. Therefore, we updated existing
protocols with available chemicals and included state of the art
techniques like Taqman probe RT-qPCR, multi-colour confocal
microscopy and flow cytometry analysis. These protocols enable
the production of a highly purified and precisely titrated stock of
chlamydia as well as the isolation and detailed characterization of
genital tract epithelial cells. These protocols will provide the basis
for a comprehensive analysis of the host immune response on
chlamydial infection.
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Local responses to virulent and avirulent Clostridium
perfringens in broilers
K. Russell
Disease Systems, Roslin Institute Building, Midlothian, UK
The main causative agent of necrotic enteritis is C. perfringens (Cp)
type A, which produces several toxins, including netB. Early host
responses therefore an in situ duodenal loop broiler model was
developed to dissect complex host-pathogen interactions at the early
stages of disease pathogenesis. Here, we investigate host responses to
virulent, netB+, and avirulent, netB-, strains of Cp and their culture
supernatants.
Six isolated duodenal loops were prepared surgically in anaesthe-
tised broilers. Loops within birds were infused with: control (growth
medium), Cp culture supernatant alone or bacteria and culture
supernatant from either the virulent or avirulent strain. Intestinal
segments were removed for histology and gene expression analysis at
0.5 or 4 h post-infusion. Expression of genes related to disease path-
ogenesis (FAS, GIMAP8), immune cell activity (BLA, NBL1) and
inflammation (IL-6, IL-1a^ and IFN-~a) were measured.
The main effects detected were that IL-6 expression was signifi-
cantly down-regulated in virulent treated birds while FAS was signif-
icantly increased in loops containing bacteria and culture
supernatant at 4 h in comparison to the control and culture super-
natant alone. There were no other significant changes in pathology
and heterophil infiltration between the treatments at these early time
points. The implication of the results will be discussed.
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Macrophage subsets exhibit selective endotoxin tolerance
induced by Escherichia coli LPS
K. Alshaghdali1, C. Haywood2, J. Beal3 & A. Foey3
1School of Biomedical and Healthcare Sciences, University of Plymouth,
Plymouth, UK, 2Derriford Hospital, Plymouth, Plymouth, UK, 3School
of Biomedical and Healthcare Sciences, Plymouth, UK
Macrophages (MФs) control gut mucosal responses; facilitating tol-
erance to commensal bacteria and food components, while keeping
the ability to trigger immune defences to pathogens. MФ reactions
are determined by both differentiation and activation stimuli, giving
rise to two distinct subsets; pro-inflammatory M1- and anti-inflam-
matory/regulatory M2- MФs. M2-like MФs take control in homeo-
static environments whereas M1-like MФs predominate in
inflammatory pathologies. Suppression of MФ responses can be ben-
eficial to either the host or pathogen. Chronic stimulation by bacte-
rial pathogen associated molecular patterns (PAMPs), such as LPS, is
well established to induce tolerance. The aim of this study was to
investigate the susceptibility of MФ subsets to Escherichia coli K12
LPS-induced suppression. M1- and M2-like MФs were generated in
vitro from the THP-1 monocyte cell line by differentiation with
PMA and vitamin D3, respectively. MФ subsets were pre-treated
K12-LPS prior to stimulation by bacterial PAMPs. Modulation of
inflammation was measured by TNFa, IL-1b, IL-6, IL-10 ELISA.
K12-LPS suppressed PAMP induced TNFa expression in M1 and
M2 but selectively suppressed IL-6 and IL-10 expression in M1 and
M2 MФs. In conclusion, E. coli LPS selectively tolerises cytokine
production between proinflammatory M1 and regulatory M2 MФs;
differential suppression exerting knock-on effects on both immuno-
pathology and homeostasis.
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Microbial PAMP co-stimulation initiates neutrophilic steroid
resistant asthma
S. Hadebe1, G. Brown1, P. Redelinghuys1, R. Drummond1,
K. Fierens2, B. Lambrecht2, F. Brombacher3, F. Kirstein3 &
S. Vautier1
1Immunity, Infection and Inflammation Programme, University of
Aberdeen, Aberdeen, UK, 2Respiratory Diseases, University of Ghent,
Laboratory of Immunoregulation and Mucosal Immuno, Ghent,
Belgium, 3Immunology, University of Cape Town, Institute of
Infectious Disease and Molecular Medi, Cape Town, South Africa
Introduction: Asthma is a complex obstructive airway disease char-
acterised by airway hyper-reactivity to innocuous allergens. It may
be categorised as either classical eosinophilic, T helper 2 type of dis-
ease or as one driven by neutrophils that may be associated with T
helper 17 cells and that is corticosteroid resistant. While the patho-
genesis of the disease is not fully understood, there is increasing evi-
dence for the role of environmentally-derived pathogen-associated
molecular patterns (PAMPs) including fungal b-(1,3)-glucans and
bacterial lipopolysaccharide (LPS) in inducing and exacerbating air-
way inflammation.
Results: We investigated the effects of these components, either
alone or in combination, in several models of pulmonary inflamma-
tion and discovered that they modified airway responses in vivo.
Notably, a combination of PAMPs drove a profound neutrophilia
that was associated with synergistic IL-17A and RANTES production.
Moreover, in allergic models using house dust mite, sensitisation
with these agonists resulted in corticosteroid resistant airway hyper-
responsiveness.
Conclusion: Sensitisation with multiple microbial PAMPs may
therefore play an important role in the pathogenesis of steroid resis-
tant asthma.
059
Microbial signals control inflammation and autoimmunity
induced by hypomorphic RAG defects
R. Rigoni1, V. Maina1, S. Mantero1, V. Marrella2, F. Grassi3,
G. Pesole4, J.R. Mora5, A. Villa2 & B. Cassani2
1Humanitas Research Hospital, Via Manzoni 113, Rozzano MI, Italy,
2IRGB-CNR, Via Manzoni 113, Rozzano MI, Italy, 3Institute for
Research in Biomedicine, via Vela, Bellinzona, Switzerland,
4Universita’ di Bari, Bari, Italy, 5Massachusetts General Hospital,
Harvard Medical Sc, Boston, USA
Hypomorphic mutations in the RAG genes result in profound lymp-
hopenia associated with multisystem autoimmune manifestations in
humans and mice. The role of gut homeostasis and microbial signals
in the immune dysfunctions and disease pathogenesis is still debated.
The Rag2R229Q/R229Q mutant mice developed an inflammatory
bowel disease involving the small intestines, characterized by marked
infiltration of CD4+ T cells and, intriguingly, also of Treg cells, in
the lamina propria compartment. Increased expression of the gut
homing receptors CCR9 and a4a^7 on peripheral CD4+ T cells con-
firmed the abnormal lymphocyte trafficking to this environmental
interface. A pro-inflammatory profile, characterized by a Th1/Th17
skewing, distinguished the intestinal immune responses in the
Rag2R229Q/R229Q mice. Remarkably, similar pattern was also evi-
dent in the periphery. On the contrary, B cells were poorly present
in the gut of mutant mice and the fecal level of IgA was obviously
reduced. Interestingly, these findings correlated with augmented
intestinal permeability and enhanced epithelial innate responses. Me-
tagenomic analysis revealed substantial changes in the composition
of the gut microbial communities in the mutant mice, with an
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overall reduced bacterial biodiversity. Importantly, decreasing micro-
bial load with antibiotic treatment significantly limited the lympho-
cytic infiltration, as demonstrated by the reduction in the frequency
of peripheral CCR9 + T cells, and ameliorated both the intestinal
and systemic inflammation by dampening pro-inflammatory Th1/
Th17 immune responses. Overall, these results suggest that microbial
factors may play a substantial role in the pathogenesis of human
autoimmune disease associated with hypomorphic RAG defects.
060
Milieu-adjusted (physiological) oxygen concentration reduces
the production of IL-8 and CCL-20 upon stimulation with
Flagellin in CaCo-2 cells
S. Klein, S. F€ormer & K. Heeg
Department of Infectious Diseases, Im Neuenheimer Feld 324,
Heidelberg, Germany
Background: Intestinal epithelial cells (IECs) line the front to micro-
bial components in the gut lumen. Their close contact to various
immune cells as well as their barrier function gives them a central
role in maintaining immunological homeostasis in the gut. While
ambient air comprises about 20% oxygen, the partial pressure of
oxygen in tissues is far below this. As many cellular and immune
functions are influenced by oxygen level, it may also be of impor-
tance in IECs.
Methods: The colon epithelial cell line CaCo-2 was investigated
under a physiological oxygen concentration of 1%. Proliferation was
measured by the incorporation of 3H-Thymidin and viability by
MTT-assay. Chemokine production was measured by ELISA or
intracellular by FACS, gene expression by RT-PCR and proteins were
detected by Western Blot.
Results: Proliferation and viability of the cells were not significantly
altered compared to conventionally cultured cells. While transepithe-
lial electrical resistance (TEER) was initially elevated under low oxy-
gen, it reached comparable levels over time. When stimulated with
the TLR 5-ligand Flagellin, IL-8 and CCL-20 production was dimin-
ished at 1% O2. Interestingly, mRNA levels of IL-8 and CCL-20 were
not significantly reduced under physiological oxygen concentration.
Analysis of MAPK by Western Blot showed a generally higher phos-
phorylation of p38, JNK and ERK1/2 under low oxygen, which was
further enhanced by stimulation with Flagellin. Inhibition of MAPK
did not alter the chemokine secretion. Intracellular IL-8 measure-
ments pointed to an alteration in chemokine transport.
Conclusions: Understanding the influence of the local oxygen pres-
sure on the physiology of the cells could contribute to a better
understanding of the complex immunological network in the intes-
tine.
061
Modeling T-cell dissemination upon nasal immunisation using a
systems biology approach
G. Prota1, A. Boianelli2, E. Pettini1, G. Pozzi1, A. Vicino2 &
D. Medaglini1
1L.A.M.M.B., Dipartimento di Biotecnologie Mediche, Universita di
Siena, Siena, Italy, 2Dipartimento di Ingegneria dell’Informazione,
CSC, Universita di Siena, Siena, Italy
The application of systems biology in vaccinology has recently been
proposed as powerful tool to characterize immune responses to vac-
cination and to predict vaccine immunogenicity and efficacy. Our
group has recently employed a branching process to model in vivo
CD4+ T-cell priming and estimate the probabilities of a cell to enter
in division, rest in quiescence or migrate/dye. This model has been
successfully applied to analyse CD4+ T-cell priming following differ-
ent mucosal routes of immunization such as vaginal or nasal immu-
nization and has allowed to estimate the probability of CD4+ T cells
in the draining lymph nodes to enter in division [Pettini E. et al.,
PlosOne 2013 8:e80545]. Here, a systems biology approach was
employed to get quantitative information on the dissemination of
primed CD4+ T cells from draining lymph nodes (LNs) to distal
lymph nodes and spleen following nasal immunization. The adoptive
transfer model of transgenic OT-II ovalbumin(OVA)-specific CD4+
T cells was employed to study the antigen-specific T-cell primary
activation following nasal immunization. OT-II CD4+ T cells were
labeled with CFSE and adoptively transferred into recipient mice,
that were immunized with OVA and CpG ODN by the nasal route.
Groups of mice were sacrificed 0, 48, 60, 72, 84, 96 and 120 hours
following immunization, and cervical, mediastinal, iliac, and mesen-
teric lymph nodes and spleen were collected. Antigen-specific CD4+
T-cell clonal expansion was observed in draining LNs already
2.5 days following mucosal immunization, while OVA-specific prolif-
erated T cells appeared in distal lymph nodes and spleen since
3.5 days following immunization. A Galton Watson multitype
branching process with emigration was successfully employed to
model in vivo dissemination of proliferated T cells. The model has
allowed to estimate the probability of CD4+ T cells to migrate from
draining lymph nodes to distal lymph nodes and spleen. In conclu-
sion, the modeling analysis shows that the developed model is reli-
able and can be fruitfully exploited for predictive simulations related
to the study of primary T-cell activation and dissemination. Key-
words: Systems biology, T-cell dissemination, nasal immunization,
mathematical modeling.
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Neonatal dendritic cell development
T.Z. Murray & A. Mowat
Institute of Infection, Immunity and Inflammation, 120 University
Avenue, Glasgow, UK
The intestinal immune system has to discriminate between inducing
tolerance and active immunity to food proteins, commensal bacteria
and pathogens. Dendritic cells (DCs) in the gut wall and draining
lymphoid tissues are central to these processes. We and others have
identified four functionally distinct populations of intestinal DCs
based on CD11b and CD103 expression. These appear to develop
from a common DC precursor, however little is known about how
the local intestinal microenvironment might determine their differ-
entiation and subsequent fate. We have begun to explore these
issues, focusing on the neonatal period when the intestinal immune
system has to adapt to rapid changes in diet, anatomical structure
and microbiota.
All four DC subsets are present in the intestinal lamina propria
(LP) from birth, although there are fewer CD103+CD11b+ DCs com-
pared with the adult. However during the first three weeks of life,
there is a progressive increase in the proportion of CD103+CD11b+
DCs, and these become the majority population around weaning,
resembling the composition of the DC compartment in the adult.
Few migratory or resident DCs are found within the draining
mesenteric lymph node (MLN) at birth, but both populations
increase gradually in number thereafter. Consistent with their migra-
tory origin from the LP, the numbers of CD103+CD11b+ and
CD103+CD11b- DCs show delayed appearance compared with the
mucosa. However by three weeks of age, the proportions of DC sub-
sets in the MLN are comparable to those observed in adults.
Together these data support the idea that intestinal environmental
factors drive differentiation of DC subsets in distinct, age-dependent
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ways. Specifically CD103+CD11b+ DCs, unique to the intestine, are
highly dependent on changes within the local environment. Identifi-
cation of these factors will aid understanding of how DCs induce
tolerance against commensal bacteria and food proteins.
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Novel markers to evaluate immunomodulatory effects of
antibiotics in DSS-colitis: micro-RNA expression and microbiota
populations
J. Garrido-Mesa1, A. Rodriguez-Nogales1, F. Algieri1,
N. Garrido-Mesa1, M.P. Utrilla1, M.E. Rodriguez-Cabezas1,
F. Garcia2, N. Chueca2 & J. Galvez1
1Pharmacology, Avenida del Conocimiento s/n, Granada, Spain,
2Universitary hospital San Cecilio, IBIG, Granada, Spain
Introduction: Minocycline and doxycycline exert immunomodula-
tory effects that could be beneficial in IBD. Micro-RNAs have been
recently reported to play a key role in intestinal homeostasis that
can be influenced by microbiota populations. The aim of the study
was to evaluate the effect of these antibiotics in the DSS-colitis
model in mice, characterizing the modifications induced in the
micro-RNA expression and bacterial diversity.
Methods: Male C57BL/6J mice were assigned into non-colitic and
DSS-colitic groups. Colitis was induced by dextran sodium sulfate
(DSS) in the drinking water (3%) for 6 days. Once the colitis pro-
cess was established, colitic mice were divided in three groups: DSS-
control (without treatment), MNC (receiving minocycline 50 mg/kg/
day) and DXC (receiving doxycycline 10 mg/kg/day). After six days
of treatment, all mice were sacrified. The inflammatory status was
evaluated by a disease activity index (DAI), qPCR of inflammatory
markers, including micro-RNAs. Also, changes in microbiota popu-
lations were characterized by pyrosequencing.
Results: According to the DAI values, minocycline and doxycycline
treatment improved the recovery of colitic mice, ameliorating some
of the inflammatory markers, including IL-1b, IL-17, TGFb, MMP-
2, MUC-2, MUC-3, ZO-1 and occludin. A micro-RNA expression
profile was established for this model of colitis showing an increased
expression of miR-155, miR-223 and miR-150 while miR-143 and
miR-375 were decreased. Both antibiotics partially restored the
expression of some of these markers. Pyrosequence characterization
of microbiota showed that minocycline and doxycycine treatments
increased the bacterial diversity, reverting the dysbiosis produced by
DSS-colitis.
Discussion and Conclusion: Minocycline and doxycycline are able
to modify the expression of different inflammatory markers and mi-
croRNAs, as well as to increase the intestinal bacterial diversity.
These observations confirm the combined contribution of antibiotic
and immunomodulatory properties ascribed to these compounds
that could be of great interest to control the complex pathogenesis
of IBD.
064
Optimization of a flow cytometric peripheral eosinophil assay
aiding in diagnosis and monitoring of allergic disorders
M. Tseng, L. Austin, M. Ryherd, R. Limgala, M. Plassmeyer,
M. Brown, R. Gupta & O. Alpan
Amerimmune, 11212 Waples Mill Road Suite 100, Fairfax, VA, USA
Introduction: Eosinophilic inflammation is an important component
of the pathology seen in allergic disorders such as eosinophilic gas-
trointestinal disorders and asthma. Expression of an integrin, CD11b
on eosinophils is one sensitive surrogate biomarker for activation,
accumulation and recruitment to inflammatory sites.
Method: We sought to optimize the assay in terms of sample post-
collection stability, staining duration and gating strategy for clinical
implementation purposes. The criteria for this evaluation are based
on the percent and CD11b expression in median fluorescent intensity
of eosinophil. The gating strategy in identifying eosinophils are aug-
mented by their auto-fluorescent properties and CD11b expression
instead of the classical definition characterized by CD9hi and CD16dim
phenotype which shows overlap with our new method. Basically, the
eosinophil events, derived from total granulocytes, are identified on
the bi-variate plot with FITC, an empty channel versus side scatter
parameters, as they are most distinctive on the lower spectrum of
wavelength. We chose an acceptance range for the criteria to be <
20%CV comparing to those parameters at 0, 4, 6, 24 and 48-hour.
Results: Among five different anti-coagulant collection tubes,
K2EDTA and 3.2% Sodium Citrate anti-coagulants shown to have at
least 24-hour stability window, which is important to further this
assay for clinical diagnostics. As a result, the optimized flow panel
design in conjunction with this new gating strategy and the extended
sample stability give the assay more flexibility, efficiency and an
additional clinical tool aiding in allergic disorders evaluation as well
as its utilization in clinical trials.
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Oral antigen modulates primary systemic KLH-specific T- and
B-cell responses in humans
T. Meyer1, B. Boortz1, C. Giesecke2, J. Maul1, J. Preiß1,
T. Doerner2 & R. Ullrich1
1Gastroenterology, Berlin, Germany, 2Rheumatology, Berlin, Germany
Oral tolerance is an antigen-specific process and refers to specific
non-reactivity of the immune system against an antigen that has
been fed to the organism and thus comes into contact with the
immune system via the mucosa of the gastrointestinal tract. Espe-
cially in humans, the underlying mechanisms are poorly understood.
In our clinical study we administered 50 mg KLH/d for 10 days
to healthy volunteers of the oral (n = 8) but not the control group
(n = 8). Afterwards both groups were subcutaneously immunised
with KLH. A DTH skin reaction was then provoked by an intrader-
mal KLH injection. Follow-up investigations were done after
6 months. During the study PBMC were isolated at defined time
points and KLH-specific T and B cells were analysed. The propor-
tions of cytokine-producing KLH-specific CD4 T cells and KLH-
induced proliferation of CD4 T cells were analysed after in-vitro res-
timulation. KLH-specific B cells were identified by fluorescent-
labeled KLH. KLH-specific serum IgG, IgA and IgM as well as IgG
subclasses were measured by ELISA.
Only 2/8 volunteers of the oral group but 7/8 volunteers of the
control group developed a subsequent skin reaction. KLH-specific
proliferation and frequencies of KLH-specific CD154+ CD4+ T cells
producing IFN-gamma, IL-2 and TNF-alpha were higher in volun-
teers with DTH compared to those without a DTH. Oral KLH
primed rather than suppressed KLH-specific B cells. Primary KLH-
specific plasma cells were not predominantly IgM+ but commonly
expressed IgA.
Tolerance induction in humans by oral antigen was confirmed
only in part. In particular, KLH-specific proliferation was not abol-
ished after oral KLH.
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Oral tolerance failure upon neonatal gut colonization with
Escherichia coli producing the genotoxin colibactin
T. Secher1, D. Payros2, C. Brehin3, M. Boury2, C. Watrin2,
M. Gillet4, I. Bernhard-Cadenat1, S. Menard4, V. Theodorou4,
A. Saoudi1, M. Olier4 & E. Oswald1
1INSERM-U1043, Toulouse, France, 2INRA-USC1360, Toulouse,
France, 3CHU Purpan, Toulouse, France, 4INRA-UMR1331, Toulouse,
France
Introduction: The commensal bacterium E. coli belongs to the pio-
neer microflora colonizing the mammalian gut immediately after
birth. E. coli can be differentiated in four major phylogenetic groups
(A, B1, B2 and D). Recent studies showed that B2 group, including
strains producing the genotoxin colibactin, is over-represented while
its prevalence is increasing among E. coli strains persisting in the
microbiota of humans from developed countries, including infants.
In parallel, recent evidences demonstrate that inflammatory-related
diseases are on the increase in developed countries. Neonatal intesti-
nal microbiota, through the modulation of metabolism and immu-
nity may have long-term consequences on host susceptibility to such
diseases.
Aims and Methods: Using an original rodent model of neonatal gut
colonization allowing the natural vertical transmission and persis-
tence of E. coli strains from mother to the offspring we analyzed the
effects of genotoxic commensal B2 E. coli on the host oral tolerance
to intestinal antigen. Pregnant rats were fed with a human commen-
sal B2 E. coli, an isogenic non-genotoxic mutant, or an isogenic
genotoxic complemented mutant. After weaning, rats were submitted
to an OVA oral tolerance and delayed-type hypersensitivity (DTH)
protocol.
Results: We report here that colibactin expression increased intesti-
nal permeability and enhanced intestinal translocation of B2 E. coli
in neonates. At adulthood, we observed impaired intestinal barrier
together with an increase of the permeability through Peyer’s patches
correlated with enhanced IFN~a levels. This alteration of the gut bar-
rier homeostasis exacerbated the mucosal and systemic immune
responses against a luminal antigen through an experimental model
of OVA-driven oral tolerance. Animals early colonized by colibactin-
producing E. coli exhibited enhanced OVA-specific response, which
was correlated with a defect in Tregs population. Submitted to a
mucosal DTH reaction, colibactin-producing E. coli colonized ani-
mals displayed exacerbated signs of inflammation which was also
correlated to a decreased in Tregs population.
Conclusion: The neonatal gut colonization by E. coli producing the
genotoxin colibactin enhances intestinal translocation and subse-
quently alters oral tolerance. Thus, through the production of colib-
actin, early gut colonization by commensal E. coli may represent a
risk factor for the development of immune-mediated diseases.
067
Oral tolerance susceptibility is related to exacerbated
granuloma development in schistosomiasis.
D. Tavares1, A.C. da Silva1 & A. Xavier2
1Departamento de Genetica, Rua S~ao Francisco Xavier, 524 - PHLC,
Lab. Rio de Janeiro, Brazil, 2Departamento de Imunobiologia,
Universidade Ferderal Fluminense (UFF), Brazil
The Schistosoma mansoni infection was studied in two strains of
mice genetically selected for extreme phenotypes of susceptibility
(TS) and resistance (TR) to oral tolerance. TR strain present good
inflammatory responses and a non-tolerogenic profile while TS are
non-inflammatory but high-tolerogenic, with high percentages of
CD4+CD25+Foxp3+ T regulatory cells, and able to produce high lev-
els of inhibitory citokynes such as IL-10. The aim of this study is to
correlate the cytokines production to the pathology caused by infec-
tion. TS strain have higher weakness, apathy, prostration and mor-
tality due to hepatosplenomegaly more intense due to the larger size
of hepatic granulomas and extensive fibrosis of these granulomas.
Both strains produced IFN-~a, but TS produced IL4 and IL-10 in a
larger quantity, however IL-10 was not able to regulate the growth
of hepatic granulomas exacerbated this lineage. High levels of IL-4
in TS strain are consistent with the exacerbation of granulomas,
since IL-4, as well as IL-13, induces collagen synthesis and is related
to the development of fibrosis in schistosomal granuloma. Additional
studies are needed to confirm our proposals and to understand the
mechanisms underlying the difference in immune response of these
strains in the schistosoma-host relationship.
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Oral tolerance susceptibility is related to higher reduction of B
lymphocytes subpopulations in schistosomiasis.
D. Tavares1, A.C. da Silva1 & A. Xavier2
1Departamento de Genetica, Rua S~ao Francisco Xavier, 524 - PHLC,
Lab. 200C, Rio de Janeiro, Brazil, 2Departamento de Imunobiologia,
Universidade Federal Fluminense (UFF)
The Schistosoma mansoni infection was studied in two strains of
mice genetically selected for extreme phenotypes of susceptibility
(TS) and resistance (TR) to oral tolerance. TR strain present good
inflammatory responses and a non-tolerogenic profile while TS are
non-inflammatory but high-tolerogenic, with high percentages of
CD4+CD25+Foxp3+ T regulatory cells, and able to produce high lev-
els of inhibitory citokynes such as IL-10. The aim of this study is to
correlate the cytokines production to the pathology caused by infec-
tion. TS strain have higher weakness, apathy, prostration and mor-
tality due to hepatosplenomegaly more intense due to the larger size
of hepatic granulomas and extensive fibrosis of these granulomas.
Both strains produced IFN-~a, but TS produced IL4 and IL-10 in a
larger quantity, however IL-10 was not able to regulate the growth
of hepatic granulomas exacerbated this lineage. High levels of IL-4
in TS strain are consistent with the exacerbation of granulomas,
since IL-4, as well as IL-13, induces collagen synthesis and is related
to the development of fibrosis in schistosomal granuloma. Additional
studies are needed to confirm our proposals and to understand the
mechanisms underlying the difference in immune response of these
strains in the schistosoma-host relationship.
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Oral tolerance susceptibility is related to ultrastructural
alterations in adult female and male Schistosoma mansoni
A. Xavier1, D. Tavares2, E. Guimar~aes3, A.C. da Silva2, M. Neto2 &
A. Henrique3
1Departamento de Imunobiologia, Niteroi, Brazil, 2Universidade do
Estado do Rio de Janeiro (UERJ), Brazil, 3Fiocruz, Brazil
The Schistosoma mansoni infection was studied in two strains of
mice genetically selected for extreme phenotypes of susceptibility
(TS) and resistance (TR) to oral tolerance. The objective was to ana-
lyze by Transmission Electron Microscopy the influence of the host
immune regulatory profile on the worm morphology. Parasites
recovered from TR mice showed no morphological changes. How-
ever, specimens collected from TS mice, exhibited tubercle swelling
with blunted and shortened spines in lower density. These tegument
alterations were similar to those described with artemether or pra-
ziquantel treatment, supporting observations that the host immune
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system influences the tegument development and function of worms
harbored in non anti-helminthic treated TS mice. The ileum oogram
from TS mice showed a higher percentage of dead eggs and a lower
percentage of immature eggs than TR mice, but had similar quanti-
ties of collected eggs. This suggests that in TS mice the alterations in
adult worm tegument prevented egg development, as a consequence
of decreased glycogen granules and extensive lysis of internal struc-
tures, but not egg production reduction. These results corroborate
our previous Scanning Electron Microscopy study indicating the
influence of the host immune regulatory profile on the development
and function of the worm reproductive system and tegument.
071
Pathogenesis of pouchitis--analysis of adherent junction
proteins
F. Lasitschka1, M. Tossing1, M. Kadmon2 & C. Leowardi2
1Pathologisches Institut, Im Neuenheimer Feld 224, Heidelberg,
Germany, 2Chirurgische Universit€atsklinik, Im Neuenheimer Feld 110,
Heidelberg, Germany
Introduction: Pouchitis, which is defined as the inflammation of the
ileum mucosa in the pouch, is one of the major complications after
restorative proctocolectomy and Ileoanal Pouchimplantation (IAP)
in ulcerative colitis (UC) patients. The severity of symptoms varies
and quality of patient’s life are impaired. There are indications that
the pathogenic mechanisms of the underlying disease, i.e. ulcerative
colitis are associated with a disturbed response to bacterial antigens
in the pathogenesis of pouchitis. An important mechanism in this
case represents a failure in the intestinal barrier, which is formed by
antimicrobial peptides, the mucus itself, tight and adherent junctions
between the intestinal epithelial cells and the mucosal immune sys-
tem.
Methods: Screening of adherent junction proteins by RTqPCR pro-
filer arrays in a defined collective of pouchitis samples. Validation of
target genes by qPCR in an independent collective. Analysis of target
antigens by immunohistochemistry. Results: Severe pouchitis in
patients with ulcerative colitis shows a significant dysregulation of
various adherent junctionproteins compared to the pouch samples
of FAP patients.
Conclusion: Pouchitis in ulcerative colitis patients is characterized
by a dysregulation of adherent junction proteins compared to FAP
patients and may contribute to a fundamental difference between the
two disease entities.
072
Perinatal exposure to bisphenol A (BPA) leads to inappropriate
innate and adaptative immune responses in intestinal and
systemic compartments at adulthood
L. Guzylack-Piriou, S. Menard, C. Cartier, C. Lencina, E. Gaultier
& E. Houdeau
INRA, 180 chemin de tournefeuille, Toulouse, France
Oral route is the major route of exposure to the food contaminant
BPA, and intestine the first organ exposed. In rodent models, BPA
has demonstrated its ability to interfere with the gut immune system,
particularly when perinatal exposure occurred, and predisposing to
food intolerance at adulthood. In this study, we report that adult
mice perinatally exposed to a low dose of BPA [5 µg/kg BW/day]
showed reduced retinoic acid (RA) production by intestinal epithe-
lial cells (IEC). A decrease in lysozyme secretion, and total IgA and
IgG production in feces was also observed. These alterations were
associated with a defect in dendritic cells maturation (DC) from
lamina propria (LP) and spleen. Frequency of these cell subsets
increased in gut mucosa while it decreased in spleen, suggesting a
domiciliation defect after perinatal BPA treatment. Concomitantly, a
decrease of regulatory and activated T cells in LP and mesenteric
lymph node was observed while these sub-populations were
increased at splenic level. Interestingly, an alteration in the frequency
of innate lymphoid cells ILC3 producing IL-17 and IL-22 occurred
in LP, associated with a decrease of aryl hydrocarbon receptor (AhR)
expression, known to drive the development of gut ILC22. Our
results demonstrated that perinatal exposure to BPA weakens protec-
tive and regulatory immune functions of IEC associated with an
alteration of DC and T cells populations and ILC3 development.
These disturbances in the progeny might impair mucosal tolerogenic
responses, and favored inflammatory systemic immune responses,
thus increasing susceptibility to food adverse reactions.
073
Post-natal mucus barrier formation in the small intestine and
distal colon
G.M.H. Birchenough, M.E.V. Johansson & G.C. Hansson
Medicinal Biochemistry and Cell Biology, Medicinaregatan 9A,
Gothenburg, Sweden
Intestinal mucus is secreted by epithelial goblet cells (GC) and is
composed of a limited number of proteins including the gel-forming
mucin Muc2. The mucus forms a barrier that restricts microbiota
access to the epithelium by region-specific mechanisms. In the colon
this is dependent on stacked, tissue adherent multimeric sheets of
Muc2 which form an impenetrable filter between bacteria and the
colonic tissue. In the small intestine the Muc2 network is non-adher-
ent and penetrable, but forms a matrix containing antimicrobial
peptides. Although developmental aspects of GC biology and mucin
composition/expression have been partially explored, surprisingly lit-
tle is known regarding the timing of functional mucus barrier for-
mation and the factors which influence this process. This is of
interest considering the susceptibility of neonates to certain intestinal
pathogens and necrotizing enterocolitis.
Initial mucus barrier formation was characterised in the small
intestine and distal colon by ex-vivo analysis of rat tissue using a
horizontal Ussing chamber-like system that allows quantification of
mucus thickness, penetrability and growth rate. Immunohistochemi-
cal staining of methanol-Carnoy fixed tissue sections with antibodies
against both the apoprotein and mature forms of Muc2 allowed
in-vivo assessment of mucus barrier formation, Muc2 synthesis/secre-
tion and GC distribution. Tissue obtained from both conventionally-
raised (ConvR) and germ-free (GF) mice was used to assess the
potential role of bacterial colonisation in barrier formation. Analysis
of the microbiota was undertaken using qPCR targeting the bacterial
16S gene with universal and taxon-specific primers.
Although GCs expressed and secreted Muc2 in-utero, generation
of a functional mucus layer in both the small intestine and the distal
colon occurred post-natally. Colonic barrier formation was charac-
terised by rapid alterations in mucus properties and GC distribution
preceding a more steady increase in the rate of mucus processing.
Slower barrier formation was observed in the small intestine, charac-
terised by the gradual release of stored Muc2 from villus GCs. Con-
vR barrier development was strongly correlated with increased
bacterial numbers and absent in GF animals providing a strong caus-
ative link between colonization and initial barrier formation.
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Protease-activated receptor 2 is required for inflammation of the
small intestine triggered by T. gondii in C57BL/6 mice
C. Bonnart1, G. Feuillet1, V. Vasseur1, N. Cenac1, B. Gilmore2 &
N. Blanchard1
1Inserm U1043 CPTP, place Baylac, Toulouse, France, 2School of
Pharmacy, 97 Lisburn Road, Belfast, UK
Toxoplasma gondii (T.g.) is a widespread parasite present on all con-
tinents. Infection by T.g. persists in one third of the human popula-
tion and can cause severe neurological and ocular pathologies called
toxoplasmosis. T.g. naturally enters the organism via the oral route
and crosses the small intestinal barrier to reach internal organs of the
body. Interestingly, in several mammals, small intestine inflammation
is a pathological feature associated with T.g. infection, which is highly
reminiscent of the Crohn’s disease (CD) pathology. Previous studies
have highlighted the contribution of proteases, protease-activated
receptors (PAR) and their signaling pathways, as inflammatory modu-
lators in the gut. Using the gut inflammation model triggered by T.g.
infection in C57BL/6 mice, we show that the development of intesti-
nal inflammation requires active PAR2 signaling. Following gavage
with T.g. cysts, PAR2-deficient animals exhibited milder inflamma-
tion, characterized by lower microscopic and macroscopic inflamma-
tion scores and lower up-regulation of pro-inflammatory mediators
IL-6 and KC. In addition, a number of pro-inflammatory polyunsat-
turated fatty acid metabolites were increased in infected wild-type ani-
mals but not in PAR2-deficient animals. Interestingly, production of
IFNc and TNFa, two key effector cytokines in this pathology, was not
affected by PAR2 deletion. Finally, using innovative protease activity-
based probes, our data revealed the existence of a clear disequilibrium
in active serine proteases between inflamed and normal gut tissues.
Identification of these dysregulated proteases is underway to investi-
gate their role in the PAR2 signaling cascade leading to gut inflamma-
tion in the small intestine. This study may pave the way towards the
discovery and modulation of new key proteases, potentially relevant
for the treatment of intestinal inflammation disorders.
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Querying the intestinal host-pathogen response to salmonella
infection using high-throughput kinomics
R. Arsenault, C. Swaggerty, K. Genovese, H. He & M. Kogut
United States Department of Agriculture, College Station, USA
Enteric pathogens have a profound impact of the functioning of the
gastrointestinal tract. Serovars of Salmonella elicit a strong pro-inflam-
matory response in species such as humans and bovine. However, in
species such as mice and chickens a significant immune response is
not observed and the bacterium appears to be well tolerated. Salmo-
nella only elicit disease in mice through the use of antibiotic pre-treat-
ment and in chickens by infecting the animals very early post-hatch.
This differential response is of significant interest as it may elucidate
mechanisms of Salmonella pathogenesis, host response and microbiota
tolerance. Our group has considered two serovars of Salmonella, Ty-
phimurium and Enteritidis, and the host-pathogen interactions in the
chicken gut. We have performed this analysis at the kinome level; the
differentially active kinases within the gut tissue. We compared
infected and non-infected animals for host response. Our observations
point to the induction of a response at the interface of immunity and
metabolism. The key cellular signaling intermediates that have
appeared in our analyses include mTOR, GSK3B, MAPKs, AKT, and
AMPK. We have observed that approximately 4 days post-infection
the response switches from one that is pro-inflammatory to one that
suppresses immune response generating a tolerance of infection. In
addition, in a study involving the Salmonella Typhimurium mutant
lacking the AvrA virulence gene we observed distinct differences in the
pattern of phosphorylation within the ErbB signaling pathway. This
included not only the ceca, the natural site of infection, but also the
adjoining jejunum, indicating that the AvrA mutant Salmonella is able
to alter signaling at alternative sites along the gastro-intestinal tract.
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Regulation of Intestinal Immune Responses by the Atypical
Chemokine Receptor ACKR4
C. Thomson, A. Mowat & R. Nibbs
Institute of Infection, Immunity and Inflammation, University of
Glasgow, UK
Whether they are aimed at conferring protective immunity or toler-
ance, immune responses in the small intestine are fundamentally
dependent on the action of chemokines and their cognate receptors.
For example, CCL19 and CCL21 facilitate the migration of CCR7+
mucosal dendritic cells from the lamina propria to the mesenteric
lymph nodes (MLN), whilst CCL25 recruits CCR9+ gut-homing leu-
kocytes into the lamina propria from the circulation. Interestingly,
CCL19, CCL21 and CCL25 also bind to ACKR4 (CCRL1), an atypi-
cal chemokine receptor that is expressed in both the intestine and
the MLN. In vitro studies show that, rather than inducing cell
migration, ACKR4 binds and internalises its ligands, targeting them
for intracellular degradation. ACKR4 is therefore proposed to regu-
late chemokine receptor dependent migration by scavenging extracel-
lular chemokines. However, the expression and function of ACKR4
in vivo, particularly in the intestinal immune system, has not been
investigated in any great depth. Here, using ACKR4-eGFP reporter
mice and ACKR4-deficient mice, we have identified which cell types
express ACKR4 in the lamina propria and gut-associated lymphoid
tissues. Furthermore, we have examined the impact of ACKR4 defi-
ciency on immune responses in the small intestine. These studies
aim to establish the role of ACKR4 in intestinal immunity, and dis-
sect the complexity of chemokine networks in the small intestine.
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Relationship between Th17 and Treg in nasopharynx-associated
lymphoid tissue and their association with age and
pneumococcal carriage in humans
A. Mubarak1, V. Casey2, N. Upile2, C. Xie2, R. Sharma2, H. Beer3,
M. McCormick3, M. Ahmed1, P. McNamara4 & Q. Zhang1
1Clinical Infection and Immunology, Liverpool, UK, 2ENT Department,
Alder Hey Children’s Hospital, Liverpool, UK, 3ENT Department,
Royal Liverpool University Hospital, Liverpool, UK, 4Department of
Women’s and Children’s Health, University of Liverpool, Liverpool, UK
Streptococcus pneumoniae is a leading cause of respiratory tract
infection in humans. S. pneumoniae colonizes human nasopharyngeal
mucosa, and carriage is common in young children that may account
for the high incidence of pneumococcal disease in this age group.
Pneumococcal carriage rate in humans decreases with age due to nat-
ural immunity. However, the immunological factors responsible for
the clearance of pneumococcal carriage remain undefined. Recent
studies in mice suggest Th17 is important in host clearance of S.
pneumonia. We have studied the relationship between numbers of
mucosal Th17 and T regulatory cells (Foxp3+ Treg) in human naso-
pharynx-associated lymphoid tissue (NALT) and age and their associ-
ation with pneumococcal carriage in children and adults. Numbers of
Th17 and Treg in adenotonsillar tissue were significantly higher than
in peripheral blood (P < 0.01) in both children and adults. There was
a negative correlation between numbers of Th17 and Treg in adeno-
ª 2014 The Authors. © 2014 John Wiley & Sons Ltd, Immunology, 143 (Suppl. 1), 12–42
Abstracts34
tonsillar tissue (r = 0.52, P < 0.01). Numbers of adenotonsillar
Th17 were shown to correlate with patients age (r = 0.62, P < 0.01),
whereas numbers of Treg were inversely correlated with patients age
(r = 0.50, P < 0.01). Furthermore, there was a positive correlation
between the Th17/Treg ratio in NALT and age of patients. Also, the
Th17/Treg ratio was significantly higher in pneumococcal carriage
negative than positive children (P < 0.05). Our findings suggest that
the balance/ratio of mucosal Th17 and Treg in nasopharynx is a criti-
cal determinant of pneumococcal clearance/carriage, and support
efforts to promote mucosal Th17 in vaccination strategy against
pneumococcal infection in humans.
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Retinoic acid modulates the early expansion and differentiation
of CD4+ T cells during the development of intestinal
inflammation
A. Rivollier1, L. Pool2, U. Frising2 & W. Agace1
1Danish Technical University, Veterinary Institute, Frederiksberg C.,
Denmark, 2Lund University, Experimental Medical Sciences, Lund,
Sweden
Epidemiological studies of vitamin A-deficient populations have
illustrated the importance of vitamin A and its metabolite all-trans
retinoic acid (RA) in mucosal immune responses. In support of that
finding, we and others have shown that RA produced by intestinal
dendritic cells is required for the generation of gut-tropic T cells and
IgA-secreting plasma cells. Evidences from the literature suggest
antagonistic roles for RA in intestinal T cell biology. In the homeo-
static intestine RA plays anti-inflammatory functions, sustaining the
development of foxp3+ regulatory T cells, while restraining Th17
effector T cell differentiation. In contrast, the role of RA in the con-
trol of intestinal CD4 T cell responses under infectious or inflamma-
tory conditions remains to be more clearly defined.
RA has been shown to control the CD4+ T cell compartment by
signaling through the RA receptor RARa. We therefore took advan-
tage of mice expressing a dominant negative form of the RARa, spe-
cifically in the CD4 T cell compartment (RARdn CD4Cre+ mice), in
order to conditionally ablate RA signaling in CD4+ T cells during
the development of intestinal inflammation in the T cell transfer
colitis model.
Histological, flow cytometry and real time PCR analyses indicate
that RA signaling negatively modulates the early expansion of CD4+
T cells following their transfer into RAG-/- mice, but also their dif-
ferentiation into IL-17-producing cells in a RORct-dependent man-
ner. Indeed RA signaling-deficient CD4+ T cells selectively
accumulate and showed increased capacities to differentiate into IL-
17+, IL-17+IFNc+ and foxp3+ cells, but reduced capacities to differ-
entiate into IFNc+ cells and were less potent at inducing intestinal
inflammation. RA signaling-deficient CD4+ T cells were also unable
to differentiate into cytotoxic T lymphocyte (CTL)-like cells within
the intraepithelial lymphocyte compartment of the colon. We are
currently deciphering the mechanisms of these effects of RA on
CD4+ T cells.
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T cell receptor repertoire in refractory celiac disease as revealed
by next generation sequencing
M. Schumann1, J.-M. Ritter2, K. Zimmermann2, B. Siegmund1,
A. Rosenwald3, S. Daum1 & M. Hummel2
1Department of Gastroenterology, Charite, Hindenburgdamm 30,
Berlin, Germany, 2Institute of Molecular Pathology, Charite, Berlin,
Germany, 3Institute of Pathology, University of W€urzburg, W€urzburg,
Germany
Introduction: Refractory celiac disease (RCD) is a Marsh III enter-
opathy with accompanying malabsorption in spite of stringent glu-
ten-free diet (GFD) for >1 year. Contrary to type-I RCD, a clonal T
cell population builds up in type-II RCD and develops further to
overt T cell lymphoma in a high percentage of cases. In most institu-
tions, diagnostics to differentiate the two subtypes is based on Gene-
Scan technology determining fragment sizes of PCR-amplified T cell
receptor (TCR) DNA sequences and immunohistology. However,
phenomena as “oligoclonality” and “pseudoclonality” are frequently
found in GeneScans and add to a specificity problem. Moreover, the
sequences of the variable regions of the involved TCRs are unknown.
Aims: To shed further light on TCR biology in RCD and to do a
proof-of-concept study for diagnostic testing.
Methods: Determination of the T cell repertoire of duodenal mucosa
by multiplex PCR of TCRb-CDR3 regions. Next generation sequenc-
ing (NGS, Illumina HiSeq 2000) of amplicons in controls, active cel-
iacs (ACD), celiacs with GFD, unclassified Marsh I cases, RCD type-
I and RCD type-II.
Results: On average, 106 sequences per sample were analyzed, yield-
ing ~1000 TCR rearrangements. Clonotypes were defined as identical
sequences of CDR3 amplicons. Averaging all RCD type-II, the most
frequent clonotype was 52.5% of all clonotypes per sample, which
was significantly higher than in controls (16.7%; P < 0.01) or RCD
type-I (17.3%; P < 0.001, cut-off>0.5%). ACD revealed a non-signif-
icant tendency towards a higher frequency. Interestingly, patients
with high clonotype frequencies developed significantly more often a
T cell-lymphoma. The technique was validated by identifying the
same top clonotypes in various individuals receiving two examina-
tions months apart. When searches for alignments with previously
published CDR3 sequences were done, a significant portion of these
sequences was found in our celiac samples, however not within the
high frequency clonotypes (HFC). Moreover, HFC´s of individual
RCD II patients did not reveal cross-homology, arguing against spe-
cific TCR motifs in RCD II pathophysiology.
Conclusion: TCRb-NGS-analysis reproducibly detects monoclonal T
cell populations in RCD-II. The TCR-CDR3-HFCS in RCD-II are
not previously described, gliadin-associated TCR sequences, which
might explain their potential to expand gliadin-independently.
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T cell specificity towards native versus deamidatede gluten
epitopes in celiac disease
K.S. Rasmussen1, A. Staal1, C. Nielsen2, T. Barington2, S. Husby3
& H. Toft-Hansen3
1University of Southern Denmark, Denmark, 2Clinical Immunology,
Odense University Hospital, Denmark, 3H. C. Andersen Children’s
Hospital, Odense University Hospital, Denmark
Background: Celiac disease (CD) is a chronic, inflammatory disease
of the small intestine, which occurs in genetically predisposed indi-
viduals after ingestion of gluten from wheat, barley and rye. The glu-
ten-specific CD4+ T cells play a crucial role in the pathogenesis of
CD, where T cell receptors (TCR) recognize gluten epitopes dis-
played by HLA-DQ2/8 molecules. Deamidation of gluten epitopes by
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tissue transglutaminase 2 is known to enhance the binding capacity
to HLA-DQ2/8. TCRs contain highly variable regions called comple-
mentarity-determining regions (CDR). In this study, we investigated
whether different mucosal gluten-specific CD4+ T cells from CD
patients recognize native and/or deamidated peptides.
Methods: We established five gluten-reactive T cell lines (TCLs)
from duodenal biopsies obtained from four children and one adult
with CD. The reactivity of the TCLs was tested in proliferation
assays against a panel of four deamidated and three native gluten
epitopes. A pair of one deamidated and one native epitope that elic-
ited the strongest T cell proliferation in all TCLs was used in nested-
PCR-based CDR3 diversity determination of one TCL.
Results: We found that all TCLs proliferated after stimulation with
both native and deamidated peptide. The response to deamidated
peptide was significantly stronger. The CDR3 length distributions of
responding cells in one TCL displayed overall three different patterns
according to the CDR3 lengths.
Conclusion: We confirmed that the deamidation of gluten epitopes
enhance the T cell proliferation, but that native peptides also induce
a response, albeit lower. We cannot yet make conclusions based on
our preliminary results from CDR3 diversity determination of one
TCL.
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TH9 cells drive IL-9 mediated colitis-associated colorectal
cancer (CAC)
K. Gerlach1, H.-A. Lehr2, A. McKenzie3, M.F. Neurath1 &
B. Weigmann1
1University Erlangen-Nuremberg, Medical Clinic 1, Erlangen,
Germany, 2Institute of Pathology, Campus Bodensee, Friedrichshafen,
Germany, 3MRC Laboratory of Molecular Biology, Cambridge, UK
Introduction: Interleukin 9 is a pleiotropic pro-inflammatory cyto-
kine mainly produced by T cells, beside B cells and mast cells.
Recently, a specialized subset of T cells has been identified, dedicated
to produce IL-9 and therefore named Th9 cells. In these cells the
IL-9 gene is regulated by transcription factors like PU.1 and IRF4.
IL-9 has been found to exert many biological functions, but the role
of Th9 cells in colitis and colitis-associated cancer is still unclear.
High concentrations of IL-9 in the colon tissue of colitis patients
point out the important role for this cytokine in the development of
colitis, but the involvement of Th9 cells in antitumor immunity is
still not known. For this reason we started to investigate the role of
IL-9 and Th9 cells in the development of colitis-associated colorectal
cancer (CAC).
Methods: Il9KO mice were subjected to the experimental oxazolone
model to induce colitis and treated with AOM/DSS for the develop-
ment of colon cancer. Miniendoscopic analysis has been done to
monitor the inflammation and the number and size of tumors. For
restoration of the IL-9 deficient phenotype an IL-9 expressing mini-
circle DNA vector was injected into Il9KO mice by hydrodynamic
injection and the model of AOM/DSS has been investigated. Tumors
of the colon have been isolated for histological sections and stained
with T cell specific antibodies and PU.1. For analysis of cytokines
and transcription factor expression RT-PCR was performed.
Results: As Il9KO mice were protected in the experimental oxazo-
lone-colitis model, we analysed those mice in the tumor model. We
observed a significant reduction of tumor size and numbers in Il9KO
mice. Furthermore, we explored the effect of IL-9 on tumor growth
by overexpression of IL-9 via mini-circle DNA and AOM/DSS treat-
ment, which led to the development of tumors when IL-9 is absent.
Additionally, in cryosections of tumorigenic colon tissue more PU.1+
T cells were found, pointing out the important relevance for Th9
cells in colon cancer.
Conclusion: Our findings uncover a crucial role of IL-9 producing
effector T cells in murine ulcerative colitis and colitis-associated neo-
plasias. The presence of PU.1+ CD4+ -expressing cells in inflamed
and tumorigenic tissue suggests that these cells belong to the recently
described Th9 T cell subset.
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The anatomical origins of migratory dendritic cells in the
intestine
S. Houston1, V. Cerovic1, O. Schulz2, O. Pabst2 & S. Milling1
1Institute of Infection, Immunity and Inflammation, GBRC, 120
Univesity Place, Glasgow, UK, 2Institute of Immunology, Carl-
Neuberg-Str. 1, Building I11, Hannover, Germany
Dendritic cells (DCs) are fundamental in controlling immune
responses in the small intestine (SI) and colon; they migrate to the
mesenteric lymph node (MLN) and prime gut-tropic effector or reg-
ulatory T cells. The aim of this work was to determine whether the
DCs that migrate to the MLN from the intestine originate in the
lamina propria (LP), or from the Peyer’s patches (PP). First, the
anatomical organisation of the lymphatic vessels draining to the
MLN from the SI and colon was investigated. Once this had been
established, the migration of DCs from the LP and PPs to the MLN
was examined.
Here, I demonstrate the anatomical segregation of DCs that
migrate to the MLN from the SI and colon. After SI photoconver-
sion in fluorescent transgenic Kaede mice, converted DCs were
found only in the SI-draining MLN. Likewise following photocon-
version of the colon in Kaede mice, converted DCs were detected
only in the colonic-draining MLN. To examine the functional conse-
quence of this anatomical compartmentalisation of lymphatic drain-
age, mice that express ovalbumin only in the SI epithelium were
used. Only DCs isolated from SI-draining MLN, but not the colon-
draining MLN, were able to present SI derived antigen and cause
proliferation of na€ıve T cells.
To investigate DC migration from PPs to the MLN, PPs in Kaede
mice were photoconverted. DCs were then detected in the SI-drain-
ing MLN, indicating that some DCs migrate from the PP to the
MLN. Migration of PP DCs to the MLN was reduced in CCR7-/-
mice and in mice pre-treated with FTY720. Thus, we have identified
that a proportion of DCs migrate from the PP to the MLN by a
CCR7 and S1P dependent mechanism. These findings open new
avenues for controlling the functions of intestinal DCs, and there-
fore manipulating the intestinal immune response, with exquisite
precision.
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The effect of oral Salmonella Typhimurium infection on
intestinal mononuclear phagocytes
L. Utriainen1, V. Cerovic1, S.A. Houston1, D.M. Wall1,
M.J. Wick2 & S. W.F. Milling1
1Institute of Infection, Immunity and Inflammation, University of
Glasgow, Glasgow, UK, 2Department of Microbiology and Immunology,
University of Gothenburg, Gothenburg, Sweden
Recent literature contains contradictory data regarding the functions,
and even the identification of the antigen presenting cells (APCs) in
the intestine that induce responses after infection with Salmonella ty-
phimurium (STM). We have developed tools to unambiguously
identify intestinal CD11c+ APC populations, and have begun to
examine the changes in dendritic cells (DCs) and macrophages that
occur after oral infection of antibiotic-treated mice with STM.
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To investigate intestinal phagocytes, WT C57BL/6 or CX3CR1+/GFP
mice were treated with an antibiotic cocktail for 14 days, rested for
48 hours and infected orally with DinvG strain of STM. Mononu-
clear phagocyte populations in the small intestinal lamina propria
(LP) and mesenteric lymph nodes (MLNs) were analysed by flow
cytometry 48 h after infection with STM. For lymph analysis, the
thoracic duct of mesenteric lymphadenectomised mice was cannu-
lated 24 h after STM infection. Lymph was collected for 16 h, and
analysed by flow cytometry.
No differences were observed in the frequency or number of total
migrating CD11c+ MHCIIhi DCs in the MLNs after STM infection,
nor were there changes in the frequencies of DC subsets. However,
analysis of small intestinal LP phagocyte populations revealed small,
but significant, differences in both CD64+ macrophages as well as in
DC subsets between infected and non-infected mice. Furthermore,
significantly higher proportions of CD11c+ MHCII+ DCs were pres-
ent in lymph collected from infected animals, and within these there
was a significant increase of the CD103+ CD11b+ DC subset. Fur-
thermore, no CX3CR1hi expressing cells were detected in lymph of
STM infected animals.
In conclusion, we provide here a detailed analysis of the intestinal
phagocyte populations after STM infection. Oral infection with STM
is reported to cause specific changes in the myeloid cells that migrate
from the intestine. We have now been able to conclusively show that
oral STM infection does indeed lead to an increase in the proportion
of migrating DCs from the intestine, and to changes in the frequen-
cies of migrating DC subsets. In addition, we demonstrate that
CX3CR1hi macrophages do not migrate into lymph after STM infec-
tion.
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The effect of probiotic consumption on routine haematological
and immune markers in a cohort of healthy active adults
M.J. Lehtinen1, N.P. West2, P.L. Horn3, S. Barrett2,
H.S. Warren4, G. Koerbin5, M. Brun5, D.B. Pyne6,
S.J. Lahtinen1, P.A. Fricker3 & A.W. Cripps2
1Nutrition and Health, Sokeritehtaantie 20, Kantvik, Finland, 2Griffith
University, Australia, 3Australian Institute of Sport, Australia, 4The
Canberra Hospital, Australia, 5ACT Pathology, Australia, 6James Cook
University, Australia
In recent meta-analyses, a positive effect of probiotics against upper
respiratory tract illnesses has been noted, but the underlying immune
system changes are still mostly obscure. We have reported in a
three-arm clinical trial ((i) Bifidobacterium lactis Bl-04 (Bl-04), (ii)
Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07
(NCFM+Bi-07), or (iii) placebo) that daily consumption of Bl-04 by
healthy active adults reduces the risk of experiencing upper respira-
tory illness (URI) episodes during 5-month winter season. To study
immune system changes, pre and post supplementation blood sam-
ples were drawn from a cohort (n = 144) of the study subjects. The
samples were analyzed for electrolytes, liver and thyroid function,
leukocyte counts, plasma immune biomarkers (n = 34), tumoricidal
NK-cell activity, and phagocytic activity of granulocytes and mono-
cytes. Differences in plasma calcium (P = 0.03) and urea (P = 0.015)
were observed between the probiotic and placebo groups, however
these were within assay-specific established laboratory reference ran-
ges.The results showed that in Bl-04 group the level of plasma
chemokine MIP-1d (CCL15) increased by 29 % compared to pla-
cebo. In NCFM+Bi-07 group there was a 7.7 % increase in total
lymphocytes and 11 % increase in plasma matrix metalloproteinase
1 level. There were no changes in granulocyte, monocyte or NK-cell
activities between the study groups. In conclusion, probiotic supple-
mentation with Bl-04 or NCFM+Bi-07 is considered safe and did
not have a major effect on the biomarker profile or innate cell func-
tions in healthy active adults.
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The gut-associated lymphoid tissues in small intestine, not the
large intestine, play a critical role in oral prion disease
pathogenesis
D. Donaldson1, K. Else2 & N. Mabbott1
1The Roslin Institute, Edinburgh, UK, 2University of Manchester,
Manchester, UK
Many prion diseases, characterised by the accumulation of PrPSc, an
abnormally folded isoform of the cellular prion protein (PrPC), are
acquired orally. Following oral exposure, high levels of PrPSc accu-
mulate upon PrPC-expressing follicular dendritic cells (FDC) in gut-
associated lymphoid tissues (GALT) prior to neuroinvasion. Accu-
mulation of PrPSc in large intestinal GALT has been used diagnosti-
cally in humans and other animal species; however, the role of
GALT in large intestines in oral prion disease pathogenesis was
unknown. In order to precisely distinguish between the influence of
GALT in the small and large intestines in oral prion pathogenesis,
we created mice that were specifically deficient in FDC-containing
GALT only in the small intestine. Oral prion disease susceptibility
was blocked in the specific absence of the GALT in small intestine.
Although these mice had FDC-containing GALT throughout their
large intestines, these tissues did not accumulate prions and the mice
were refractory to infection after oral exposure. We also studied
whether pathology specifically within the large intestine might influ-
ence prion pathogenesis. Congruent infection with the nematode
parasite Trichuris muris at the time of prion exposure did not signif-
icantly affect disease pathogenesis. Together, these data definitively
demonstrate that FDC-containing GALT in the small intestine are
the critical early sites of prion accumulation and neuroinvasion after
oral exposure. In contrast, large intestinal GALT does not influence
prion pathogenesis during steady-state or inflammatory conditions.
The demonstration that GALT in the small intestine, not the large
intestine, are the important sites of prion accumulation and neuroin-
vasion has important implications for our understanding of the fac-
tors influencing the risk to infection and the pre-clinical diagnosis of
disease.
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The inhibition of IKB kinase ameliorates experimental colitis in
rats
A.R. Nogales1, F. Algieri1, J. Garrido-Mesa1, P. Utrilla1,
M. Rodrıguez-cabezas1, C. Thiemermann2 & J. Galvez1
1Pharmacology, Granada, Spain, 2Nephrology and Critical Care,
London, UK
Introduction: The transcription factor NFjB seems to play a crucial
role in the pathogenesis of IBD conditions. In this study we have
investigated the impact of IKK inhibition on TNBS experimental
colitis in rats.
Methods: Wistar rats (200 g) were assigned to five groups (n = 10):
Non colitic, control colitic and colitic groups treated intraperitone-
ally with IKK 16 (inhibitor of IKK) (0.3 and 1 mg/kg/day), and
dexamethasone (1.2 mg/kg/day), starting the same day of TNBS coli-
tis induction (10 mg). Rats were sacrificed one week after, and colo-
nic damage was assessed histologically and biochemically, by
myeloperoxidase activity (MPO). In addition, colonic qPCR analysis
was performed to evaluate the expression of pro-inflammatory cyto-
kines (TNFa, IL-1b, IL-6, IL-12, IL-17), the enzyme iNOS, chemo-
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kines (MCP-1 and CINC-1), the adhesion molecule ICAM-1, as well
as proteins involved in the preservation of intestine epithelia (muc-
ins MUC-2 and MUC-3, trefoil factor TFF-3 and villin).
Results: IKK 16 administration resulted in an intestinal anti-inflam-
matory effect as evidenced macroscopically by a reduced extension
of colonic damage in comparison with control colitic rats. Biochemi-
cally, a decrease in colonic MPO activity was observed, indicating a
lower neutrophil infiltration in the inflamed tissue. qPCR evaluation
of cytokines expression showed that IKK 16 treatment decreased
colonic expression of the proinflammatory cytokines TNFa, IL-1b,
IL-6, IL-12 and IL-17. In addition, the IKK inhibitor reduced the
expression of the chemokines CINC-1 and MCP-1, the inducible
enzyme iNOS, and the adhesion molecule ICAM-1. In addition, this
compound significantly up-regulated the expression of markers of
intestine epithelial integrity. These effects were similar to those
obtained with dexamethasone.
Discussion and Conclusion: The inhibition of NFjB signalling path-
way by the IKK inhibitor IKK 16 results in beneficial effects in TNBS
rat colitis through an improvement of the exacerbated immune
response that characterizes the colonic inflammatory process.
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The intestinal mucus phenotype in Clca3 deficient mice
E. Nystro¨m, L. Arike, G. Hansson & M.E.V. Johansson
Medicinal biochemistry, Medicinaregatan 9A, G€oteborg, Sweden
The intestinal mucus has been shown to be important for innate
immunity by keeping bacteria at a distance. The MUC2 protein is
the main component in the mucus, giving the mucus its features
and network-like structure. Proteomics has also revealed Clca3 (chlo-
ride channel, calcium activated 3) as one of the most abundant non-
mucin proteins found in the intestinal mucus. Clca3 was first pro-
posed to be a calcium regulated chloride channel but is today con-
sidered to be fully secreted. Despite extensive research the function
of Clca3 in the mucus is still obscure.
The domain architecture which includes a metallohydrolase
domain followed by a von Willebrand factor type A domain suggests
both protease activity and potential binding to other proteins. The
abundance of Clca3 in mucus together with the domain architecture
has led to the hypothesis that Clca3 has an important and structural
role in the intestinal mucus.
We have examined the mucus phenotype in Clca3 deficient mice
to test our hypothesis. MUC2 expression and distribution has been
investigated by immunohistochemistry which has also allowed exam-
ination of the mucus structure. Further, the mucus layer thickness,
growth, tissue attachment and responsiveness to stimulation were
examined in an Ussing chamber-like ex vivo explant system. The
barrier function of the mucus against bacteria was assessed by an ex
vivo penetrability assay in parallel with fluorescent in situ hybridiza-
tion of Carnoy-fixed tissue sections. In addition, a proteomic com-
parison between wild-type and Clca3-/- mucus was performed to
look at differences in other major mucus components.
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The liver: An underestimated effector site of the intestinal IgA
response?
L. Moro-Sibilot1, P. Blanc1, A. Sanlaville1, J. Gaillard1,
M. Chevandier1, E. Bardel1, A. Traverse-Glehen2, T. Defrance1,
D. Kaiserlian1 & B. Dubois3
1International Center for Infectiology Research, 21, avenue Tony
Garnier, Lyon, France, 2Pathological Anatomy and Cytology Unit,
HCL, CHLS - 165 chemin du grand Revoyet, Pierre-Benite, France,
3Tumor Cells and their Immune Environment, Cancer Research Center
Lyon, 28 rue Laennec, Lyon, France
IgA, the most abundant immunoglobulin of the body, maintains
host-microbiota homeostasis and protection against infectious
microbes, without inducing overt tissue inflammation. IgA isotype
switching and B cell differentiation into plasma cells [PC] are mainly
initiated in mucosal-associated lymphoid tissues [MALT] and
involve a range of cells and factors involved in oral tolerance. Capi-
talizing on our recent demonstration that the liver is a critical induc-
tive site of T cell tolerance to intestinal antigens [Ag] (drained to
the liver via the portal vein), and is enriched in tolerogenic dendritic
cells which favor IgA responses, we explored the role of the liver in
the IgA response at steady state and after oral immunization.
Mouse liver at steady state contains around 20% of B cells,
including a majority of IgD+ follicular B2 cells, few B1 cells, and is
enriched in IgA PC (75% of liver PC), compared to the bone mar-
row, mesenteric LN, spleen and blood. In addition, we found that
human liver contains around 5% of CD19+ cells, mostly represented
by PC, half of which producing IgA. These IgA PC are localized in
the hepatic parenchyma close to portal tracts.
Oral immunization with the T-cell-independent Ag NP-Ficoll and
cholera toxin as adjuvant generated specific IgA producing cells in
the liver and intestinal lamina propria, suggesting that the liver
might constitute an alternative site of the IgA response. Using a
transfer model of NP-specific transgenic B cells from Quasi Mono-
clonal mice, we found that oral immunization with NP-Ficoll
induced IgA-expressing B cells initially in Peyer’s patches, and later
IgA+CD19lowCD138+ cells in the liver, indicating that IgA isotype
switching in MALT was rapidly followed by homing of IgA plasma-
blasts/PC to the liver. In this respect, a unique phenotype in term of
i) proliferative state, ii) expression of B cell and PC markers, and iii)
homing molecules (chemokine receptors CXCR-4, CCR-9, CCR-10,
integrin a4b7) was observed on liver IgA PC at homeostasis. Taken
together, these data indicate that the liver constitutes an early site of
homing of IgA PC primed in the intestine.
We propose that both in mice and human, the liver may be an
underestimated effector site for the mucosal IgA response, which
may maintain local homeostasis and fuel the duodenum with IgA
translocating via the bile.
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The mucosal environment influences the systemic inflammation
observed in Spondyloarthropathy patients
P.B. Wright1, H.M. Wessel1, A. McEntegart2, D. McCarey2,
D. Gaya2 & S. W.F. Milling1
1Institute of Infection, Immunity and Inflammation, University of
Glasgow, UK, 2Department of Rheumatology, Glasgow Royal Infirmary,
UK
Ankylosing Spondylitis (AS) is a chronic systemic inflammatory dis-
ease belonging to the spondyloarthropathy (SpA) group of geneti-
cally and pathophysiologically related diseases. Alongside
inflammation within the vertebral column and sacroiliac joints, AS
patients often develop extra-articular disease manifestations, includ-
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ing inflammatory bowel disease (IBD). Specifically, approximately
10% of AS patients develop overt IBD whilst 60–70% of AS patients
show evidence of subclinical intestinal inflammation. Dendritic cells
(DCs) activate na€ıve T cells and maintain the balance between
immunity and tolerance, and may therefore contribute to controlling
inflammation in AS. To understand the contribution of DCs to AS,
it is important to establish their role in driving systemic and tissue-
localised inflammatory responses in patients. We therefore character-
ised circulating and intestinal DC populations, to elucidate the
unique and shared immunological pathways driving these intercon-
nected diseases.
Compared to age-matched HCs, blood from AS patients con-
tained a significantly higher ratio of pro-inflammatory (CD16+
CD14 CD11c+) mononuclear cells compared to CD1c+ DCs. This
CD16+ population induced CCR6 expression on responding na€ıve T
cells and promoted secretion of the Th17-associated cytokines IL-1b
and IL-6. Interestingly, the frequency of circulating CCR9+ CD4+ T
cells in AS patients increased with inflammation, indicating potential
mucosal involvement. We have now developed robust methods for
purification of live cells from fresh intestinal tissue, allowing enu-
meration and functional analyses of intestinal myeloid populations.
Initial analyses of intestinal DC subsets (CD45+ CD14 CD64
CD11c+ MHC II+ CD103+/-) in health and disease have been per-
formed.
In summary, we have identified a shift in circulating myeloid
populations towards the CCR6-inducing CD16+ population that may
contribute to the induction of T cell-mediated AS pathogenesis. Fur-
thermore, our data implicate mucosal DCs in driving systemic
inflammation in AS patients. Our analyses of live cells prepared from
fresh intestinal tissue enable precise examination of the disease-
inducing tissue resident effector populations. We anticipate that
comparisons of these immune cell populations in AS and IBD
patients with healthy controls will reveal important details about
pathogenic mechanisms controlling disease development.
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The neoantigen KLH induces antigen-specific regulatory T cells
in humans
B. Boortz1, T. Meyer1, J. Maul1, J. Preiß1, T. D€orner2 & R. Ullrich1
1Gastroenterologie, Hindenburgdamm 30, Berlin, Germany,
2Rheumatologie
Oral tolerance can prevent and treat autoimmunity in animal mod-
els, but its efficacy in humans is unclear. We use the neoantigen key-
hole limpet hemocyanin (KLH) to healthy volunteers to investigate
antigen-specific tolerance. Foxp3(+) CD4(+) CD25(+) regulatory T
cells (Treg) are known for their suppressive function. Here we report
our investigations about the systemic Treg population. Two groups
of eight healthy volunteers each were compared. One group received
50 mg KLH per day orally for ten days, the other did not and served
as control. Both groups were then subcutaneously immunized with
KLH and a DTH skin reaction was provoked by an intradermal
KLH injection. Follow-up investigations were done six months later.
At selected time points, PBMC were isolated and samples were stim-
ulated for 16 hours by anti-CD28, by anti-CD28 in combination
with KLH, and by staphylococcal enterotoxin B (SEB). Afterwards
the samples were stained for CD4, Foxp3, CD25, CD127, CD45RA,
CD137, CD154, CD14, CD19, and analyzed by flow cytometry.
The study is ongoing and three subjects were analyzed so far.
Comparing cells stimulated by anti-CD28 combined with KLH and
anti-CD28 alone, KLH-specific Treg were identified as the Foxp3(+)
CD4(+) CD25(+) population after the exclusion of CD14(+) CD19
(+) L/D aqua(+) cells. Treg were seen only after parenteral immuni-
zation but not after oral antigen alone. Treg appeared ten days after
parenteral immunization and were detectable for at least two weeks
with at most 1.5 % KLH-specific Treg per CD4(+) T cells. At fol-
low-up after six months no KLH-specific Treg were found but these
reappeared quickly three days after reimmunization; similar kinetics
were found in the CD4(+) CD127(-), the CD4(+) CD137(+) CD154
(-) and the CD4(+) CD45RA(-) Foxp3(+) populations. Ten days
after initial parenteral immunization with the neoantigen KLH anti-
gen-specific Treg can be detected in the peripheral blood. As
expected for a secondary immune response Treg reappear quickly
after reimmunization at follow-up. The effect of oral KLH on anti-
gen-specific Treg induction remains to be analyzed.
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The novel oral vaccine delivery technology SmPill significantly
increases vaccine-specific intestinal antibody responses
S. Longet1, C. Davitt1, E. McNeela1, V. Aversa2, J. Tobias3,
M. Lebens3, M. Rosa2, J. Holmgren3, I. Coulter2 & E.C. Lavelle1
1Trinity College Dublin, Dublin, Ireland, 2Dublin City University,
Dublin, Ireland, 3University of Gothenburg, Gothenburg, Sweden
Enteric infections are a major worldwide health problem causing
high levels of mortality and morbidity especially in developing coun-
tries. Oral vaccination is regarded as the optimal means to fight
intestinal infections as it elicits immune responses at intestinal and
systemic levels. However, one of challenges of oral vaccination is the
degradation of active components by stomach acids and enzymes.
This challenge can be overcome by the use of a novel technology
named Single Multiple Pill (SmPill). SmPill comprises 1-mm
microspheres allowing encapsulation of active components. A unique
coating surrounds the core of the microspheres protecting the pay-
load from destruction at low pH and allows its specific release at
higher pH in the small intestine. A formalin-killed whole cell entero-
toxigenic Escherichia coli (ETEC) candidate vaccine and the effective
oral adjuvant a-Galactosylceramide have been enclosed inside the
microspheres. Microscopy studies clearly demonstrated aggregates of
bacteria inside the microspheres. In addition, simulated intestinal
fluid (pH 6.8) was shown to induce the disorganization of the inter-
nal structure of microspheres as well as the release of bacteria.
Finally, we assessed that SmPill significantly increased the ability of
the ETEC vaccine to rapidly generate high titres of vaccine-specific
intestinal IgA and IgG in mice. Intestinal T and dendritic cell
responses as well as the underlying mechanisms of intestinal B cell
responses leading to enhanced antibody responses are currently being
analysed. In summary, these data highlight the potential that
SmPill technology has to enhance the effectiveness of oral vaccine
delivery.
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The phagocyte oxidase in infection: A gut perspective
G. Pircalabioru1, M. Kubica1, G. Aviello2, B. Bourke2 &
U.G. Knaus1
1Conway Institute, University College Dublin, Belfield, Dublin 4,
Dublin, Ireland, 2National Children’s Research Centre, Our Lady’s
Children’s Hospital, Crumlin, Dublin, Ireland
Well recognized for their role in phagocyte-mediated pathogen kill-
ing, reactive oxygen species (ROS) such as O2 and H2O2 are also an
integral part of the host defense system and inflammatory responses
at mucosal surfaces. The cellular sources of pathogen-triggered ROS
generation are predominantly NADPH oxidases. The best character-
ized member of the NADPH oxidase family is the phagocyte
NADPH oxidase (Nox2 complex). Its critical role in host defense is
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highlighted by the life-threatening recurrent fungal and bacterial
infections observed in patients with chronic granulomatous disease
(CGD), a genetic disorder in which Nox2 function is defective due
to mutations in its essential subunits. We used Nox2 knockout (KO)
mice for investigating the interplay between inflammation, anti-bac-
terial immunity and microbiota afterCitrobacter rodentium infection.
Infection with upregulated expression of Nox1 and Duox2, the main
oxidases expressed in the intestinal barrier, in a similar manner in
both wild type (WT) and KO mice. However, loss of Nox2 activity
and consequently of ROS generation increased the overall pathology
after oral challenge with C. rodentium. Nox2-deficient mice showed
increased pathogen colonization followed by pronounced mucosal
and submucosal colon damage. Changes in the microbiota composi-
tion affect the physiology and homeostasis of the host GI tract.
Although C. rodentium infection changed the microbiota complexity
in WT and KO mice, the shift was more pronounced in Nox2 KO
mice with a significant increase of the Bacteroidetesphyla. Loss of
Nox2-derived ROS caused overgrowth of Enterobacteriaceae, a family
of bacteria previously linked to host gut inflammation. Long term
antibiotic treatment induces dysbiosis and susceptibility to infection
and colitis. Our results reveal that dysbiotic Nox2 KO mice infected
with C. rodentium exhibited poor survival despite enhanced Nox1
and Duox2 levels. Even though pathogen colonization of the GI tract
was similar to dysbiotic WT mice, Nox2 KO mice showed bacterial
translocation to liver, spleen and cardiac blood. These findings sug-
gest a role of phagocyte-derived ROS in limiting bacterial dissemina-
tion and systemic disease in the absence of microbiota-mediated
protection.
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The role of dendritic cells in inducing Th2 responses to
schistosoma mansoni eggs
J. Mayer1, L. Webb2, S. Houston1, V. Cerovic1, A. MacDonald2 &
S. Milling1
1Institute of Infection, Immunity and Inflammation, 120 University
Place, Glasgow, UK, 2MCCIR University of Manchester, 46 Grafton
Street, Manchester
Schistosoma mansoni eggs (SME), which are the main cause of
chronic Schistosomiasis, provoke a strong Th2 immune response
that can lead to granulomatous reactions and fibrosis in affected
organs. Recently, CD11c depletion has been shown to severely dis-
rupt Th2 immune responses against Schistosoma mansoni, suggest-
ing that antigen presenting cells, which express CD11c, mediate this
immune response. Dendritic cells (DCs) are the most likely CD11c-
positive candidates, as they continuously migrate from epithelia, car-
rying antigens, to the draining lymph nodes where they activate
naive T-cells. However, the precise roles of DCs in inducing immune
responses against SME have not been studied.
We have developed an in vivo mouse model to inject SME in the
subserosal layer of the small intestine of C57BL/6 mice, the anatomi-
cal location where SME naturally become lodged. This provokes a
Th2 response in the draining mesenteric lymph nodes (MLNs). To
test the role of DCs in this response, we will purify migrating DCs
from egg challenged mice and control animals and then transfer
these cells into the subcapsular region of the MLN of naive mice.
Detection of an antigen-specific Th2 response in those mice will
indicate that migratory DCs are sufficient to carry and present egg
antigens and drive Th2 responses in our model.
This knowledge will contribute to a better understanding of how
the early immune response against SME is mediated. This informa-
tion can be applied to battle chronic Schistosomiasis and may help
understand Th2 driven responses against other parasites or Th2
allergic responses.
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The role of follicular dendritic cells in CTA1-DD mediated
germinal centre formation
S. Schussek, J. Mattsson, K. Sch€on & N. Lycke
Biomedicine, Gothenburg, Sweden
In the germinal centre (GC), follicular dendritic cells (FDC) provide
a depot of antigen and support the survival of antigen-specific B
cells, which can then be induced to differentiate into high-affinity B
cell clones, long-lived plasma cells or memory B cells by follicular T
helper cells (Tfh). Specific targeting of adjuvants and vaccines to cell
populations critical for the induction and augmentation of GC
responses could greatly improve vaccine safety and enhance vaccine
efficacy. A derivative of cholera toxin, the CTA1-DD adjuvant was
exceptionally effective at promoting the formation of large and
numerous GC, as well as enhanced antibody responses and memory
B cells development. We previously explored the in vivo distribution
of CTA1-DD in tissues and observed that CTA1-DD- mediated acti-
vation of complement and binding to follicular dendritic cells via
complement receptor 2 was crucial for adjuvant-induced GC forma-
tion and antibody production. On-going analysis of gene-expression
levels in FDCs following CTA1-DD immunisation suggests a direct
effect of the adjuvant on FDC functionality and their capacity to
promote GC formation. In order to isolate and track FDCs more
easily, we have created a mouse model expressing the GFP marker
gene under the CD21 promotor. Using this model, we are assessing
the activation status and localisation of FDCs and Tfh in response to
CTA1-DD, which will delineate the key elements required for the
adjuvant’s effects and potentially identify key regulators of GC B cell
activation, memory development and vaccine-induced protection.
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The viability of lactobacillus fermentum CECT5716 is not
required to exert its intestinal anti-inflammatory activity
T. Vezza1, A. Rodrıguez1, F. Algieri1, N. Garrido1, A. Zarzuelo1,
M. Olivares2, M. Comalada3, M.E. Rodrıguez1 & J. Galvez1
1Pharmacology, Granada, Spain, 2Research Department of Biosearch,
Granada, Spain, 3Institute for Research in Biomedicine, Barcelona,
Spain
Introduction: Lactobacillus fermentum CECT5716 is a probiotic
with immunomodulatory properties that has been reported to show
intestine anti-inflammatory activity in experimental colitis. Some
studies have proposed that the viability of the probiotics is not
essential to exert their beneficial effects. In the present study, we
studied if the administration of viable Lactobacillus fermentum is
necessary to obtain its intestine anti-inflammatory effect. Also, in vi-
tro studies were performed to confirm these observations.
Methods: Lactobacillus fermentum CECT5716 was administered
orally (5 x 108 CFU/rat/day) to Wistar rats, live or dead (95C for
30 min) for two weeks before colitis induction, and thereafter until
colonic evaluation one week later, both macroscopically and bio-
chemically: myeloperoxidase activity, glutathione content, TNFa and
IL1b levels, as well as iNOS expression. In vitro experiments were
performed in Caco-2 (intestine epithelium) and RAW 264.7 (macro-
phages) cells, which were incubated with the probiotic (live or
death) (108 CFU/ml), and stimulated with LPS (100 ng/ml) or IL-
1b (1 ng/ml) for 30 minutes (western blot) or 24 h (IL-8 or nitrite
determination).
Results: The probiotic, live or dead, showed intestine anti-inflamma-
tory effect, by reducing the colonic damage area. Biochemically,
reduction in MPO activity, indicating lower neutrophil infiltration,
and increase in glutathione content was observed in treated groups.
Also, both treatments reduced the levels of the proinflammatory
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cytokines TNFa and IL1b, and inhibited the increased iNOS expres-
sion in colitic rats. In vitro studies showed that live or dead probiot-
ic inhibited the stimulated production of IL-8 (Caco-2 cells) and
nitric oxide (RAW 264.7) in a similar way. In the epithelial cells, this
inhibitory effect was associated with a reduced phosphorylation of
p42/44 ERK and SAPK/JNK when compared with stimulated cells
without probiotic.
Discussion and Conclusion: The viability of L. fermentum
CECT5716 to downregulate the stimulated immune response and
exert its intestine anti-inflammatory effect is not essential.
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TLO Developmental Program: Divergent paradigm of lymphoid
organogenesis
S. Nayar1, J. Campos1, B. Glaysher2, J.H. Caamano1,
D.R. Withers1, K.M. Toellner1, S. Luther3, T.D. Randall4,
M. Coles2, C.D. Buckley1 & F. Barone1
1Immunity and Infection, University of Birmingham, Birmingham UK,
2Centre of Immunity and Infection, University of York, UK,
3Department of Biochemistry, University of Lausanne, Switzerland,
4Division of Clinical Immunology, UAB, USA
Tertiary lymphoid organs (TLOs) represent the histological hallmark
of many immune-mediated inflammatory diseases. TLOs are charac-
terized by a functional leukocyte aggregation and network of lym-
phoid-like stromal cells (LLSc). LLSc express lymphoid chemokines
(CXCL13, CCL19, and CCL21), survival factors (BAFF and IL-7),
lymphoid markers and adhesion molecules (gp38, RANKL, ICAM-1
and VCAM-1) that locally support lymphocytes survival and organi-
zation in ectopic sites areas. Using a combination of inducible mod-
els of TLO formation we demonstrated that the acquisition of this
lymphoid phenotype by the non-activated resident stroma requires a
multistep process, fundamentally different from that responsible of
secondary lymphoid organ formation. We showed that early, during
TLO formation, IL-4Ra engagement via IL-13 on quiescent tissue-
resident fibroblasts induces LLSc priming and mediates the up-regu-
lation of gp38 and lymphoid-associated adhesion molecules. Expan-
sion of this activated lymphoid stroma requires IL-22/IL-22R
mediated signaling. Lack of IL-22 or its receptor induces defective
LLS proliferation, abrogation of CXCL13 expression and TLO invo-
lution. Finally we demonstrated that, similarly to secondary lym-
phoid organ, stabilization of the stroma to a functional lymphoid
phenotype requires lymphocyte infiltration and lymphotoxin beta
expression. This work highlights critical differences between the
embryonic program responsible for SLO formation and the inflam-
matory development of TLOs and unveils novel potential targets for
TLO targeting.
098
TLR2 located in subcellular compartments negatively regulates
TLR4-mediated inflammatory response of macrophages to
internalized bacteria
L. Butto1, S. Melgar1, J. O’Callaghan2, I. Jeffery1, H. Harris2,
J. MacSharry1, F. Shanahan1, P. O’Toole1 & K. Nally1
1Alimentary Pharmabiotic Centre, Cork city, Ireland, 2University
College Cork, Cork city, Ireland
Recognition of microbes by toll-like receptors (TLRs) is critical for
initiation of appropriate innate and adaptive immune responses.
How cross-talk between TLRs situated in various cellular locations
contributes to host-microbe dialogue and immunoregulation is pres-
ently unclear. Here we report a dual role for TLR2 in regulating the
response of macrophages to internalized bacteria. Cell surface TLR2
initiated an inflammatory response while subcellular TLR2 negatively
regulated a TLR4-mediated hyper-inflammatory response that was
phagocytosis-dependent and driven by a type I interferon autocrine
loop. TLR2-deficient macrophages were hyper-responsive to bacteria
and developed an M1-like phenotype, which was absent in TLR2/
TLR4-deficient macrophages. Our findings identify subcellular TLR2
as being important for the negative regulation of inappropriate
TLR4-mediated inflammatory responses to bacteria.
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TRPV1 expression in spleenocytes of different mouse strains
could be critical in understanding variations in immune
responses
M. Bakri1, M. Jaleel2 & P. Joanne3
1King Abul Aziz University, Saudi Arabia, 2University of Manchester,
United Kingdom, 3Univeristy of Manchester, United Kingdom
Objectives: This study discusses for the first time TRPV1 expression,
functionality and subsequent release of CGRP from immune cells in
the spleens of AKR, BALB/c and C57.
Material and Methods: TRPV1 expression on spleenocytes: Spleen
cells were disassociated and stained with different dilutions of 6
flourochromes. conjugated antibodies for CD11c, F480, CD4, CD8,
CD19, IgM, IgD, Gr1 were then along with TRPV1 biotinylated anti-
body were administered. Calcium signaling: Indo-1 was administered
to spleenocytes at 5x105 cells/sample. samples were treated with
either capsaicin, anandamide or both at concentrations 6, 12, 25, 50,
100uM. specific cell types’ calcium signaling was examined with a
single concentration of agonists (100uM). CGRP release from
spleenocytes: 1x106 cells per sample were treated with 100uM with
capsaicin, anadamide or both. The supernatants were collected
5 minutes post treatment. The remaining cells were collected and
sonicated. both supernatants and sonicated cells were examined for
CGRP via ELISA.
Results:
1-TRPV1 is expressed on immune cells in spleen of all mouse
strains in study (AKR, BALB/c and C57)
2-BALB/c have a higher percentage of TRPV1 on CD11c+ cells,
F4/80+ cells and CD11c+F4/80+ cells
3-AKR had higher percentage of TRPV1 on IgM+ cells, IgD+ cells
and IgD+IgM+ cells.
4-C57 had significantly higher percentage of TRPV1 in CD8+
cells.
5-CGRP release appears to be impaired in AKR compared to
BALB/c post capsaicin treatment.
6-CGRP inhibited Th1 cytokines in all three strains while promot-
ing Th2.
Conclusion: This study shows for the first time TRPV1 expression
on immune cells in the spleen. Also, it discusses TRPV1 signalling
and subsequent release of CGRP. Findings are then studied in the
light of the known immune phenotypes that all three mouse strains
develop in reponse to the helminth trichuris muris (t.muris). This
study suggests that lack CGRP release in AKR is impaired compared
to BALB/c and C57 mice.
The Authors would like to Thank KAU for their support of Dr
Bakri M Assas.
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Vagus nerve modulates colonic inflammation in an alpha-7
nicotinic receptor (a7AChR) independent mechanism
M.D. Giovangiulio, N. Stakenborg, G. Bosmans, G. Farro,
P.J. Gomez-Pinilla, G. Matteoli & G.E. Boeckxstaens
Department Clinical and Experimental Medicine, KU Leuven, Leuven,
Belgium
To preserve intestinal immune homeostasis, our immune system has
evolved redundant regulatory strategies to prevent inappropriate
immune reactions against innocent luminal antigens. Recently, we
have shown that the parasympathetic nervous system through the
vagus nerve (VN) dampens intestinal muscular macrophages via
alpha-7 nicotinic receptor (a7AChR) in a model of postoperative
ileus. Similarly, we showed that vagotomy induces loss of oral toler-
ance by reducing the conversion of antigen-specific Tregs in the lam-
ina propria and increases the severity of colitis. However, the role of
a7nAChR and the immune cells involved in the vagal control of
colitis is still not clearly defined. To study the influence of a7nAChR
on Th cells, two groups of RAG1-/- mice were injected respectively
with na€ıve Th cells from WT or a7nAChR-/- mice. To define the
role of a7nAChR on innate immune cells, a7nAChR-RAG1 double
knockout mice were injected with WT na€ıve Th cells. In both experi-
mental approaches, recipient mice developed similar severity of coli-
tis as shown by histology score, cytokine expression and colonic Th
cells polarization. Altogether, our results suggest that a7nAChR defi-
ciency either on Th or on innate immune cells is not crucial for con-
trolling colonic inflammation. Further, studies will be required to
define if other nicotinic receptors or other neurotransmitters are
responsible for the vagal anti-inflammatory effect in the colon.
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Visualizing macromolecule passage through epithelia
J.F. Richter1, R. Schmauder2, A. Gebert1 & M. Schumann3
1Department of Anatomy II, University Hospital Jena, Jena, Germany,
2Department of Physiology II, University Hospital Jena, Kollegiengasse
9, Jena, Germany, 3Department of Gastroenterology, Charite University
Medi, Hindenburgdamm 30, Berlin, Germany
Introduction: Epithelial layers are the body´s interfaces between
internal and external compartments. As physical barriers to poten-
tially antigenic macromolecules epithelia prevent uncontrolled access
to immune competent compartments. The current discussion about
disease initiation in IBD focusses on mucosal barrier function, since
loss of barrier function appears to trigger an untempered immune
reaction to the commensal intestinal flora. Progress in understanding
such barrier defects is largely hampered by a lack of methods that
can locally resolve passage sites of macromolecules. To date, epithe-
lial macromolecule passage is analyzed using global measurements
such as tracer flux studies which average contributions from many
cells. As these global measurements do not locally resolve barrier
defects, leak property distribution cannot be analyzed and rare
events may be missed. Therefore, local identification of barrier
breaks is interesting and needed.
Aims: To localize and characterize macromolecule passage sites in
epithelia.
Methods: Using MDCKII, Caco-2/BBe, HT-29/B6 epithelia and rat
colonic mucosae we applied fluorescent dextran tracers of various
sizes which bind to cell-adherent scavenger molecules at the basolat-
eral membranes of single-layered epithelial sheets in vitro and ex
vivo. Tracer molecule binding was analyzed using fluorescence
microscopy.
Results: When administered from the apical side, only dextrans that
passed the epithelial barrier bind to the scavenger and hence label
sites of increased permeability to macromolecules at a resolution in
the µm-range. Using standard epithelial two-compartment culture
systems spontaneous macromolecule passage was detected in all cell
lines analyzed. Passage was generally rare, occurred through big leaks
very inhomogeneous in distribution and magnitude and was reduced
with increased culture duration. The basolateral label increased when
barrier function was disrupted with EGTA or TNFalpha, and corre-
lated well with a corresponding global flux measurement.
Conclusion: We propose a new imaging approach that allows for
local analysis of macromolecule passage which provides new insights
in immunologically relevant leaks in epithelial barriers in health and
disease.
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Vitamin-D status and its regulation of cd T-cells in Behcet’s
disease
M.D. Samiul Hasan, L.A. Bergmeier & F. Fortune
Institute of Dentistry, Queen Mary University, 4, Newark street,
London, UK
Background: Behcet’s disease (BD) is a multisystem inflammatory
disorder characterized by oro-genital ulcerations, ocular manifesta-
tions, arthritis, vasculitis etc. with episodes of exacerbations and
remissions. BD is often regarded as at the crossroad between autoim-
munity and auto-inflammation however, the pathogenesis remains
inconclusive. Besides genetic predisposition, immune-dysregulation
involving cytotoxic lymphocytes such as cd T-cells is reported to
have a role. Vc9Vd2, a major subset of these atypical T-cells are
present in the inflammatory lesion and lead to rapid cytokine pro-
duction, particularly of Th1-type when exposed to bacterial phosp-
hoantigens and thus might be responsible for inducing and/or
maintaining the pro-inflammatory environment characteristic of the
disease. Vitamin-D (Vit-D) has regulatory properties for immune
system function and has been implicated as a protective factor in
some diseases but to date, no studies have addressed the effect of
Vit-D on cd T-cells in BD.
Materials and Methods: Serum 25-hydroxyvitamin-D levels of BD
patients were measured. Vc9Vd2 T-cells from BD patients were pre-
treated with Vit-D, followed by stimulation with the phosphoanti-
gen, HDMAPP. Antigen induction of IFNc, TNFa and IL10 expres-
sion was measured using flow cytometry and ELISA.
Results: 80% of BD patients are deficient in serum 25-hydroxyvita-
min-D levels. In-vitro treatment with Vit-D significantly reduced
IFNc (P = 0.002) and TNFa (P = 0.001) expression by Vc9Vd2 T-
cells. There was no effect on IL10 production.
Discussion and Conclusion: The data indicate a role of Vit-D
in Vc9Vd2 T-cell regulation in BD. BD patients are deficient in
Vit-D suggesting that this may contribute to the prolonged inflam-
mation. Vc9Vd2 T-cell is a poor source of IL10 and there is
IL10 polymorphism in some BD patients which might explain the
IL10 data. Our data support the notion that Vit-D negatively regu-
late the proinflammatory function of cd T-cells and may be implied
as a protection against autoinflammatory and autoimmune disorders
including BD.
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